Processing 00000000.tx.1: Loss of HNF-1 Function in Mice Leads to Abnormal Expression of Genes Involved in Pancreatic Islet Development and Metabolism David Q. 

Phrase: "Loss of HNF-1 Function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1517945:Loss [Quantitative Concept]

Phrase: "in Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "Leads to Abnormal Expression of Genes"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   767   C0017262:Gene Expression [Genetic Function]
   753   C0017337:Genes [Gene or Genome]
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0181586:leads [Medical Device]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0205161:Abnormal [Qualitative Concept]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C2347472:% Abnormal [Quantitative Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C2699333:ABNORMAL [Intellectual Product]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "Involved in Pancreatic Islet Development"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0022131:Pancreatic islet [Body Part, Organ, or Organ Component]
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1314939:Involved [Functional Concept]
   760   C1527148:Development [Functional Concept]

Phrase: "and"

Phrase: "Metabolism David Q."
Processing 00000000.tx.2: Shih1, Seamus Screenan2, Karla N. 

Phrase: "Shih1,"

Phrase: "Seamus Screenan2,"

Phrase: "Karla N."
Processing 00000000.tx.3: Munoz1, Lou Philipson2, Marco Pontoglio3, Moshe Yaniv3, Kenneth S. 

Phrase: "Munoz1,"

Phrase: "Lou Philipson2,"

Phrase: "Marco Pontoglio3,"

Phrase: "Moshe Yaniv3,"

Phrase: "Kenneth S."
Processing 00000000.tx.4: Polonsky2,3, and Markus Stoffel1 1 Laboratory of Metabolic Diseases, the Rockefeller University, New York, New York 2 Department of Medicine, University of Chicago Pritzker School of Medicine, Chicago, Illinois 3 Unit des Virus Oncognes, URA CNRS 1644, Institut Pasteur, Paris, France 4 Department of Medicine, Washington University School of Medicine, St. 

Phrase: "Polonsky2,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "Markus Stoffel1 1 Laboratory of Metabolic Diseases,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1557169:METABOLIC/LABORATORY [Finding]
   748   C0022877:Laboratory [Manufactured Object,Organization]
   748   C3244292:laboratory [Functional Concept]

Phrase: "the Rockefeller University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "New York 2 Department of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704729:Department [Organization]

Phrase: "University of Chicago Pritzker School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0036375:School [Manufactured Object,Organization]

Phrase: "Chicago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008044:Chicago [Geographic Area]

Phrase: "Illinois 3 Unit des Virus Oncognes,"

Phrase: "URA CNRS 1644,"

Phrase: "Institut Pasteur,"

Phrase: "Paris,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030561:Paris [Geographic Area]
  1000   C0331677:Paris [Plant]
  1000   C1824032:PARIS [Gene or Genome]
   966 E C1824369:PARI [Gene or Genome]

Phrase: "France 4 Department of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "Washington University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.5: Louis, Missouri  ABSTRACT TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Mutations in hepatocyte nuclear factor 1 (HNF-1) lead to maturity-onset diabetes of the young type 3 as a result of impaired insulin secretory response in pancreatic -cells. 

Phrase: "Louis,"

Phrase: "Missouri  ABSTRACT TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0035171:Research Design [Research Activity]
   795   C0035168:research [Research Activity]
   795   C0242481:Research [Research Activity]
   795   C1707689:Design [Activity]
   795   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Mutations in hepatocyte nuclear factor 1 (HNF-1) lead"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "to maturity-onset diabetes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332162:Onset [Qualitative Concept]
   827   C0449989:Maturity [Qualitative Concept]
   827   C0700597:Maturity [Temporal Concept]
   755 E C0205286:Mature [Temporal Concept]

Phrase: "of the young type 3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0441731:Type 3 [Classification]
   827   C0332239:Young [Temporal Concept]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "as a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "of impaired insulin secretory response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]

Phrase: "in pancreatic -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.6: The expression of 50 genes essential for normal -cell function was studied to better define the molecular mechanism underlying the insulin secretion defect in Hnf-1-/- mice. 

Phrase: "The expression of 50 genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0017262:Gene Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "essential for normal -cell function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205224:Essential [Qualitative Concept]

Phrase: "was"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "to better"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0332272:Better [Qualitative Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205170:Well [Qualitative Concept]
   827 E C3146287:Well [Manufactured Object]

Phrase: "define"

Phrase: "the molecular mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "underlying"

Phrase: "the insulin secretion defect in Hnf-1-/- mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1457869:Defect [Functional Concept]
   744   C1861101:DEFECT [Disease or Syndrome]
Processing 00000000.tx.7: We found decreased steady-state mRNA levels of genes encoding glucose transporter 2 (Glut2), neutral and basic amino acid transporter, liver pyruvate kinase (L-Pk), and insulin in Hnf-1-/- mice. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "decreased steady-state mRNA levels of genes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   757   C0683927:state level [Spatial Concept]
   748   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "glucose transporter 2 (Glut2),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420172:GLUCOSE TRANSPORTER 2 [Gene or Genome]
   901   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "neutral and basic amino acid transporter,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   919   C1420122:NEUTRAL AMINO ACID TRANSPORTER [Gene or Genome]
   885   C0301715:Neutral amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1882074:Neutral [Qualitative Concept]
   799   C2825492:Neutral [Phenomenon or Process]

Phrase: "liver pyruvate kinase (L-Pk),"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034348:Pyruvate Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0034354:pyruvate [Organic Chemical]
   827   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "insulin in Hnf-1-/- mice."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.8: In addition, we determined that the expression of several islet-enriched transcription factors, including Pdx-1, Hnf-4, and Neuro-D1/Beta-2, was reduced in Hnf-1-/- mice. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "determined"

Phrase: "that"

Phrase: "the expression of several islet-enriched transcription factors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Pdx-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "Hnf-4,"

Phrase: "and"

Phrase: "Neuro-D1/Beta-2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C1416886:D1 [Gene or Genome]
   812   C2004068:Beta [Qualitative Concept]

Phrase: "was"

Phrase: "reduced in Hnf-1-/- mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0392756:Reduced [Qualitative Concept]
Processing 00000000.tx.9: These changes in pancreatic islet mRNA levels were already apparent in newborn animals, suggesting that loss of Hnf-1 function rather than chronic hyperglycemia is the primary cause of the altered gene expression. 

Phrase: "These changes in pancreatic islet mRNA levels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   714 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "already apparent in newborn animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0750489:apparent [Idea or Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that loss of Hnf-1 function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "rather than"

Phrase: "chronic hyperglycemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0342300:Chronic hyperglycaemia [Pathologic Function]
   861   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "is"

Phrase: "the primary cause of the altered gene expression."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0015127:cause [Functional Concept]
   744   C0205225:Primary [Qualitative Concept]
   744   C0439631:Primary [Therapeutic or Preventive Procedure]
   744   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.10: This expression profile was pancreatic isletspecific and distinct from hepatocytes, where we found normal expression of Glut2, L-Pk, and Hnf-4 in the liver of Hnf-1-/- mice. 

Phrase: "This expression profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1979963:Profile [Laboratory Procedure]
   861   C2003903:Profile [Functional Concept]

Phrase: "was"

Phrase: "pancreatic isletspecific"

Phrase: "and"

Phrase: "distinct from hepatocytes,"

Phrase: "where"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "normal expression of Glut2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "L-Pk,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034348:Pyruvate Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0034354:pyruvate [Organic Chemical]
   827   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "Hnf-4 in the liver"

Phrase: "of Hnf-1-/- mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.11: The expression of small heterodimer partner (Shp-1), an orphan receptor that can heterodimerize with Hnf-4 and inhibit its transcriptional activity, was also reduced in Hnf-1-/- islets. 

Phrase: "The expression of small heterodimer partner (Shp-1),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "an orphan receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "that"

Phrase: "can"

Phrase: "heterodimerize with Hnf-4"

Phrase: "and"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "its transcriptional activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "also"

Phrase: "reduced in Hnf-1-/- islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1416480:ISLET 1 [Gene or Genome]
   760   C0392756:Reduced [Qualitative Concept]
Processing 00000000.tx.12: We characterized a 0.58-kb Shp-1 promoter and determined that the decreased expression of Shp-1 may be indirectly mediated by a downregulation of Hnf-4. 

Phrase: "We"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "a 0.58-kb Shp-1 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "determined"

Phrase: "that"

Phrase: "the decreased expression of Shp-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "be"

Phrase: "indirectly"

Phrase: "mediated by a downregulation of Hnf-4."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0013081:Down-Regulation [Cell Function,Molecular Function]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.13: We further showed that Shp-1 can repress its own transcriptional activation by inhibiting Hnf-4 function, thereby establishing a feedback autoregulatory loop. 

Phrase: "We further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that Shp-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1334896:SMALL HETERODIMER PARTNER [Gene or Genome]
  1000   C1335142:Small Heterodimer Partner [Amino Acid, Peptide, or Protein,Receptor]
   827   C0682323:Partner [Family Group]
   827   C0700321:Small [Quantitative Concept]

Phrase: "can"

Phrase: "repress"

Phrase: "its own transcriptional activation by inhibiting Hnf-4 function,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0162493:Transcriptional Activation [Genetic Function]
   762   C1321099:Activation function [Physiologic Function]
   742   C1879547:Activation [Activity]

Phrase: "thereby"

Phrase: "establishing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establishing [Qualitative Concept]

Phrase: "a feedback autoregulatory loop."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0419518:Loop [Medical Device]
   827   C0445022:Loop [Spatial Concept]
Processing 00000000.tx.14: Our results indicate that loss of Hnf-1 function leads to altered expression of genes involved in glucose-stimulated insulin secretion, insulin synthesis, and -cell differentiation.  

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that loss of Hnf-1 function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "leads to altered expression of genes"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   767   C0017262:Gene Expression [Genetic Function]
   753   C0017337:Genes [Gene or Genome]
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0181586:leads [Medical Device]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0392747:Altered [Functional Concept]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "involved in glucose-stimulated insulin secretion,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C1256369:insulin secretion [Cell Function]
   783   C1719133:Glucose/Insulin [Quantitative Concept]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C1314939:Involved [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "insulin synthesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "and -"

Phrase: "cell differentiation."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.15: INTRODUCTION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Maturity-onset diabetes of the young (MODY) is characterized by autosomal dominant inheritance, onset of diabetes usually before 25 years of age, and deficient insulin secretory response (1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Maturity-onset diabetes of the young (MODY)"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
  1000   C2984262:Maturity onset diabetes of the young [Functional Concept]
   833   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0332162:Onset [Qualitative Concept]
   753   C0449989:Maturity [Qualitative Concept]
   753   C0700597:Maturity [Temporal Concept]

Phrase: "is"

Phrase: "characterized by autosomal dominant inheritance,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0443147:Autosomal dominant inheritance [Intellectual Product]
           Autosomal dominant
   806   C0678942:dominant inheritance [Genetic Function]
   797   C0678944:autosomal inheritance [Genetic Function]
   760   C0242538:Inheritance [Quantitative Concept]
   760   C0596142:autosomal [Cell Component]
   760   C0728826:Inheritance [Functional Concept]
   760   C1527180:Dominant [Functional Concept]
   760   C1880022:Characterized [Activity]

Phrase: "onset of diabetes usually before 25 years of age,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   770   C3274945:Year of Onset [Temporal Concept]
   742   C0332162:Onset [Qualitative Concept]

Phrase: "and"

Phrase: "deficient insulin secretory response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.16: Genetic studies have identified mutations in at least six genes associated with different forms of MODY. 

Phrase: "Genetic studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C2827447:Genetic Study [Research Activity]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "identified mutations in"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0026882:Mutations [Genetic Function]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "at least six genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "associated with different forms of MODY."
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   825   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   825   C2984262:Maturity onset diabetes of the young [Functional Concept]
   775   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   756   C0332281:Associated with [Qualitative Concept]
           Associated
   738   C0011847:Diabetes [Disease or Syndrome]
   738   C0011849:Diabetes [Disease or Syndrome]
   738   C0332162:Onset [Qualitative Concept]
   738   C0332239:Young [Temporal Concept]
   738   C0348078:forms [Qualitative Concept]
   738   C0376315:Forms [Manufactured Object]
   738   C0449989:Maturity [Qualitative Concept]
   738   C0700597:Maturity [Temporal Concept]
   738   C1705242:Different [Qualitative Concept]
   704 E C0750490:Associate [Idea or Concept]
   704 E C1522492:Form [Functional Concept]
   704 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.17: The MODY2 gene encodes the glycolytic enzyme glucokinase (GCK), and MODY subtypes 1, 3, 4, 5, and 6 are caused by mutations in transcription factors hepatocyte nuclear factor (HNF)-4, -1, PDX-1, HNF-1, and NEURO-D/BETA-2, respectively (2,3,4,5,6,7). 

Phrase: "The MODY2 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "the glycolytic enzyme glucokinase (GCK),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415014:GLUCOKINASE [Gene or Genome]

Phrase: "and"

Phrase: "MODY subtypes 1,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   909   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   909   C2984262:Maturity onset diabetes of the young [Functional Concept]
   800   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]
   744   C0332162:Onset [Qualitative Concept]
   744   C0449989:Maturity [Qualitative Concept]
   744   C0700597:Maturity [Temporal Concept]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "6"

Phrase: "are"

Phrase: "caused by mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0026882:Mutations [Genetic Function]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in transcription factors hepatocyte nuclear factor (HNF)-4, -"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   887   C1420639:TRANSCRIPTION FACTOR 4 [Gene or Genome]
   861   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0227525:Hepatocyte [Cell]
   799   C0521447:Nuclear [Spatial Concept]
   799   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "PDX-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "HNF-1,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]
   923   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0227525:Hepatocyte [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "NEURO-D/BETA-2,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0297513:NeuroD [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1417683:NEUROD [Gene or Genome]
   861   C3273872:NEUROD [Gene or Genome]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C2004068:Beta [Qualitative Concept]

Phrase: "respectively"

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.18: In addition, patients with mutations in the insulin gene itself are predisposed to impaired glucose tolerance (8). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "patients with mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030705:Patients [Patient or Disabled Group]

Phrase: "in the insulin gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1337112:Insulin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "itself"

Phrase: "are"

Phrase: "predisposed to impaired glucose tolerance"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   862   C0271650:Impaired glucose tolerance [Disease or Syndrome]
   806   C0178665:Glucose tolerance [Physiologic Function]
   760   C0013220:Tolerance [Finding]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0020963:Tolerance [Pathologic Function]
   760   C0220929:tolerance [Mental Process]
   760   C0221099:Impaired [Functional Concept]
   760   C0231197:Tolerance [Physiologic Function]
   760   C0231203:Predisposed [Functional Concept]
   760   C0684336:Impaired [Pathologic Function]
   760   C1704410:Tolerance [Qualitative Concept]
   704 E C0680282:toleration [Social Behavior]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.19: There is increasing evidence suggesting that a transcriptional network is crucial for normal pancreatic -cell function. 

Phrase: "There"

Phrase: "is"

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a transcriptional network"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1720950:Transcriptional Network [Molecular Function]
   861   C1513822:Network [Professional or Occupational Group]
   861   C1705739:Network [Manufactured Object]
   861   C1882071:Network [Conceptual Entity]

Phrase: "is"

Phrase: "crucial for normal pancreatic -cell function."
Processing 00000000.tx.20: In vitro studies have shown that the forkhead transcription factor HNF-3 is a transcriptional activator of PDX-1, HNF-4, and HNF-1, suggesting that HNF-3 is a master regulator of this transcriptional hierarchy (9,10,11,12). 

Phrase: "In vitro studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C0681828:in vitro study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the forkhead transcription factor HNF-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C1336596:TRANSCRIPTION FACTOR 3 [Gene or Genome]
   884   C1336780:Transcription Factor 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   845   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0227525:Hepatocyte [Cell]
   795   C0521447:Nuclear [Spatial Concept]
   795   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a transcriptional activator of PDX-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1336776:Transcriptional Activator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1419349:activator 1 [Gene or Genome]

Phrase: "HNF-4,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   923   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0227525:Hepatocyte [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "HNF-1,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]
   923   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0227525:Hepatocyte [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that HNF-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0227525:Hepatocyte [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "is"

Phrase: "a master regulator of this transcriptional hierarchy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0182953:REGULATOR [Medical Device]
   748   C1704734:Regulator [Medical Device]
   748   C1704735:Regulator [Conceptual Entity]

Phrase: "(9,"

Phrase: "10,"

Phrase: "11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.21: The HNF-1 promoter contains evolutionarily conserved binding sites for transcription factors HNF-4 and HNF-3. 

Phrase: "The HNF-1 promoter"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   771   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]
   717   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "evolutionarily"

Phrase: "conserved"

Phrase: "binding sites for transcription factors HNF-4"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   767   C1149367:transcription factor binding [Genetic Function]
   764   C0005456:Binding Sites [Receptor]
   742   C0205145:Sites [Spatial Concept]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   731 E C0682969:Binding Site [Amino Acid Sequence]
   708 E C1515974:Site [Body Location or Region]
   708 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "HNF-3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0227525:Hepatocyte [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.22: The presence of these binding sites is crucial for HNF-1 activity both in vivo and in vitro (13,14,15,16). 

Phrase: "The presence of these binding sites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "crucial for HNF-1 activity"

Phrase: "both in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(13,"

Phrase: "14,"

Phrase: "15,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.23: Furthermore, Hnf-1 regulates the expression of Hnf-4 and Hnf-1 in extraembryonic visceral endoderm cells, indicating that it may also be an upstream regulator of the MODY1 and MODY3 genes in pancreatic islets (17,18). 

Phrase: "Furthermore,"

Phrase: "Hnf-1"

Phrase: "regulates"

Phrase: "the expression of Hnf-4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Hnf-1 in extraembryonic visceral endoderm cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   762   C1183500:Endoderm cell [Cell]
   748   C0007634:Cells [Cell]
   748   C0014144:Endoderm [Embryonic Structure]
   748   C0442045:Visceral [Spatial Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "it"

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "an upstream regulator of the MODY1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0182953:REGULATOR [Medical Device]
   753   C1704734:Regulator [Medical Device]
   753   C1704735:Regulator [Conceptual Entity]

Phrase: "and"

Phrase: "MODY3 genes in pancreatic islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017337:Genes [Gene or Genome]

Phrase: "(17,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.24: Less information is available on the transcriptional regulation of HNF-1 on other islet-enriched transcription factors. 

Phrase: "Less information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1533716:Information [Idea or Concept]
   789 E C3242430:informational [Idea or Concept]

Phrase: "is"

Phrase: "available on the transcriptional regulation of HNF-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0470187:Available [Functional Concept]
           Availability of

Phrase: "on other islet-enriched transcription factors."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0040649:Transcription [Genetic Function]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.25: HNF-1 is a homeodomain transcription factor composed of an NH2-terminal dimerization domain, a POU-homeobox DNA binding domain, and a COOH-terminal transactivation domain (19). 

Phrase: "HNF-1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]
   923   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0227525:Hepatocyte [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "is"

Phrase: "a homeodomain transcription factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040649:Transcription [Genetic Function]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "composed of an NH2-terminal dimerization domain,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0002508:NH2 [Organic Chemical]
   748   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   748   C0205088:Terminal [Temporal Concept]
   748   C0376525:Dimerization [Natural Phenomenon or Process]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]

Phrase: "a POU-homeobox DNA binding domain,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   897   C1518803:POU Domain [Amino Acid Sequence]
   884   C1511662:DNA Binding Domain [Amino Acid Sequence]
   840   C1148673:DNA Binding [Genetic Function]
   804   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "a COOH-terminal transactivation domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0040624:Transactivation [Genetic Function]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.26: HNF-1 is expressed in liver, kidney, intestine, and pancreatic islets (20). 

Phrase: "HNF-1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]
   923   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0227525:Hepatocyte [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "is"

Phrase: "expressed in liver,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0023884:Liver [Body Part, Organ, or Organ Component]
   790   C0736268:LIVER [Body Part, Organ, or Organ Component]
   790   C1278929:Liver [Body Part, Organ, or Organ Component]
   790   C2346688:LIVER [Food]
   734 E C0205054:Hepatic [Body Location or Region]

Phrase: "kidney,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "intestine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021853:Intestine [Body Part, Organ, or Organ Component]
  1000   C1708548:INTESTINE [Tissue]

Phrase: "and"

Phrase: "pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.27: Mice with heterozygous mutations in Hnf-1 gene are phenotypically normal. 

Phrase: "Mice with heterozygous mutations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]

Phrase: "in Hnf-1 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: "are"

Phrase: "phenotypically normal."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205307:Normal [Qualitative Concept]
   861   C0439166:% normal [Quantitative Concept]
   861   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.28: However, homozygous inactivating mutations have been shown to have type 2 diabetes, dwarfism, renal Fanconi syndrome, and hypercholesterolemia (21,22,23). 

Phrase: "However,"

Phrase: "homozygous inactivating mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "dwarfism,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013336:Dwarfism [Congenital Abnormality,Disease or Syndrome]

Phrase: "renal Fanconi syndrome,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0341703:Renal Fanconi Syndrome [Disease or Syndrome]
   901   C0015624:Fanconi Syndrome [Disease or Syndrome]
   901   C0015625:fanconi syndrome [Disease or Syndrome]
   901   C1857395:Fanconi syndrome [Disease or Syndrome]
   827   C0039082:Syndrome [Disease or Syndrome]

Phrase: "and"

Phrase: "hypercholesterolemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020443:Hypercholesterolaemia [Disease or Syndrome]
  1000   C1522133:Hypercholesterolemia [Finding]

Phrase: "(21,"

Phrase: "22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.29: Clinical studies in humans have shown that heterozygous mutations in HNF-1 are associated with impaired pancreatic -cell function that is characterized by impaired insulin secretion (24,25). 

Phrase: "Clinical studies in humans"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0008972:Clinical Studies [Research Activity]
   819   C0178693:humans studies [Research Activity]
   770   C0205210:Clinical [Qualitative Concept]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that heterozygous mutations in HNF-1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0026882:Mutations [Genetic Function]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "associated with impaired pancreatic -cell function"
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   790   C0007613:Cell Function [Cell Function]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   783   C0232786:Pancreatic function [Organ or Tissue Function]
   783   C0699040:cell associated [Cell Component]
   783   C1292719:Associated function [Functional Concept]
   753   C0007634:Cell [Cell]
   753   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   753   C0031843:function [Physiologic Function]
   753   C0221099:Impaired [Functional Concept]
   753   C0542341:Function [Functional Concept]
   753   C0684336:Impaired [Pathologic Function]
   753   C0700205:FUNCTION [Classification]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1705273:Function [Intellectual Product]
   753   C1948049:Cell [Spatial Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "that"

Phrase: "is"

Phrase: "characterized by impaired insulin secretion"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C1256369:insulin secretion [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C0221099:Impaired [Functional Concept]
   760   C0684336:Impaired [Pathologic Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1880022:Characterized [Activity]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(24,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.30: The majority of mutations in the HNF-1 gene that have been identified in individuals with MODY3 can be predicted to result in loss of function, although some mutations may exhibit a weak dominant negative activity (26). 

Phrase: "The majority of mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680220:majority [Social Behavior]

Phrase: "in the HNF-1 gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0017337:Gene [Gene or Genome]
   771   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]
   717   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "have"

Phrase: "been"

Phrase: "identified in individuals"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   756   C0027361:Individual [Population Group]
   756   C0237401:Individual [Human]

Phrase: "with MODY3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1838100:MODY3 [Disease or Syndrome]
  1000   C3273648:MODY3 [Gene or Genome]

Phrase: "can"

Phrase: "be"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "result in loss of function,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1274040:Result [Functional Concept]
   760   C1517945:Loss [Quantitative Concept]
   760   C1546471:Result [Idea or Concept]
   760   C1705273:Function [Intellectual Product]
   760   C2825142:Result [Finding]

Phrase: "although"

Phrase: "some mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "may"

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a weak dominant negative activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.31: The spectrum of mutations (missense, insertions, deletions, and splicing) also suggests that a gene dosage mechanism is responsible for the development of this autosomal dominant disorder. 

Phrase: "The spectrum of mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1883073:Spectrum [Quantitative Concept]
   770   C2827424:Spectrum [Conceptual Entity]

Phrase: "(missense,"

Phrase: "insertions,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441587:insertions [Health Care Activity]
   966 E C0021107:Insertion [Therapeutic or Preventive Procedure]
   966 E C1512796:Insertion [Genetic Function]
   966 E C1883719:Insertion [Functional Concept]

Phrase: "deletions,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1880274:Deletions [Activity]
   966 E C1442161:Deletion [Cell or Molecular Dysfunction]
   966 E C1511760:Deletion [Genetic Function]

Phrase: "and"

Phrase: "splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035687:Splicing [Genetic Function]
  1000   C2610186:splicing [Genetic Function]

Phrase: ")"

Phrase: "also"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a gene dosage mechanism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]
   734   C0178655:Gene Dosage [Quantitative Concept]

Phrase: "is"

Phrase: "responsible for the development of this autosomal dominant disorder."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1273518:Responsible [Finding]
Processing 00000000.tx.32: Decreased levels of HNF-1 are likely to result in reduced transactivation of HNF-1 target genes. 

Phrase: "Decreased levels of HNF-1"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456947:Level 1 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "result in reduced transactivation of HNF-1 target genes."
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   797   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]
   775   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   775   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1332838:Target Gene [Gene or Genome]
   738   C0017337:Genes [Gene or Genome]
   738   C0040624:Transactivation [Genetic Function]
   738   C0227525:Hepatocyte [Cell]
   738   C0392756:Reduced [Qualitative Concept]
   738   C0521447:Nuclear [Spatial Concept]
   738   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   738   C1274040:Result [Functional Concept]
   738   C1521761:Factor [Functional Concept]
   738   C1521840:Target [Functional Concept]
   738   C1546471:Result [Idea or Concept]
   738   C2825142:Result [Finding]
   738   C2827422:Factor [Conceptual Entity]
   738   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.33: Previous physiological studies using pancreatic islets from Hnf-1deficient mice showed that -cell dysfunction in these animals is likely to result from its defective glycolytic signaling proximal to mitochondrial oxidation (27,28). 

Phrase: "Previous physiological studies"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   827   C0205463:Physiological [Functional Concept]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   755 E C0031842:Physiology [Biomedical Occupation or Discipline]
   755 E C0031843:physiology [Physiologic Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "pancreatic islets from Hnf-1deficient mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   767   C1522528:Mouse Islets [Tissue]
   753   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that -cell dysfunction in these animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031847:dysfunction [Functional Concept]
   753   C0277785:Dysfunction, NOS [Qualitative Concept]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "result from its defective glycolytic signaling"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0037083:Signaling [Cell Function]
   753   C0332452:Defective [Functional Concept]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]
   753   C3537152:signaling [Biologic Function]

Phrase: "proximal to mitochondrial oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205107:Proximal [Spatial Concept]

Phrase: "(27,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.34: This conclusion is based on the following findings: 1) insulin secretion and intracellular calcium responses to glucose and glyceraldehyde are reduced; 

Phrase: "This conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "is"

Phrase: "based on the following findings"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C2607943:findings [Functional Concept]
   760   C2926606:Findings [Clinical Attribute]
   760   C3539655:Findings [Intellectual Product]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0037088:Finding [Sign or Symptom]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C0243095:Finding [Finding]
   726   C0332283:follow [Temporal Concept]
   726   C1719822:Follow [Intellectual Product]
   726 E C1880279:Base [Biomedical or Dental Material]
   726 E C2825141:Finding [Finding]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "intracellular calcium responses to glucose"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "glyceraldehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017854:Glyceraldehyde [Carbohydrate]

Phrase: "are"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.35: 2) glucose flux through glycolysis and the generation of ATP and NADH are decreased; 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "glucose flux through glycolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348693:Flux [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "the generation of ATP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079411:Generation [Temporal Concept]
   770   C3146294:Generation [Activity]

Phrase: "and"

Phrase: "NADH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027289:NADH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "are"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.36: 3) ATP-sensitive K+-currents (KATP) in -cells from Hnf-1-/- mice are not suppressed by glucose but normally sensitive to ATP; 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "ATP-sensitive K+-currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0521116:currents [Temporal Concept]
   779 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "(KATP"

Phrase: ")"

Phrase: "in -cells from Hnf-1-/- mice"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "suppressed by glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C1260953:Suppressed [Functional Concept]

Phrase: "but"

Phrase: "normally sensitive to ATP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332324:Sensitive to [Functional Concept]
           Sensitive
   770   C1550474:sensitive [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.37: and 4) mitochondrial substrates can suppress KATP and correct the insulin secretion defect of Hnf-1-/- islets. 

Phrase: "and"

Phrase: "4"

Phrase: ")"

Phrase: "mitochondrial substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "can"

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "KATP"

Phrase: "and"

Phrase: "correct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349182:Correct [Qualitative Concept]

Phrase: "the insulin secretion defect of Hnf-1-/- islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1457869:Defect [Functional Concept]
   744   C1861101:DEFECT [Disease or Syndrome]
Processing 00000000.tx.38: The results are also supported by recent studies showing reduced expression of liver pyruvate kinase (L-Pk) and glucose transporter 2 (Glut2) in islets of Hnf-1-/- mice (29) and downregulation of Glut2, L-Pk, and insulin in cell lines that express a dominant negative form of HNF-1 (30). 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "also"

Phrase: "supported by recent studies"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0332185:Recent [Temporal Concept]
   770   C0947630:studies [Laboratory Procedure]
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "reduced expression of liver pyruvate kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(L-Pk"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034348:Pyruvate Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0034354:pyruvate [Organic Chemical]
   827   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]

Phrase: ")"

Phrase: "and"

Phrase: "glucose transporter 2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420172:GLUCOSE TRANSPORTER 2 [Gene or Genome]
   901   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Glut2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420172:GLUCOSE TRANSPORTER 2 [Gene or Genome]
   901   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "in islets"

Phrase: "of Hnf-1-/- mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(29"

Phrase: ")"

Phrase: "and"

Phrase: "downregulation of Glut2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0013081:Down-Regulation [Cell Function,Molecular Function]

Phrase: "L-Pk,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034348:Pyruvate Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0034354:pyruvate [Organic Chemical]
   827   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "insulin in cell lines"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0007600:Cell lines [Cell]
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]
   708   C0030281:Insulin Cell [Cell]

Phrase: "that"

Phrase: "express"

Phrase: "a dominant negative form of HNF-1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   742   C0205160:Negative [Qualitative Concept]
   742   C0348078:Form [Qualitative Concept]
   742   C0376315:Form [Manufactured Object]
   742   C1513916:Negative [Finding]
   742   C1522492:Form [Functional Concept]
   742   C1527180:Dominant [Functional Concept]
   742   C2825415:Negative [Conceptual Entity]
   742   C2825491:Negative [Qualitative Concept]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.39: In contrast to the above reports, a recent in vitro study suggested that a mitochondrial defect may contribute to the -cell defect in HNF-1deficient diabetes (31). 

Phrase: "In contrast to the above reports,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "a recent in vitro study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0681828:in vitro study [Research Activity]
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a mitochondrial defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1457869:Defect [Functional Concept]
   861   C1861101:DEFECT [Disease or Syndrome]

Phrase: "may"

Phrase: "contribute to the -cell defect"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1457869:Defect [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1861101:DEFECT [Disease or Syndrome]
   760   C1880177:Contribute [Activity]
   760   C1948049:Cell [Spatial Concept]

Phrase: "in HNF-1deficient diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0011849:Diabetes [Disease or Syndrome]
   717   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.40: In this report, a dominant negative Hnf-1, HNF-1-P291fsinsC, was expressed in insulinoma INS-1 cells and resulted in reduced expression levels of mitochondrial 2-oxoglutarate dehydrogenase (Ogdh) E1 subunit and increased expression of uncoupling protein 2 (Ucp2), thereby leading to impaired mitochondrial oxidation and consequently defective insulin secretory response (31). 

Phrase: "In this report,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "a dominant negative Hnf-1,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   812   C0205160:Negative [Qualitative Concept]
   812   C1513916:Negative [Finding]
   812   C1527180:Dominant [Functional Concept]
   812   C2825415:Negative [Conceptual Entity]
   812   C2825491:Negative [Qualitative Concept]

Phrase: "HNF-1-P291fsinsC,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   771   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]
   717   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "expressed in insulinoma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0021670:insulinoma [Neoplastic Process]

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "resulted in reduced expression levels of mitochondrial 2-oxoglutarate dehydrogenase (Ogdh) E1 subunit"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   753   C0022626:Oxoglutarate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1417943:OXOGLUTARATE DEHYDROGENASE [Gene or Genome]
   751   C1419450:E1-2 [Gene or Genome]
   736   C0026237:Mitochondrial [Cell Component]
   736   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   736   C0185117:Expression [Therapeutic or Preventive Procedure]
   736   C0392756:Reduced [Qualitative Concept]
   736   C0441889:Levels [Qualitative Concept]
   736   C0521451:Mitochondrial [Functional Concept]
   736   C1711351:Subunit [Quantitative Concept]
   734   C0456948:Level 2 [Intellectual Product]
   719   C3244092:expression level [Idea or Concept]
   703 E C0456079:Level [Classification]
   703   C1274040:Result [Functional Concept]
   703   C1546471:Result [Idea or Concept]
   703 E C1547707:Level [Geographic Area]
   703   C2825142:Result [Finding]
   703 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "increased expression of uncoupling protein 2 (Ucp2),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "thereby"

Phrase: "leading to impaired mitochondrial oxidation"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   760   C0026237:Mitochondrial [Cell Component]
   760   C0030011:Oxidation [Molecular Function]
   760   C0221099:Impaired [Functional Concept]
   760   C0332152:Leading [Temporal Concept]
   760   C0521451:Mitochondrial [Functional Concept]
   760   C0684336:Impaired [Pathologic Function]
   760   C1522538:Leading [Functional Concept]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "consequently defective insulin secretory response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0871261:Response [Organism Attribute]
   804   C1704632:Response [Finding]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.41: These inconsistent findings have yet to be resolved. 

Phrase: "These inconsistent findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "have"

Phrase: "yet to"

Phrase: "be"

Phrase: "resolved."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514893:Resolved [Idea or Concept]
  1000   C2699488:Resolved [Conceptual Entity]
Processing 00000000.tx.42: In this study, we explored the molecular basis by which Hnf-1 deficiency causes pancreatic -cell dysfunction by comparing pancreatic islet gene expression profiles from wild-type and Hnf-1-/- mice in vivo. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "explored"

Phrase: "the molecular basis by which Hnf-1 deficiency"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1853126:MOLECULAR BASIS [Idea or Concept]
   744   C1527178:Basis [Functional Concept]
   744   C1874451:Basis [Pharmacologic Substance]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "pancreatic -cell dysfunction by comparing pancreatic islet gene expression profiles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0031847:dysfunction [Functional Concept]
   739   C0277785:Dysfunction, NOS [Qualitative Concept]

Phrase: "from wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "Hnf-1-/- mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.43: Our results indicate that Hnf-1 deficiency results in a pleiotropic defect that includes dysregulation of glycolytic genes as well as other transcription factors of the pancreatic islet transcription factor network. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that Hnf-1 deficiency"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0011155:Deficiency [Functional Concept]
   827   C0162429:Deficiency [Disease or Syndrome]
   827   C1623416:deficiency [Qualitative Concept]
   755 E C1636779:% deficient [Quantitative Concept]

Phrase: "results in a pleiotropic defect"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C1274040:Result [Functional Concept]
   760   C1457869:Defect [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C1861101:DEFECT [Disease or Syndrome]
   760   C2825142:Result [Finding]

Phrase: "that"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "dysregulation of glycolytic genes"

Phrase: "as well as"

Phrase: "other transcription factors of the pancreatic islet transcription factor network."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0040649:Transcription [Genetic Function]
   722   C1720950:Transcriptional Network [Molecular Function]
   706   C1521761:Factor [Functional Concept]
   706   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.44: Our results localize the transcriptional defect in islets of Hnf-1-/- mice to the glycolytic pathway and provide evidence for a wider role of Hnf-1 in the regulation of islet-enriched transcription factors that are critical for -cell differentiation than has previously been anticipated.  

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "localize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:localize [Spatial Concept]

Phrase: "the transcriptional defect in islets of Hnf-1-/- mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1457869:Defect [Functional Concept]
   742   C1861101:DEFECT [Disease or Syndrome]

Phrase: "to the glycolytic pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C1512233:Glycolysis Pathway [Molecular Function]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "and"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence for a wider role of Hnf-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of islet-enriched transcription factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0040649:Transcription [Genetic Function]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "are"

Phrase: "critical for -cell differentiation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511545:Critical [Qualitative Concept]

Phrase: "than"

Phrase: "has"

Phrase: "previously"

Phrase: "been"

Phrase: "anticipated."
Processing 00000000.tx.45: RESEARCH DESIGN AND METHODS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Vectors. 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   876   C0086912:methods research [Research Activity]
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Vectors."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vectors [Spatial Concept]
   966 E C1705099:Vector [Idea or Concept]
Processing 00000000.tx.46: The construction of expression vector pCMV-pHNF-4 was described previously (15). 

Phrase: "The construction of expression vector pCMV-pHNF-4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.47: The vector pcDNA3-pHNF-1 was generated by cloning a 2.8-kb NotI/BamHI fragment from pBJ5-pHNF-1 (a gift from G. Crabtree, Stanford University, Stanford, CA) containing the entire rat HNF-1 coding sequence into pcDNA3. 

Phrase: "The vector pcDNA3-pHNF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vector [Spatial Concept]
   812   C1705099:Vector [Idea or Concept]

Phrase: "was"

Phrase: "generated by cloning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0009015:Cloning [Research Activity]
   790   C3146294:Generated [Activity]

Phrase: "a 2.8-kb NotI/BamHI fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0332255:fragment [Functional Concept]
   799   C1708096:Fragment [Qualitative Concept]

Phrase: "from pBJ5-pHNF-1"

Phrase: "("

Phrase: "a gift from G. Crabtree,"

Phrase: "Stanford University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Stanford,"

Phrase: "CA)"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the entire rat HNF-1 coding sequence into pcDNA3."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   756   C0079941:Coding Sequence [Gene or Genome]
   738   C0004793:Sequence [Nucleotide Sequence]
   738   C0009219:Coding [Occupational Activity]
   738   C0162326:Sequence [Nucleotide Sequence]
   738   C0162327:Sequence [Nucleotide Sequence]
   738   C1519249:Sequence [Functional Concept]
   704 E C0805701:Code [Intellectual Product]
Processing 00000000.tx.48: The pcDNA3-pSHP-1 expression vector was constructed by polymerase chain reaction (PCR) amplification of an 850-bp mouse Shp fragment that contained the entire open reading frame using mouse liver cDNA as a template. 

Phrase: "The pcDNA3-pSHP-1 expression vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0442335:Vector [Spatial Concept]
   804   C1705099:Vector [Idea or Concept]

Phrase: "was"

Phrase: "constructed by polymerase chain reaction (PCR) amplification of an 850-bp mouse Shp"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   770   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   736   C0025914:Mouse [Mammal]
   736   C0025929:mouse [Mammal]
   736   C0026809:Mouse [Mammal]
   736   C0337112:Chain [Manufactured Object]
   736   C0443286:Reaction [Functional Concept]
   736   C1114821:Reaction [Clinical Attribute]
   736   C1334896:SHP [Gene or Genome]
   736   C1335142:SHP [Amino Acid, Peptide, or Protein,Receptor]
   736   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   736   C1517480:Amplification [Molecular Biology Research Technique]
   736   C1521871:Amplification [Phenomenon or Process]
   736   C1524075:Chain [Idea or Concept]
   736   C1705299:SHP [Gene or Genome]
   736   C1705759:Amplification [Cell or Molecular Dysfunction]
   703   C2827421:Construct [Classification]

Phrase: "fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "that"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "the entire open reading frame"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   923   C0079941:Open Reading Frame [Gene or Genome]
   861   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   812   C0034754:Reading [Daily or Recreational Activity]
   812   C0175566:Open [Spatial Concept]
   812   C0180979:Frame [Medical Device]
   812   C1705179:Reading [Finding]
   812   C1705858:Frame [Manufactured Object]
   741 E C0547049:Openness [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "mouse liver cDNA as a template."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.49: This fragment was cloned into the EcoRI site of pcDNA3. 

Phrase: "This fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "cloned into the EcoRI site of pcDNA3."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C2945843:Site of [Qualitative Concept]
   748   C0009013:cloned [Cell]
   748   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205145:Site [Spatial Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]
   714 E C1522642:Clone [Tissue]
Processing 00000000.tx.50: The reporter plasmid pGL2-pSHP-1 was constructed by PCR amplification of the human SHP-1 promoter (Genbank accession no. AF044316), using oligonucleotides SHP-Pm-1 (5'-TCCTAGACTGGACAGTGGGCA-3') and SHP-Pm-2 (5'-CTTCCAGCTCTCTG GCTCTGT-3') and subsequent cloning of the 582-bp fragment into plasmid pPCR2.1. 

Phrase: "The reporter plasmid pGL2-pSHP-1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0335038:Reporter [Professional or Occupational Group]
   804   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   804   C1705915:Reporter [Conceptual Entity]
   804   C1709908:Reporter [Group]
   804   C1866552:PGL2 [Disease or Syndrome]
   804   C3273616:PGL2 [Gene or Genome]

Phrase: "was"

Phrase: "constructed by PCR amplification of the human SHP-1 promoter"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   770   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   753   C1335283:SHP-1 [Gene or Genome]
   753   C1705637:SHP-1 [Gene or Genome]
   736   C0086418:Human [Human]
   736   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   736   C0337112:Chain [Manufactured Object]
   736   C0443286:Reaction [Functional Concept]
   736   C1114821:Reaction [Clinical Attribute]
   736   C1334896:SHP [Gene or Genome]
   736   C1335142:SHP [Amino Acid, Peptide, or Protein,Receptor]
   736   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   736   C1517480:Amplification [Molecular Biology Research Technique]
   736   C1521871:Amplification [Phenomenon or Process]
   736   C1524075:Chain [Idea or Concept]
   736   C1705299:SHP [Gene or Genome]
   736   C1705759:Amplification [Cell or Molecular Dysfunction]
   703   C2827421:Construct [Classification]

Phrase: "(Genbank accession"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1510755:Accession [Intellectual Product]
   861   C1706078:Accession [Activity]

Phrase: "no. AF044316"

Phrase: ")"

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "oligonucleotides SHP-Pm-1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   875   C1335283:SHP-1 [Gene or Genome]
   875   C1705637:SHP-1 [Gene or Genome]
   861   C1441094:PM-1 [Immunologic Factor]
   812   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1334896:SHP [Gene or Genome]
   812   C1335142:SHP [Amino Acid, Peptide, or Protein,Receptor]
   812   C1705299:SHP [Gene or Genome]

Phrase: "(5'-TCCTAGACTGGACAGTGGGCA-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "SHP-Pm-2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0656342:SHP-2 [Amino Acid, Peptide, or Protein,Enzyme]
   913   C1335280:SHP-2 [Gene or Genome]
   913   C1706044:SHP-2 [Gene or Genome]
   827   C1334896:SHP [Gene or Genome]
   827   C1335142:SHP [Amino Acid, Peptide, or Protein,Receptor]
   827   C1705299:SHP [Gene or Genome]

Phrase: "(5'-CTTCCAGCTCTCTG GCTCTGT-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439084:>5 [Quantitative Concept]
   812   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "subsequent cloning of the 582-bp fragment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0009015:Cloning [Research Activity]

Phrase: "into plasmid pPCR2.1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.51: A KpnI/XhoI fragment from this plasmid was then subcloned into the pGL2, inserting the SHP promoter upstream of the luciferase reporter gene. 

Phrase: "A KpnI/XhoI fragment from this plasmid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332255:fragment [Functional Concept]
   748   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "then subcloned into the pGL2,"

Phrase: "inserting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0441587:Insert [Health Care Activity]
   966   C1743766:Insert [Medical Device]
   966   C1883719:Insert [Functional Concept]

Phrase: "the SHP promoter upstream of the luciferase reporter gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0314621:Promoter gene [Gene or Genome]
   742   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.52: Vector pGL2-pSHPmut was generated by PCR using oligonucleotides SHPmut-F (5'-TCCTAGACTGGACAGTAA AAAAAGCCT-3') and SHP-Pm-2, as well as pGL2-pSHP as a template. 

Phrase: "Vector pGL2-pSHPmut"

Phrase: "was"

Phrase: "generated by PCR"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0337112:Chain [Manufactured Object]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1524075:Chain [Idea or Concept]
   760   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "oligonucleotides SHPmut-F (5'-TCCTAGACTGGACAGTAA AAAAAGCCT-3'"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   795   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0439133:(f) [Intellectual Product]
   795   C1553038:[f] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "SHP-Pm-2,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0656342:SHP-2 [Amino Acid, Peptide, or Protein,Enzyme]
   913   C1335280:SHP-2 [Gene or Genome]
   913   C1706044:SHP-2 [Gene or Genome]
   827   C1334896:SHP [Gene or Genome]
   827   C1335142:SHP [Amino Acid, Peptide, or Protein,Receptor]
   827   C1705299:SHP [Gene or Genome]

Phrase: "as well as"

Phrase: "pGL2-pSHP as a template."
Processing 00000000.tx.53: This fragment, containing a mutated HNF-4 binding site, was cloned into pPCR2.1 before insertion into pGL2. 

Phrase: "This fragment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a mutated HNF-4 binding site,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   818   C0005456:Binding Site [Receptor]
   818   C0682969:Binding Site [Amino Acid Sequence]
   795   C0205145:Site [Spatial Concept]
   795   C0243122:binding [Functional Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1515974:Site [Body Location or Region]
   795   C2825164:Site [Spatial Concept]
   710   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]

Phrase: "was"

Phrase: "cloned into pPCR2.1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0009013:cloned [Cell]
   737 E C1522642:Clone [Tissue]

Phrase: "before insertion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021107:Insertion [Therapeutic or Preventive Procedure]
  1000   C0441587:Insertion [Health Care Activity]
  1000   C1512796:Insertion [Genetic Function]
  1000   C1883719:Insertion [Functional Concept]

Phrase: "into pGL2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1866552:PGL2 [Disease or Syndrome]
  1000   C3273616:PGL2 [Gene or Genome]
Processing 00000000.tx.54: The sequences of all PCR-generated clones were confirmed by dideoxynucleotide sequencing. 

Phrase: "The sequences of all PCR-generated clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0162326:Sequences [Nucleotide Sequence]
   708 E C0004793:Sequence [Nucleotide Sequence]
   708 E C0162327:Sequence [Nucleotide Sequence]
   708 E C1519249:Sequence [Functional Concept]

Phrase: "were"

Phrase: "confirmed by dideoxynucleotide sequencing."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0599651:dideoxynucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0750484:Confirmed [Idea or Concept]
   770   C1553778:Sequencing [Intellectual Product]
   770   C1561491:Sequencing [Functional Concept]
   737 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.55: Pancreatic islet and RNA isolation. 

Phrase: "Pancreatic islet"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic islet [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "RNA isolation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0204727:Isolation [Therapeutic or Preventive Procedure]
   861   C0205409:Isolation [Functional Concept]
   861   C0220862:isolation [Laboratory Procedure]
   789 E C1548221:Isolated [Idea or Concept]
Processing 00000000.tx.56: Pancreatic islets were isolated from 4- to 6-week-old Hnf-1-/- mice and their heterozygous (Hnf-1+/-) and wild-type (Hnf-1+/+) littermates. 

Phrase: "Pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "isolated from 4-"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "to 6-week-old Hnf-1-/- mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "their heterozygous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygous [Organism Attribute]

Phrase: "(Hnf-1+/-"

Phrase: ")"

Phrase: "and"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(Hnf-1+/+"

Phrase: ")"

Phrase: "littermates."
Processing 00000000.tx.57: We used collagenase digestion and differential centrifugation through Ficoll gradients, with a modification of procedures previously described (32). 

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "collagenase digestion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0012238:Digestion [Organism Function]
   861   C2349986:Digestion [Research Activity]
   805 E C0443277:Peptic [Functional Concept]

Phrase: "and"

Phrase: "differential centrifugation through Ficoll gradients,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0007703:Centrifugation [Laboratory Procedure]
   760   C0443199:Differential [Qualitative Concept]
   760   C1705242:Differential [Qualitative Concept]

Phrase: "with a modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392747:Modification [Functional Concept]
  1000   C1554963:modification [Qualitative Concept]

Phrase: "of procedures previously"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.58: Islets were cultured overnight in RPMI 1640 medium supplemented with 10% fetal calf serum and 11.1 mmol/l glucose. 

Phrase: "Islets"

Phrase: "were"

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "overnight in RPMI 1640 medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C0439583:Overnight [Temporal Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]

Phrase: "supplemented with 10% fetal calf serum"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0230445:Calf [Body Location or Region]
   753   C0521457:Fetal [Functional Concept]
   753   C1305418:Calf [Body Part, Organ, or Organ Component]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "11.1 mmol/l glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.59: Whole pancreata were removed from newborn mice. 

Phrase: "Whole pancreata"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   827   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "removed from newborn mice."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0021289:Newborn [Age Group]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0849355:Removed [Qualitative Concept]
   770   C2239178:Newborn, NOS [Finding]
   770   C2939425:Newborn, NOS [Temporal Concept]
   737 E C1883720:Remove [Activity]
   737 E C3244314:remove [Functional Concept]
Processing 00000000.tx.60: Total RNA was then extracted using TRIzol reagent (Gibco-BRL) and following the manufacturers instructions. 

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "TRIzol reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Gibco-BRL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412820:BRL [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the manufacturers instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.61: Contaminating genomic DNA was removed using 1 l RNase free DNase-I (Boehringer) per 5 g RNA. 

Phrase: "Contaminating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205279:contaminate [Functional Concept]

Phrase: "genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "1 l RNase free DNase-I"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   858   C0035541:RNase I [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0011519:DNAase I [Amino Acid, Peptide, or Protein,Enzyme]
           DNase
   827   C1148702:DNase I [Genetic Function]
   799   C0011522:DNAase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(Boehringer"

Phrase: ")"

Phrase: "per 5 g RNA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.62: Reverse transcriptasePCR. 

Phrase: "Reverse transcriptasePCR."
Processing 00000000.tx.63: Conditions used for reverse transcriptase (RT)-PCR followed the method of Wilson and Melton (33), with minimal modifications. 

Phrase: "Conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "used for reverse transcriptase (RT)-PCR"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   897   C0599161:Reverse Transcriptase Polymerase Chain Reaction [Molecular Biology Research Technique]
   814   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   778   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0337112:Chain [Manufactured Object]
   748   C0443286:Reaction [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]
   748   C1273517:used [Finding]
   748   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1524075:Chain [Idea or Concept]
   748   C1555029:Reverse [Idea or Concept]
   748   C2257077:transcriptase [Genetic Function]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: "followed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332283:followed [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the method of Wilson"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025663:Method [Intellectual Product]
   770   C0449851:Method [Functional Concept]
   770   C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "Melton"

Phrase: "(33"

Phrase: ")"

Phrase: ","

Phrase: "with minimal modifications."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392747:Modification [Functional Concept]
   827   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.64: cDNAs were synthesized using MMLV-RT (Stratagene) with dNTPs and random hexamer primers (Stratagene). 

Phrase: "cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "MMLV-RT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1555029:Reverse [Idea or Concept]
   827   C2257077:transcriptase [Genetic Function]

Phrase: "(Stratagene"

Phrase: ")"

Phrase: "with dNTPs"

Phrase: "and"

Phrase: "random hexamer primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Stratagene"

Phrase: ")."
Processing 00000000.tx.65: These cDNAs provided templates for PCRs using specific primers at annealing temperatures of 6065C in the presence of dNTPs and Taq polymerase. 

Phrase: "These cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "templates for PCRs"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0728990:templates [Medical Device]
   756 E C1514575:Template [Conceptual Entity]
   756 E C1705542:Template [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "specific primers at annealing temperatures of 6065C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of dNTPs"

Phrase: "and"

Phrase: "Taq polymerase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0075813:Taq Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.66: Typically, between 20 and 28 cycles were used for amplification in the linear range. 

Phrase: "Typically,"

Phrase: "between 20"

Phrase: "and"

Phrase: "28 cycles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]

Phrase: "were"

Phrase: "used for amplification"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C1273517:used [Finding]
   790   C1517480:Amplification [Molecular Biology Research Technique]
   790   C1521871:Amplification [Phenomenon or Process]
   790   C1705759:Amplification [Cell or Molecular Dysfunction]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "in the linear range."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]
Processing 00000000.tx.67: The sequences of the primers that were used for the amplification of cDNAs are available upon request from M.S. 

Phrase: "The sequences of the primers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0162326:Sequences [Nucleotide Sequence]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]

Phrase: "that"

Phrase: "were"

Phrase: "used for the amplification of cDNAs"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   767   C1524063:Use of [Functional Concept]
   753   C1273517:used [Finding]
   753   C1517480:Amplification [Molecular Biology Research Technique]
   753   C1521871:Amplification [Phenomenon or Process]
   753   C1705759:Amplification [Cell or Molecular Dysfunction]
   719   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: "available upon request"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]

Phrase: "from M.S."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.68: Immunohistochemistry. 

Phrase: "Immunohistochemistry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]
Processing 00000000.tx.69: Glut2 immunofluorescence was performed on 5-m sections from 6-week-old Hnf-1+/+, Hnf-1+/-, and Hnf-1-/- mice that were prepared as previously described (27). 

Phrase: "Glut2 immunofluorescence"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0016318:Immunofluorescence [Laboratory Procedure]
   812   C0079603:Immunofluorescence [Laboratory Procedure]
   756 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   756   C1420172:GLUCOSE TRANSPORTER 2 [Gene or Genome]
   741 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "performed on 5-m sections"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   797   C1440942:M-5 [Immunologic Factor]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C0884358:Performed [Functional Concept]
   726   C0205155:Section [Spatial Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726   C1705191:Section [Physical Object]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "from 6-week-old Hnf-1+/+,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0332174:/week [Temporal Concept]
   804   C0439230:week [Temporal Concept]
   804   C0580836:Old [Temporal Concept]

Phrase: "Hnf-1+/-,"

Phrase: "and"

Phrase: "Hnf-1-/- mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "were"

Phrase: "prepared as previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1521827:Prepare [Functional Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.70: Sections were blocked for 30 min with normal rabbit serum at a concentration of 1:100 in phosphate-buffered saline (PBS). 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "blocked for 30 min"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C0702093:/min [Temporal Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "with normal rabbit serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0034493:Rabbit [Mammal]
   827   C0205307:Normal [Qualitative Concept]
   827   C0229671:Serum [Body Substance]
   827   C0439166:% normal [Quantitative Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C2347086:% Normal [Quantitative Concept]

Phrase: "at a concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100 in phosphate-buffered saline (PBS)."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.71: Sections were stained with rabbit anti-mouse Glut2 antibody (Chemicon International, Temecula, CA) in PBS at a dilution of 1:200. 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "stained with rabbit anti-mouse Glut2 antibody"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   790   C1420172:GLUCOSE TRANSPORTER 2 [Gene or Genome]
   764   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]
   742   C0034493:Rabbit [Mammal]
   742   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C2986582:Stained [Qualitative Concept]
   708 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Chemicon International, Temecula,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1555271:Temecula [Population Group]

Phrase: "CA) in PBS"

Phrase: "at a dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079240:Dilution [Laboratory Procedure]
  1000   C1948037:Dilution [Functional Concept]

Phrase: "of 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200."
Processing 00000000.tx.72: The secondary antibody, a TRITC-labeled guinea pig anti-rabbit IgG, was applied at a concentration of 1:100 in PBS. 

Phrase: "The secondary antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "a TRITC-labeled guinea pig anti-rabbit IgG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   829   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0034493:Rabbit [Mammal]

Phrase: "was"

Phrase: "applied at a concentration of 1"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0086045:Concentration [Mental Process]
   753   C0185125:Applied [Health Care Activity]
   753   C1446561:Concentration [Quantitative Concept]
   719 E C1632850:Apply [Functional Concept]
   719 E C1879355:Apply [Functional Concept]

Phrase: ":"

Phrase: "100 in PBS."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.73: Sections were washed twice in PBS between each step and after the application of the secondary antibody and were mounted in PBS:glycerol, 1:9. 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice in PBS"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   760   C1720725:Twice [Intellectual Product]
   760   C1948050:Twice [Quantitative Concept]

Phrase: "between each step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1261552:Step [Conceptual Entity]
  1000   C1704379:Step [Functional Concept]
  1000   C1705117:Step [Quantitative Concept]
  1000   C2825408:Step [Manufactured Object]

Phrase: "and after the application of the secondary antibody"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0027627:secondary [Neoplastic Process]
   744   C0175668:Secondary [Temporal Concept]
   744   C0185125:Application [Health Care Activity]
   744   C0205436:Secondary [Quantitative Concept]
   744   C1515981:And [Idea or Concept]
   744   C1947919:Application [Intellectual Product]
   744   C2347934:Application [Intellectual Product]
   744   C3539080:APPLICATION [Quantitative Concept]

Phrase: "and"

Phrase: "were"

Phrase: "mounted in PBS"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C0449878:mounted [Finding]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726 E C0181909:Mount [Medical Device]

Phrase: ":"

Phrase: "glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "9."
Processing 00000000.tx.74: Measurements of pyruvate kinase activity. 

Phrase: "Measurements of pyruvate kinase activity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0373716:Pyruvate kinase measurement [Laboratory Procedure]
   781   C0302278:Pyruvate measurement [Laboratory Procedure]
   760   C0242485:measurements [Functional Concept]
Processing 00000000.tx.75: Pyruvate kinase enzyme activity was measured in extracts of islets isolated from four mice. 

Phrase: "Pyruvate kinase enzyme activity"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   923   C0427509:pyruvate kinase activity [Molecular Function]
   875   C1150423:kinase activity [Molecular Function]
   861   C0243102:enzyme activity [Molecular Function]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "measured in extracts of islets"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0444706:Measured [Qualitative Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726   C2828366:Extract [Substance]

Phrase: "isolated from four mice."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0205409:Isolated [Functional Concept]
   770   C0205450:Four [Quantitative Concept]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.76: After overnight culture in RPMI 1640 containing 11.6 mmol/l glucose, islets were hand picked, washed twice in PBS, and transferred to a homogenization buffer consisting of 200 mmol/l mannitol, 70 mmol/l sucrose, 5 mmol/l potassium HEPES buffer (pH 7.5), and 1 mmol/l dithiothreitol. 

Phrase: "After overnight culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "in RPMI 1640"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "11.6 mmol/l glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "islets"

Phrase: "were"

Phrase: "hand picked"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0018563:Hand [Body Part, Organ, or Organ Component]
   861   C1281583:Hand [Body Part, Organ, or Organ Component]
   861   C1552914:hand [Quantitative Concept]
   861   C1707391:Picked [Activity]
   827 E C1826583:PICK [Gene or Genome]
   805 E C0024763:Manual [Intellectual Product,Manufactured Object]
   805 E C0175674:Manual [Functional Concept]

Phrase: ","

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice in PBS,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   760   C1720725:Twice [Intellectual Product]
   760   C1948050:Twice [Quantitative Concept]

Phrase: "and"

Phrase: "transferred to a homogenization buffer"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0348011:transferred [Functional Concept]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]

Phrase: "consisting of 200 mmol/l mannitol,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1532563:mmol/L [Quantitative Concept]
   753   C0024730:Mannitol [Carbohydrate,Pharmacologic Substance]
   753   C0439190:MMOLE [Quantitative Concept]
   719   C0332529:CONSIST [Qualitative Concept]

Phrase: "70 mmol/l sucrose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "5 mmol/l potassium HEPES buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(pH 7.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "1 mmol/l dithiothreitol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.77: The islets were washed twice in buffer containing 1 mmol/l EGTA and then twice in buffer without EGTA. 

Phrase: "The islets"

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice in buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C1720725:Twice [Intellectual Product]
   790   C1948050:Twice [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1 mmol/l EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "then twice in buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C1720725:Twice [Intellectual Product]
   770   C1883708:Then [Temporal Concept]
   770   C1948050:Twice [Quantitative Concept]

Phrase: "without EGTA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.78: The islets were then sonicated (Ultrasonics Sonicator Cell Disrupter, Model W 185 F; Heat Systems, Plainview, NY) and centrifuged at 105,000 x g for 60 min at 4C. 

Phrase: "The islets"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "sonicated"

Phrase: "(Ultrasonics Sonicator Cell Disrupter,"

Phrase: "Model W 185 F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "; Heat Systems,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]

Phrase: "Plainview,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "centrifuged at 105,000 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439267:g% [Quantitative Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "for 60 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.79: The protein content of the islet extracts was measured (Biorad, #500-0006), and the activity was measured in equivalent amounts of protein from the different mice. 

Phrase: "The protein content of the islet extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "(Biorad,"

Phrase: "#500-0006"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured in equivalent amounts of protein"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205163:Equivalent [Qualitative Concept]
   753   C0439185:equivalent [Quantitative Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C1265611:amounts [Quantitative Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "from the different mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.80: Pyruvate kinase enzyme activity was measured in a reaction buffer consisting of 80 mmol/l triethanolamine chloride buffer (pH 7.5), 5 mmol/l MgSO4, 100 mmol/l KCl, 2.5 mmol/l ADP, 0.14 mmol/l NADH, 1 mmol/l dithiothreitol, and 7 mmol/l phosphoenolpyruvate and 2.5 units of lactic dehydrogenase (all reagents were purchased from Sigma, St. Louis, MO). 

Phrase: "Pyruvate kinase enzyme activity"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   923   C0427509:pyruvate kinase activity [Molecular Function]
   875   C1150423:kinase activity [Molecular Function]
   861   C0243102:enzyme activity [Molecular Function]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "measured in a reaction buffer"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0443286:Reaction [Functional Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "consisting of 80 mmol/l triethanolamine chloride buffer"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C1532563:mmol/L [Quantitative Concept]
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0008203:Chloride, NOS [Inorganic Chemical]
   744   C0077089:triethanolamine [Organic Chemical,Pharmacologic Substance]
   744   C0439190:MMOLE [Quantitative Concept]
   744   C0596019:Chloride [Element, Ion, or Isotope]
   711   C0332529:CONSIST [Qualitative Concept]

Phrase: "(pH 7.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "5 mmol/l MgSO4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C2348935:.5 L [Quantitative Concept]

Phrase: "100 mmol/l KCl,"

Phrase: "2.5 mmol/l ADP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0523452:ADP [Laboratory Procedure]

Phrase: "0.14 mmol/l NADH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0027289:NADH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "1 mmol/l dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "7 mmol/l phosphoenolpyruvate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0031642:Phosphoenolpyruvate [Biologically Active Substance,Organophosphorus Compound]

Phrase: "and"

Phrase: "2.5 units of lactic dehydrogenase"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0439148:Units [Quantitative Concept]
   753   C1519795:Units [Quantitative Concept]
   719 E C1704753:Unit [Manufactured Object]
   719 E C1880519:Unit [Quantitative Concept]

Phrase: "("

Phrase: "all reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "purchased from Sigma,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]

Phrase: "St. Louis,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.81: Each reaction was carried out in a final volume of 1 ml and was started by the addition of the islet extract. 

Phrase: "Each reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in a final volume of 1 ml"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0205088:Final [Temporal Concept]
   744   C0439526:/mL [Quantitative Concept]
   744   C0439787:Out [Spatial Concept]
   744   C0449468:*Volume [Quantitative Concept]
   744   C0849355:Out [Qualitative Concept]
   744   C1546485:Final [Idea or Concept]
   744   C1690016:% volume [Qualitative Concept]
   744   C1705102:Volume [Intellectual Product]
   744   C2700258:Volume [Laboratory Procedure]

Phrase: "and"

Phrase: "was"

Phrase: "started by the addition of the islet extract."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   744   C1272689:Started [Qualitative Concept]
   744   C1883712:Addition [Functional Concept]
   744   C2828366:Extract [Substance]
   711 E C0439659:Start [Temporal Concept]
Processing 00000000.tx.82: NADH levels were measured as fluorescence emitted at 448 nm in response to excitation at 340 nm for 10 min (31). 

Phrase: "NADH levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "measured as fluorescence"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0016315:Fluorescence [Natural Phenomenon or Process]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]
   718 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "emitted at 448 nm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0312860:NM [Cell Function]
   737   C0162676:EMIT [Laboratory Procedure]
   737   C1623049:EMIT [Laboratory Procedure]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to excitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excitation [Activity]

Phrase: "at 340 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "for 10 min (31"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0456692:/10 min [Temporal Concept]
   827   C0450355:31 [Intellectual Product]
   827   C0702093:/min [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.83: The rates of consumption of NADH were similar in Hnf-1+/+ (n = 4), Hnf-1+/- (n = 5), and Hnf-1-/- (n = 4) mice. 

Phrase: "The rates of consumption of NADH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0871208:Rate [Activity]
   719   C1521828:Rate [Quantitative Concept]

Phrase: "were"

Phrase: "similar in Hnf-1+/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "(n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Hnf-1+/-"

Phrase: "(n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Hnf-1-/-"

Phrase: "(n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.84: Electrophoretic mobility shift analysis. 

Phrase: "Electrophoretic mobility shift analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]
Processing 00000000.tx.85: In vitro translated proteins or nuclear cell extracts were incubated with 32P-labeled ds-stranded oligonucleotide probes containing the wild-type or mutant HNF-4 binding sites in the SHP promoter (sequences: 5'-TGGACAGTGGGCAAAGTCC-TCCC-3' and 5'-TGGACAGTAAAAAAAGTCCT CCC-3', respectively). 

Phrase: "In vitro translated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "nuclear cell extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0007592:Cell Extracts [Cell Component]
   896   C1518434:Nuclear Extract [Biomedical or Dental Material]
   793   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "incubated with 32P-labeled ds-stranded oligonucleotide probes"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   770   C0028952:Oligonucleotide Probes [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0182400:Probes [Medical Device]
   744   C1439852:Incubated [Laboratory Procedure]
   744   C1553631:32p [Medical Device]
   744   C1708632:Labeled [Qualitative Concept]
   711 E C0181496:Label [Manufactured Object]
   711 E C1704681:Probe [Gene or Genome]
   711 E C2347609:Probe [Chemical Viewed Functionally]
   711 E C2827499:Label [Governmental or Regulatory Activity]
   711 E C3536729:Probe [Manufactured Object]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "mutant HNF-4 binding sites in the SHP promoter (sequences"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0005456:Binding Sites [Receptor]
   736   C0205145:Sites [Spatial Concept]
   736   C0243122:binding [Functional Concept]
   736   C1145667:Binding [Activity]
   736   C1167622:Binding [Molecular Function]
   719 E C0682969:Binding Site [Amino Acid Sequence]
   703 E C1515974:Site [Body Location or Region]
   703 E C2825164:Site [Spatial Concept]

Phrase: ":"

Phrase: "5'-TGGACAGTGGGCAAAGTCC-TCCC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439084:>5 [Quantitative Concept]
   812   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-TGGACAGTAAAAAAAGTCCT CCC-3',"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439084:>5 [Quantitative Concept]
   812   C0728893:+5 [Quantitative Concept]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.86: The 15-l reaction mixture contained 20 mmol/l Hepes buffer (pH 7.9), 40 mmol/l KCl, 1 mmol/l MgCl2, 0.1 mmol/l EGTA, 0.5 mmol/l DTT, 4% Ficoll, and 2 g of poly(dIdC) at 25C for 20 min. 

Phrase: "The 15-l reaction mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439962:Mixture [Substance]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "20 mmol/l Hepes buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(pH 7.9"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "40 mmol/l KCl,"

Phrase: "1 mmol/l MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "0.1 mmol/l EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "0.5 mmol/l DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "4% Ficoll,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016071:Ficoll [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "2 g of poly(dIdC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0032411:Poly G [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "at 25C"

Phrase: "for 20 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.87: Supershift analysis was performed by incubating the antibody with the protein or nuclear extracts for 5 min on ice before adding the probe. 

Phrase: "Supershift analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed by incubating"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C1550369:Performed By [Qualitative Concept]
   790   C0884358:Performed [Functional Concept]
   790   C1439852:incubating [Laboratory Procedure]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "the antibody with the protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or"

Phrase: "nuclear extracts for 5 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   773   C1518434:Nuclear Extract [Biomedical or Dental Material]
   760   C0521447:Nuclear [Spatial Concept]
   726   C2828366:Extract [Substance]

Phrase: "on ice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]

Phrase: "before adding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1883712:Add [Functional Concept]

Phrase: "the probe."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.88: The reaction mixture was loaded on a 6% nondenaturing polyacrylamide gel containing 0.25x TBE buffer (0.023 mol/l Tris-borate and 0.5 mmol/l EDTA) and run at 4C. 

Phrase: "The reaction mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "loaded on a 6% nondenaturing polyacrylamide gel"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   778   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   748   C1382104:Gel [Substance]
   748   C1708715:Loaded [Activity]
   714 E C1550025:Load [Idea or Concept]
   714 E C1704782:Load [Manufactured Object]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.25x TBE buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0146923:TBE buffer [Organic Chemical]
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(0.023 mol/l Tris-borate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0006007:Borate [Chemical Viewed Structurally]
   799   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   799   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   799   C0814229:TRI [Intellectual Product]

Phrase: "and"

Phrase: "0.5 mmol/l EDTA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "run at 4C."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0035953:run [Daily or Recreational Activity]
   790   C0600140:run [Finding]
   790   C1704688:Run [Functional Concept]
   790   C2346414:Run [Finding]
Processing 00000000.tx.89: Nuclear extracts were prepared as described (15). 

Phrase: "Nuclear extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "prepared as described"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1552738:described [Idea or Concept]
   756   C1521827:Prepare [Functional Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.90: Tissue culture, transient transfections, and luciferase assay. 

Phrase: "Tissue culture,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0040284:Tissue culture [Laboratory Procedure]
   861   C0010453:Culture [Idea or Concept]
   861   C0040300:Tissue [Tissue]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1547928:Tissue [Intellectual Product]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "transient transfections,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "luciferase assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.91: Cos7 and HepG2 cells were grown on minimum essential medium supplemented with 10% fetal calf serum and Dulbeccos modified Eagles medium (DMEM) supplemented with 15% fetal calf serum, respectively. 

Phrase: "Cos7"

Phrase: "and"

Phrase: "HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown on minimum essential medium"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0009458:Medium [Intellectual Product]
   760   C0205224:Essential [Qualitative Concept]
   760   C0439536:Medium [Quantitative Concept]
   760   C1524031:Minimum [Qualitative Concept]
   760   C1552614:minimum [Idea or Concept]
   760   C1705217:Medium [Substance]
   760   C2826545:MINIMUM [Quantitative Concept]
   760   C3244283:medium [Intellectual Product]

Phrase: "supplemented with 10% fetal calf serum"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0230445:Calf [Body Location or Region]
   753   C0521457:Fetal [Functional Concept]
   753   C1305418:Calf [Body Part, Organ, or Organ Component]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "Dulbeccos modified Eagles medium (DMEM)"

Phrase: "supplemented with 15% fetal calf serum,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0230445:Calf [Body Location or Region]
   753   C0521457:Fetal [Functional Concept]
   753   C1305418:Calf [Body Part, Organ, or Organ Component]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "respectively."
Processing 00000000.tx.92: HIT-T15 cells were grown in DMEM supplemented with 5% fetal calf serum and 10% horse serum. 

Phrase: "HIT-T15 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in DMEM"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0009458:Medium [Intellectual Product]
   753   C0325564:Eagles [Bird]
   753   C0392747:Modified [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]
   719 E C1551720:Eagle [Population Group]

Phrase: "supplemented with 5% fetal calf serum"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0230445:Calf [Body Location or Region]
   753   C0521457:Fetal [Functional Concept]
   753   C1305418:Calf [Body Part, Organ, or Organ Component]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "10% horse serum."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1518416:Serum, Horse [Immunologic Factor]
   827   C0019944:Horse [Mammal]
   827   C0229671:Serum [Body Substance]
   827   C0242616:Horse [Mammal]
   827   C1265527:Horse [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
Processing 00000000.tx.93: A modified calcium phosphate precipitation procedure was used for transient transfections (15). 

Phrase: "A modified calcium phosphate precipitation procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   804   C1948041:Procedure [Therapeutic or Preventive Procedure]
   804   C2700391:Procedure [Activity]
   804   C3274430:PROCEDURE [Health Care Activity]
   804   C3538935:Procedure [Idea or Concept]
   804   C3539779:Procedure [Intellectual Product]

Phrase: "was"

Phrase: "used for transient transfections"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]
   770   C0040704:Transient [Population Group]
   770   C0205374:Transient [Temporal Concept]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.94: In short, 0.5 ml of the precipitate, containing 1 g CMV-LacZ, 0.5 g luciferase reporter construct, and the indicated amount of expression vectors and carrier DNA (up to 10 g), were added per 60-mm dish. 

Phrase: "In short, 0.5 ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439526:/mL [Quantitative Concept]

Phrase: "of the precipitate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1 g CMV-LacZ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0022959:LacZ [Gene or Genome]

Phrase: "0.5 g luciferase reporter construct,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "the indicated amount of expression vectors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "and"

Phrase: "carrier DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "("

Phrase: "up to 10 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "added per 60-mm dish."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0020498:DISH [Disease or Syndrome]
   760   C1524062:Added [Functional Concept]
   726 E C1883712:Add [Functional Concept]
Processing 00000000.tx.95: Luciferase was normalized for transfection efficiency by the corresponding -galactosidase activity (34). 

Phrase: "Luciferase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "normalized for transfection efficiency"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0013682:Efficiency [Quantitative Concept]
   770   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   770   C1882115:Normalized [Research Activity]

Phrase: "by the corresponding -galactosidase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1150051:galactosidase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.96: Statistical analysis. 

Phrase: "Statistical analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.97: Results are given as mean  SE. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "given as mean  SE."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0444504:Mean [Quantitative Concept]
   770   C1442162:GIVEN [Conceptual Entity]
   770   C1550718:given [Idea or Concept]
   770   C2347634:Mean [Quantitative Concept]
   770   C2348143:Mean [Quantitative Concept]
   770   C3244317:given [Intellectual Product]
   737 E C1947971:Give [Functional Concept]
Processing 00000000.tx.98: Statistical analyses were performed by using a Students t test, and the null hypothesis was rejected at the 0.05 level.  

Phrase: "Statistical analyses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0871424:statistical analysis [Research Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed by"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1550369:Performed By [Qualitative Concept]
   833   C0884358:Performed [Functional Concept]
   799 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Students t test,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:Students [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   793 E C1551041:student [Idea or Concept]
   793 E C1552573:student [Intellectual Product]

Phrase: "and"

Phrase: "the null hypothesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456148:Null [Quantitative Concept]
   861   C1512571:Hypothesis [Idea or Concept]

Phrase: "was"

Phrase: "rejected at the 0.05 level."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C1548437:Rejected [Idea or Concept]
   753   C2946261:Level [Pharmacologic Substance]
   719 E C2700401:Reject [Activity]
Processing 00000000.tx.99: RESULTS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Impaired expression of genes involved in glucose-stimulated insulin secretion. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Impaired expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0017262:Gene Expression [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "involved in glucose-stimulated insulin secretion."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C1256369:insulin secretion [Cell Function]
   783   C1719133:Glucose/Insulin [Quantitative Concept]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C1314939:Involved [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1948023:Stimulated [Natural Phenomenon or Process]
Processing 00000000.tx.100: Insulin secretory responses to glucose are markedly reduced in Hnf-1-/- mice compared with littermate controls. 

Phrase: "Insulin secretory responses to glucose"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "are"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "reduced in Hnf-1-/- mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0392756:Reduced [Qualitative Concept]

Phrase: "compared with littermate controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1707455:Compared [Activity]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.101: Methylpyruvate, an insulin secretagogue that freely permeates the mitochondrial membrane, can suppress ATP-dependent K+-channel activity in Hnf-1-/- pancreatic islets, suggesting that the defect in glucose metabolism is upstream of mitochondrial glucose metabolism. 

Phrase: "Methylpyruvate,"

Phrase: "an insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "secretagogue"

Phrase: "that freely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879743:Freely [Qualitative Concept]

Phrase: "permeates"

Phrase: "the mitochondrial membrane,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0596952:Mitochondrial membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "can"

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "ATP-dependent K+-channel activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1153410:channel activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "in Hnf-1-/- pancreatic islets,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   812   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the defect in glucose metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1457869:Defect [Functional Concept]
   760   C1861101:DEFECT [Disease or Syndrome]

Phrase: "is upstream of mitochondrial glucose metabolism."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0596620:glucose metabolism [Molecular Function]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]
   753   C0026237:Mitochondrial [Cell Component]
   753   C0521451:Mitochondrial [Functional Concept]
   753   C0522505:Upstream [Spatial Concept]
Processing 00000000.tx.102: To test which genes involved in glucose metabolism were affected by the disruption of Hnf-1, we measured the mRNA levels of glucose transporters, amino acid transporters, and all glycolytic enzymes. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "which genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "involved in glucose metabolism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0596620:glucose metabolism [Molecular Function]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]
   770   C1314939:Involved [Functional Concept]

Phrase: "were"

Phrase: "affected by the disruption of Hnf-1,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0332453:Disruption [Functional Concept]
   748   C0392760:Affected [Functional Concept]
   748   C1314939:Affected [Functional Concept]
   714 E C0001721:Affect [Mental Process]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the mRNA levels of glucose transporters,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   783   C0428548:glucose levels [Laboratory or Test Result]
   767 E C0337438:glucose level [Laboratory Procedure]
   753   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "amino acid transporters,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0949771:Amino Acid Transporters [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0596902:transporters [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "and"

Phrase: "all glycolytic enzymes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]
   789   C0017952:Glycolysis [Molecular Function]
Processing 00000000.tx.103: We also measured the proximal rate-limiting enzymes of oxidative phosphorylation, including components of the pyruvate dehydrogenase complex (pyruvate decarboxylase and dihydrolipoyl dehydrogenase), aconitase, isocitrate dehydrogenase, and -ketoglutarate dehydrogenase complex (2-oxoglutarate dehydrogenase, dihydrolipoyl succinyl-transferase, and dihydrolipoyl dehydrogenase) as well as Ucp2. 

Phrase: "We also"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the proximal rate-limiting enzymes of oxidative phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0014442:Enzymes [Enzyme,Organic Chemical]
   744   C0014445:enzymes [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "components of the pyruvate dehydrogenase complex"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0449432:Components [Manufactured Object]
   719 E C1705248:Component [Conceptual Entity]

Phrase: "(pyruvate decarboxylase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0034342:Pyruvate Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0007054:Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0034354:pyruvate [Organic Chemical]
   861   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "and"

Phrase: "dihydrolipoyl dehydrogenase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023783:Dihydrolipoyl Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1414063:DIHYDROLIPOYL DEHYDROGENASE [Gene or Genome]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: ","

Phrase: "aconitase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001156:Aconitase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "isocitrate dehydrogenase,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022157:Isocitrate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0022160:isocitrate [Organic Chemical]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0220861:isocitrate [Biologically Active Substance,Organic Chemical]

Phrase: "and -"

Phrase: "ketoglutarate dehydrogenase complex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0022626:Ketoglutarate Dehydrogenase Complex [Amino Acid, Peptide, or Protein,Enzyme]
   901   C2755851:dehydrogenase complex [Cell Component]
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]
   734   C0599061:ketoglutarate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(2-oxoglutarate dehydrogenase,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0022626:2-Oxoglutarate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
           Oxoglutarate Dehydrogenase
   901   C1291208:2-Oxoglutarate [Organic Chemical,Pharmacologic Substance]
   901   C1417943:OXOGLUTARATE DEHYDROGENASE [Gene or Genome]
   827   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "dihydrolipoyl succinyl-transferase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "dihydrolipoyl dehydrogenase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023783:Dihydrolipoyl Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1414063:DIHYDROLIPOYL DEHYDROGENASE [Gene or Genome]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "as well as"

Phrase: "Ucp2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0536847:uncoupling protein-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421314:UNCOUPLING PROTEIN 2 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.104: Furthermore, we determined the mRNA levels of the sulfonylurea receptor-1 (Sur-1), ATP-dependent K+-channel (Kir6.2), prohormone convertase-2 and -3 (Pc2, Pc3), pterin-4-carbinolamine dehydratase (Pcd, DCoh), insulin, glucagon, somatostatin, pancreatic polypeptide (YY), and pancreatic peptide (PP). 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "determined"

Phrase: "the mRNA levels of the sulfonylurea receptor-1 (Sur-1),"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   750   C0456947:Level 1 [Intellectual Product]
   744   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "ATP-dependent K+-channel"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0439799:Channel [Spatial Concept]
   812   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1701901:Dependent [Qualitative Concept]
   812   C1706095:Channel [Conceptual Entity]
   812   C1708601:K' [Quantitative Concept]
   812   C3244310:dependent [Functional Concept]

Phrase: "(Kir6.2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416578:Kir6.2 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "prohormone convertase-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0083957:Prohormone Convertase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1258132:Prohormone Convertase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0301817:Prohormone [Hormone]

Phrase: "and -"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(Pc2,"

Phrase: "Pc3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2677316:PC-3 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "pterin-4-carbinolamine dehydratase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020239:Dehydratase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Pcd,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1824492:PCD [Gene or Genome]

Phrase: "DCoh"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418296:DCOH [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "glucagon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "somatostatin,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037659:Somatostatin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1881011:Somatostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   916 E C0373723:somatostatins [Laboratory Procedure]

Phrase: "pancreatic polypeptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0030298:Pancreatic Polypeptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1418856:pancreatic polypeptide [Gene or Genome]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   861   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "(YY"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "pancreatic peptide (PP)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030298:Pancreatic peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.105: Hypoxanthine phosphoribosyltransferase expression levels were determined to show that each sample contained equivalent amounts of mRNA. 

Phrase: "Hypoxanthine phosphoribosyltransferase expression levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C3244092:expression level [Idea or Concept]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "determined"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "each sample contained equivalent amounts of mRNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:amounts [Quantitative Concept]
Processing 00000000.tx.106: No products were amplified in the absence of reverse transcriptase, indicating the absence of genomic DNA in the mRNA samples. 

Phrase: "No products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "amplified in the absence of reverse transcriptase,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0332197:absence [Quantitative Concept]
   748   C1555029:Reverse [Idea or Concept]
   748   C1689985:Absence [Anatomical Abnormality]
   748   C2257077:transcriptase [Genetic Function]

Phrase: "indicating"

Phrase: "the absence of genomic DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "in the mRNA samples."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.107: The cDNA of each sample was derived from one animal, and five to six animals of each genotype (Hnf-1+/+, Hnf-1+/-, and Hnf-1-/-) were studied. 

Phrase: "The cDNA of each sample"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "derived from one animal,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0003062:Animal [Animal]
   770   C0205447:One [Quantitative Concept]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "five to six animals of each genotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0003062:Animals [Animal]
   748   C0017431:Genotype [Organism Attribute]
   748   C0205451:Five [Quantitative Concept]
   748   C0205452:Six [Quantitative Concept]

Phrase: "(Hnf-1+/+,"

Phrase: "Hnf-1+/-,"

Phrase: "and"

Phrase: "Hnf-1-/-"

Phrase: ")"

Phrase: "were"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.108: RNAs for genes encoding L-Pk, Gck, Glut2, neutral and neutral and basic amino acid transporter (Nbat), insulin (Ins-1), glucagon, and Dcoh were significantly reduced (Fig. 1A). 

Phrase: "RNAs for genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035668:rnas [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "L-Pk,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034348:Pyruvate Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0034354:pyruvate [Organic Chemical]
   827   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]

Phrase: "Gck,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1415014:GCK [Gene or Genome]
  1000   C1417019:GCK [Gene or Genome]

Phrase: "Glut2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420172:GLUCOSE TRANSPORTER 2 [Gene or Genome]
   901   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "neutral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1882074:Neutral [Qualitative Concept]
  1000   C2825492:Neutral [Phenomenon or Process]

Phrase: "and"

Phrase: "neutral and basic amino acid transporter (Nbat),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   919   C1420122:NEUTRAL AMINO ACID TRANSPORTER [Gene or Genome]
   885   C0301715:Neutral amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1882074:Neutral [Qualitative Concept]
   799   C2825492:Neutral [Phenomenon or Process]

Phrase: "insulin (Ins-1),"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "glucagon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "Dcoh"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418296:DCOH [Gene or Genome]

Phrase: "were"

Phrase: "significantly"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.109: The absence of Glut2 protein in mice that lack Hnf-1 was also confirmed by immunohistochemistry of pancreatic sections (Fig. 2). 

Phrase: "The absence of Glut2 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332197:absence [Quantitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "Hnf-1"

Phrase: "was"

Phrase: "also"

Phrase: "confirmed by immunohistochemistry of pancreatic sections"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   753   C0021044:Immunohistochemistry [Laboratory Procedure]
   753   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   753   C0750484:Confirmed [Idea or Concept]
   719   C0205155:Section [Spatial Concept]
   719   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   719 E C1456348:Confirm [Qualitative Concept]
   719   C1522472:Section [Substance]
   719   C1552923:Section [Quantitative Concept]
   719   C1705191:Section [Physical Object]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.110: The expression of other glucose (Glut1) and amino acid (neutral amino acid transporter) transporters remained unchanged (data not shown). 

Phrase: "The expression of other glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Glut1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1335837:GLUT1 [Gene or Genome]
  1000   C1504631:Glut-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1705603:GLUT1 [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "amino acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(neutral amino acid transporter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420122:NEUTRAL AMINO ACID TRANSPORTER [Gene or Genome]
   923   C0949771:Amino Acid Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0301715:Neutral amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "transporters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596902:transporters [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "remained"

Phrase: "unchanged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442739:Unchanged [Finding]
  1000   C2346711:Unchanged [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.111: The expression of the remaining glycolytic enzymes, including phosphoglucose isomerase, phosphofructokinase, aldolase B, triosephosphate isomerase, glucosephosphate dehydrogenase, phosphoglycerate kinase, phosphoglycerate mutase, 2,3-bisphosphoglycerate mutase, and -, -, and -enolases were also similar in islets of Hnf-1+/+ and Hnf-1-/- animals (Fig. 1B, data not shown). 

Phrase: "The expression of the remaining glycolytic enzymes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "phosphoglucose isomerase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017759:Phosphoglucose Isomerase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1333690:PHOSPHOGLUCOSE ISOMERASE [Gene or Genome]
   861   C0022202:Isomerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phosphofructokinase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031651:Phosphofructokinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0162449:PHOSPHOFRUCTOKINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "aldolase B,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001999:Aldolase B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412347:ALDOLASE B [Gene or Genome]
   861   C0016762:Aldolase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "triosephosphate isomerase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041078:Triose-Phosphate Isomerase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0022202:Isomerase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0370101:Triosephosphate [Biologically Active Substance,Carbohydrate]

Phrase: "glucosephosphate dehydrogenase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017757:Glucosephosphate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017761:glucose phosphate [Carbohydrate]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phosphoglycerate kinase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031656:PHOSPHOGLYCERATE KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0597219:phosphoglycerate [Carbohydrate]

Phrase: "phosphoglycerate mutase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031659:Phosphoglycerate Mutase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0524938:Mutase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0597219:phosphoglycerate [Carbohydrate]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3-bisphosphoglycerate mutase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0005651:Bisphosphoglycerate Mutase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1412816:BISPHOSPHOGLYCERATE MUTASE [Gene or Genome]
   827   C0524938:Mutase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and -"

Phrase: ", -"

Phrase: ","

Phrase: "and -"

Phrase: "enolases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0031691:ENOLASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "also similar in islets of Hnf-1+/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "Hnf-1-/- animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "(Fig. 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.112: Expression of mitochondrial genes involved in the TCA cycle, such as Ogdh, as well as Kir6.2, Sur-1, Pc2, and Pc3, were also unchanged (Fig. 1B, data not shown). 

Phrase: "Expression of mitochondrial genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0017262:Gene Expression [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "involved in the TCA cycle,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0008858:TCA Cycle [Molecular Function]
   760   C0041405:TCA [Geographic Area]
   760   C0085758:TCA [Congenital Abnormality]
   760   C1314939:Involved [Functional Concept]
   760   C1415587:TCA [Gene or Genome]
   760   C1511572:Cycle [Temporal Concept]
   760   C3536819:TCA [Pharmacologic Substance]

Phrase: "such as Ogdh,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022626:Oxoglutarate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417943:OXOGLUTARATE DEHYDROGENASE [Gene or Genome]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "as well as"

Phrase: "Kir6.2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416578:Kir6.2 [Gene or Genome]

Phrase: "Sur-1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]
   827   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: "Pc2,"

Phrase: "and"

Phrase: "Pc3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2677316:PC-3 [Gene or Genome]

Phrase: "were"

Phrase: "also unchanged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0442739:Unchanged [Finding]
   861   C2346711:Unchanged [Qualitative Concept]

Phrase: "(Fig. 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.113: The expression of different islet cell type markers, such as Iapp, somatostatin, and YY genes, did not differ, suggesting that the various islet cell types contributed equally in wild-type and Hnf-1-/- animals (data not shown). 

Phrase: "The expression of different islet cell type markers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "such as Iapp,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:IAPP [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:IAPP [Gene or Genome]

Phrase: "somatostatin,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037659:Somatostatin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1881011:Somatostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   916 E C0373723:somatostatins [Laboratory Procedure]

Phrase: "and"

Phrase: "YY genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the various islet cell types"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0449475:Cell types [Intellectual Product]
   827 E C0007634:Cell Type [Cell]
   812   C0332307:Types [Qualitative Concept]
   779 E C1547052:*Type [Quantitative Concept]

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "equally in wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "Hnf-1-/- animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.114: As expected, glucagon expression was slightly reduced in hyperglycemic Hnf-1-/- mice (Fig. 1A). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "glucagon expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "reduced in hyperglycemic Hnf-1-/- mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0162418:Hyperglycemic Mice [Mammal]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0392756:Reduced [Qualitative Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.115: View larger version (60K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(60K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.116: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.117: Steady-state mRNA levels of target genes in Hnf-1+/+, Hnf-1+/-, and Hnf-1-/- pancreatic islets of 4- to 6week-old mice. 

Phrase: "Steady-state mRNA levels of target genes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   757   C0683927:state level [Spatial Concept]
   748   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "in Hnf-1+/+,"

Phrase: "Hnf-1+/-,"

Phrase: "and"

Phrase: "Hnf-1-/- pancreatic islets of 4-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   767   C1416480:ISLET 1 [Gene or Genome]
   753   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "to 6week-old mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.118: A: RT-PCR analysis of islet-enriched transcription factors and candidate HNF-1 target genes in pancreata of newborn mice and adult islets. 

Phrase: "A"

Phrase: ":"

Phrase: "RT-PCR analysis of islet-enriched transcription factors"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   820   C0599161:Reverse Transcriptase Polymerase Chain Reaction [Molecular Biology Research Technique]
   808   C0814037:reverse transcription polymerase chain reaction [Genetic Function]
   797   C0200931:Polymerase chain reaction analysis [Laboratory Procedure]
   775   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   756   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   754   C0035380:Reverse Transcription [Genetic Function]
   754   C0085801:analysis factors [Quantitative Concept]
   738   C0002778:Analysis [Laboratory Procedure]
   738   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0337112:Chain [Manufactured Object]
   738   C0443286:Reaction [Functional Concept]
   738   C0936012:Analysis [Research Activity]
   738   C1114821:Reaction [Clinical Attribute]
   738   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C1524024:analysis [Functional Concept]
   738   C1524075:Chain [Idea or Concept]
   738   C1555029:Reverse [Idea or Concept]
   738   C2257077:transcriptase [Genetic Function]

Phrase: "and"

Phrase: "candidate HNF-1 target genes in pancreata of newborn mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   751   C1332838:Candidate Genes [Gene or Genome]
           Target Gene
   736   C0017337:Genes [Gene or Genome]
   734   C1417166:MICE gene [Gene or Genome]

Phrase: "and"

Phrase: "adult islets."
Processing 00000000.tx.119: B: RT-PCR analysis of glycolytic and mitochondrial gene mRNA levels in the adult islets. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "RT-PCR analysis of glycolytic"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   869   C0599161:Reverse Transcriptase Polymerase Chain Reaction [Molecular Biology Research Technique]
   833   C0200931:Polymerase chain reaction analysis [Laboratory Procedure]
   800   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0337112:Chain [Manufactured Object]
   744   C0443286:Reaction [Functional Concept]
   744   C0936012:Analysis [Research Activity]
   744   C1114821:Reaction [Clinical Attribute]
   744   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1524024:analysis [Functional Concept]
   744   C1524075:Chain [Idea or Concept]
   744   C1555029:Reverse [Idea or Concept]
   744   C2257077:transcriptase [Genetic Function]

Phrase: "and"

Phrase: "mitochondrial gene mRNA levels in the adult islets."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C0066598:mRNA, mitochondrial [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.120: At least five different animals for each genotype were measured by RT-PCR using [-32P]dCTP (expression levels of only two animals per genotype are shown). 

Phrase: "At least five different animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "for each genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "were"

Phrase: "measured by RT-PCR"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   897   C0599161:Reverse Transcriptase Polymerase Chain Reaction [Molecular Biology Research Technique]
   814   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   778   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0337112:Chain [Manufactured Object]
   748   C0443286:Reaction [Functional Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C1114821:Reaction [Clinical Attribute]
   748   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1524075:Chain [Idea or Concept]
   748   C1555029:Reverse [Idea or Concept]
   748   C2257077:transcriptase [Genetic Function]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "[-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]dCTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045191:dCTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(expression levels of only two animals"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   756   C3244092:expression level [Idea or Concept]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "per genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.121: PCR products were separated by PAGE, and bands were visualized by autoradiography. 

Phrase: "PCR products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]
   756   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "were"

Phrase: "separated by PAGE,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]
   790   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "visualized by autoradiography."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004400:Autoradiography [Laboratory Procedure]
   790   C0234621:Visualized [Functional Concept]
Processing 00000000.tx.122: Quantitative measurements were obtained by densitometry. 

Phrase: "Quantitative measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:measurements [Functional Concept]

Phrase: "were"

Phrase: "obtained by densitometry."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0011321:Densitometry [Laboratory Procedure]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.123: WT/Mut indicates the ratio of expression levels of the means of wild-type (Hnf-1+/+) and null (Hnf-1-/-) mice (n = 56). 

Phrase: "WT/Mut"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1417504:MUT [Gene or Genome]

Phrase: "indicates"

Phrase: "the ratio of expression levels of the means of wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0456603:Ratio [Quantitative Concept]
   738   C1547037:Ratio [Intellectual Product]

Phrase: "(Hnf-1+/+"

Phrase: ")"

Phrase: "and"

Phrase: "null"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456148:Null [Quantitative Concept]

Phrase: "(Hnf-1-/-"

Phrase: ")"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "(n = 56"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.124: *P 0.05; 

Phrase: "*P 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.125: **P 0.01; 

Phrase: "*"

Phrase: "*P 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.126: ***P 0.005.  

Phrase: "*"

Phrase: "*"

Phrase: "*P 0.005."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.127: View larger version (108K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(108K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.128: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.129: Immunofluorescence staining of pancreatic islets for Glut2 protein. 

Phrase: "Immunofluorescence staining of pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]

Phrase: "for Glut2 protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C2599779:Glucose & Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Carbohydrate]
   875   C0007292:Transporter Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1420172:GLUCOSE TRANSPORTER 2 [Gene or Genome]
Processing 00000000.tx.130: Pancreatic tissue sections showing representative islets from 4-week-old Hnf-1+/+ and Hnf-1-/- mice are shown. 

Phrase: "Pancreatic tissue sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C2316368:Tissue section [Tissue]
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "representative islets from 4-week-old Hnf-1+/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   750   C1416480:ISLET 1 [Gene or Genome]

Phrase: "and"

Phrase: "Hnf-1-/- mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.131: Sections were stained with antibodies against Glut2, as described in RESEARCH DESIGN AND METHODS. 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "stained with antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C2986582:Stained [Qualitative Concept]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "against Glut2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420172:GLUCOSE TRANSPORTER 2 [Gene or Genome]
   901   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as"

Phrase: "described in RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0035171:Research Design [Research Activity]
   770   C0035168:research [Research Activity]
   770   C0242481:Research [Research Activity]
   770   C1552738:described [Idea or Concept]
   770   C1707689:Design [Activity]
   770   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.132: Pancreas sections from HNF-1 wild-type littermates demonstrated red fluorescence staining on the membranes of the cells at the center of the pancreatic islets, indicating the presence of Glut2 in the membranes of pancreatic -cells. 

Phrase: "Pancreas sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "from HNF-1 wild-type littermates demonstrated red fluorescence staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   788   C0487602:Staining [Laboratory Procedure]
   788   C1704680:Staining [Finding]

Phrase: "on the membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "of the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "at the center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205099:Center [Spatial Concept]

Phrase: "of the pancreatic islets,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "indicating"

Phrase: "the presence of Glut2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "of pancreatic -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.133: In contrast, there was no staining evident in the islets of Hnf-1-/- mice. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "there"

Phrase: "was"

Phrase: "no staining evident in the islets"

Phrase: "of Hnf-1-/- mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.134: Staining in HNF-1 heterozygous mice was similar to that in the wild-type mice (data not shown).  

Phrase: "Staining in HNF-1 heterozygous mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0487602:Staining [Laboratory Procedure]
   744   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "in the wild-type mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.135: Because hyperglycemia and hypoinsulinemia in Hnf-1-/- animals can lead to secondary changes in gene expression (35), the expression of the above-mentioned genes were also studied in pancreata of newborn animals that had not been exposed to chronic hyperglycemia. 

Phrase: "Because"

Phrase: "hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "and"

Phrase: "hypoinsulinemia in Hnf-1-/- animals"

Phrase: "can"

Phrase: "lead to secondary changes"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   819   C0175668:Secondary to [Temporal Concept]
           Secondary
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0027627:secondary [Neoplastic Process]
   770   C0205436:Secondary [Quantitative Concept]
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "in gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(35"

Phrase: ")"

Phrase: ","

Phrase: "the expression of the above-mentioned genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0017262:Gene Expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "also"

Phrase: "studied in pancreata of newborn animals"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0003065:Animals, Newborn [Animal]
   753   C0003062:Animals [Animal]
   753   C0021289:Newborn [Age Group]
   753   C2239178:Newborn, NOS [Finding]
   753   C2939425:Newborn, NOS [Temporal Concept]
   750   C0683949:Animal Study [Animal]
   719   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   719   C0557651:Study [Manufactured Object]
   719   C1278931:Pancreas [Body Part, Organ, or Organ Component]
   719   C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "had"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "exposed to chronic hyperglycemia."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   833   C0342300:Chronic hyperglycaemia [Pathologic Function]
   770   C0020456:Hyperglycaemia [Disease or Syndrome]
   770   C0205191:chronic [Temporal Concept]
Processing 00000000.tx.136: We found that the expression of Glut2, L-Pk, Dcoh, and Ins-1 was already decreased shortly after birth (Fig. 1A), suggesting that Hnf-1 deficiency leads to the reduced expression of these genes. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the expression of Glut2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "L-Pk,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034348:Pyruvate Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0034354:pyruvate [Organic Chemical]
   827   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]

Phrase: "Dcoh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418296:DCOH [Gene or Genome]

Phrase: "and"

Phrase: "Ins-1"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "already"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "shortly after birth"
Meta Candidates (Total=16; Excluded=13; Pruned=0; Remaining=3)
   827   C0005615:Birth [Organism Function]
   827   C1550722:birth [Idea or Concept]
   827   C3245487:birth [Intellectual Product]
   771 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   771 E C0314603:Genetic [Functional Concept]
   771 E C0454729:Natal [Geographic Area]
   743 E C0035150:Reproduction [Organism Function]
   743 E C0079946:origin [Classification]
   743 E C0439659:Origin [Temporal Concept]
   743 E C1550512:origin [Intellectual Product]
   727 E C0559522:Genital [Body System]
   727 E C1546649:Genital [Intellectual Product]
   727 E C1550642:Genital [Body Substance]
   721 E C0205313:Original [Idea or Concept]
   721 E C2347409:Original [Occupational Activity]
   708 E C0598240:originality [Mental Process]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that Hnf-1 deficiency"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0011155:Deficiency [Functional Concept]
   827   C0162429:Deficiency [Disease or Syndrome]
   827   C1623416:deficiency [Qualitative Concept]
   755 E C1636779:% deficient [Quantitative Concept]

Phrase: "leads to the reduced expression of these genes."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   750   C0017262:Gene Expression [Genetic Function]
   744   C0017337:Genes [Gene or Genome]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0181586:leads [Medical Device]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0392756:Reduced [Qualitative Concept]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522538:Lead [Functional Concept]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.137: In contrast, glucagon and Gck mRNA levels were not altered in newborn pancreata (Fig. 1A), demonstrating that the decreased expression in Hnf-1-/- adult islets is likely due to hyperglycemia or hypoinsulinemia in these mice. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "Gck mRNA levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "altered in newborn pancreata"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0021289:Newborn [Age Group]
   770   C0392747:Altered [Functional Concept]
   770   C2239178:Newborn, NOS [Finding]
   770   C2939425:Newborn, NOS [Temporal Concept]
   737   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   737   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "demonstrating"

Phrase: "that"

Phrase: "the decreased expression in Hnf-1-/- adult islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "likely due to hyperglycemia"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0678226:Due to [Functional Concept]
           due
   770   C0020456:Hyperglycaemia [Disease or Syndrome]
   770   C0332148:Likely [Qualitative Concept]
   770   C0750492:Likely [Idea or Concept]
   770   C3146286:Due [Idea or Concept]

Phrase: "or"

Phrase: "hypoinsulinemia in these mice."
Processing 00000000.tx.138: Finally, we found that the expression of L-Pk was markedly reduced in islets of adult and newborn Hnf-1-/- animals. 

Phrase: "Finally,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the expression of L-Pk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "reduced in islets of adult"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0001675:Adult [Age Group]
   760   C0392756:Reduced [Qualitative Concept]
   760   C1706450:Adult [Human]

Phrase: "and"

Phrase: "newborn Hnf-1-/- animals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C0003065:Animals, Newborn [Animal]
   812   C0003062:Animals [Animal]
Processing 00000000.tx.139: This transcriptional defect was specific for L-Pk, and expression levels of the muscle isoform (M2Pk) were unchanged in Hnf-1-/- mice. 

Phrase: "This transcriptional defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1457869:Defect [Functional Concept]
   861   C1861101:DEFECT [Disease or Syndrome]

Phrase: "was"

Phrase: "specific for L-Pk,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "expression levels of the muscle isoform"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   756   C3244092:expression level [Idea or Concept]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "(M2Pk"

Phrase: ")"

Phrase: "were"

Phrase: "unchanged in Hnf-1-/- mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0442739:Unchanged [Finding]
   760   C2346711:Unchanged [Qualitative Concept]
Processing 00000000.tx.140: To estimate the effect of the reduced L-Pk expression on overall pyruvate kinase activity, we measured total pyruvate kinase activity in islets of Hnf-1+/+ and Hnf-1-/- mice (data not shown). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "estimate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimate [Quantitative Concept]

Phrase: "the effect of the reduced L-Pk expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "on overall pyruvate kinase activity,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0427509:pyruvate kinase activity [Molecular Function]
   861   C1150423:kinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "total pyruvate kinase activity in islets of Hnf-1+/+"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0427509:pyruvate kinase activity [Molecular Function]
   764   C1150423:kinase activity [Molecular Function]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "Hnf-1-/- mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.141: No differences were detected in total pyruvate kinase activity, supporting previous findings that M2Pk is the major pyruvate kinase isoform in pancreatic islets (36,37). 

Phrase: "No differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "detected in total pyruvate kinase activity,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   833   C0427509:pyruvate kinase activity [Molecular Function]
   790   C0034348:Pyruvate Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1150423:kinase activity [Molecular Function]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0034354:pyruvate [Organic Chemical]
   753   C0205177:Activity [Functional Concept]
   753   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
   753   C0439167:% activity [Quantitative Concept]
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]
   753   C0441655:Activity [Activity]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "previous findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "that M2Pk"

Phrase: "is"

Phrase: "the major pyruvate kinase isoform in pancreatic islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "(36,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.142: Abnormal gene expression of islet-enriched transcription factors in Hnf-1-/- mice. 

Phrase: "Abnormal gene expression of islet-enriched transcription factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   776   C0812327:Transcription Factor Gene [Gene or Genome]
   770   C0017262:Gene Expression [Genetic Function]
   767   C0040649:Gene Transcription [Genetic Function]
   744   C0017337:Gene [Gene or Genome]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in Hnf-1-/- mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.143: The effect of Hnf-1 deficiency on the expression of islet-enriched transcription factors was determined in islets of 4-week-old Hnf-1-/-, Hnf-1+/-, and Hnf-1+/+ littermates by RT-PCR. 

Phrase: "The effect of Hnf-1 deficiency"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of islet-enriched transcription factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0040649:Transcription [Genetic Function]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]

Phrase: "was"

Phrase: "determined in islets"

Phrase: "of 4-week-old Hnf-1-/-,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0332174:/week [Temporal Concept]
   804   C0439230:week [Temporal Concept]
   804   C0580836:Old [Temporal Concept]

Phrase: "Hnf-1+/-,"

Phrase: "and"

Phrase: "Hnf-1+/+ littermates"

Phrase: "by RT-PCR."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0599161:Reverse Transcriptase Polymerase Chain Reaction [Molecular Biology Research Technique]
   884   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   840   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0337112:Chain [Manufactured Object]
   804   C0443286:Reaction [Functional Concept]
   804   C1114821:Reaction [Clinical Attribute]
   804   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1524075:Chain [Idea or Concept]
   804   C1555029:Reverse [Idea or Concept]
   804   C2257077:transcriptase [Genetic Function]
Processing 00000000.tx.144: Steady-state mRNA levels of Hnf-4, an upstream regulator of Hnf-1, were reduced in islets of Hnf-1-/- mice, suggesting that Hnf-1 is critical for the normal expression of Hnf-4 in pancreatic islets (Fig. 1A). 

Phrase: "Steady-state mRNA levels of Hnf-4,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   757   C0456950:Level 4 [Qualitative Concept]
   757   C0683927:state level [Spatial Concept]
   748   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "an upstream regulator of Hnf-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0182953:REGULATOR [Medical Device]
   753   C1704734:Regulator [Medical Device]
   753   C1704735:Regulator [Conceptual Entity]

Phrase: "were"

Phrase: "reduced in islets of Hnf-1-/- mice,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   757   C1416480:ISLET 1 [Gene or Genome]
   757   C1522528:Mouse Islets [Tissue]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0392756:Reduced [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that Hnf-1"

Phrase: "is"

Phrase: "critical for the normal expression of Hnf-4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1511545:Critical [Qualitative Concept]

Phrase: "in pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.145: We also found that expression levels of several other islet-enriched transcription factors, including Pdx-1, Neuro-D1, and Shp-1, were reduced 2- to 11-fold in islets of Hnf-1-/- mice (Fig. 1A). 

Phrase: "We also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that expression levels of several"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C3244092:expression level [Idea or Concept]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "other islet-enriched transcription factors,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0040649:Transcription [Genetic Function]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Pdx-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "Neuro-D1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416886:D1 [Gene or Genome]

Phrase: "and"

Phrase: "Shp-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1334896:SMALL HETERODIMER PARTNER [Gene or Genome]
  1000   C1335142:Small Heterodimer Partner [Amino Acid, Peptide, or Protein,Receptor]
   827   C0682323:Partner [Family Group]
   827   C0700321:Small [Quantitative Concept]

Phrase: "were"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "to 11-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "in islets"

Phrase: "of Hnf-1-/- mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.146: In contrast, the expression levels of Hnf-1, -3, -3, -3, -4, -6, Nkx-2.2, Pax-4, Pax-6, Isl-1, Cdx2/3, and Lim-1 did not differ between Hnf-1-/- and Hnf-1+/+ mice (Fig. 1A, data not shown). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the expression levels of Hnf-1, -"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   767   C0456947:Level 1 [Intellectual Product]
   756   C3244092:expression level [Idea or Concept]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "3, -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "3, -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "3, -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4, -"

Phrase: "6,"

Phrase: "Nkx-2.2,"

Phrase: "Pax-4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3542477:PAX [Gene or Genome]

Phrase: "Pax-6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3542477:PAX [Gene or Genome]

Phrase: "Isl-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416480:ISL1 [Gene or Genome]
   861   C0020750:ISL [Geographic Area]

Phrase: "Cdx2/3,"

Phrase: "and"

Phrase: "Lim-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1334337:LIM-1 [Gene or Genome]
  1000   C1705893:LIM-1 [Gene or Genome]
   861   C0449205:LIM [Body Location or Region]
   861   C1538613:LIM [Gene or Genome]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ between Hnf-1-/-"

Phrase: "and"

Phrase: "Hnf-1+/+ mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.147: Steady-state mRNA levels were also measured in pancreata of newborn mice. 

Phrase: "Steady-state mRNA levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   858   C0683927:state level [Spatial Concept]
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "also"

Phrase: "measured in pancreata of newborn mice."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   753   C0021289:Newborn [Age Group]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0444706:Measured [Qualitative Concept]
   753   C2239178:Newborn, NOS [Finding]
   753   C2939425:Newborn, NOS [Temporal Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   750   C1518865:Mouse Pancreas [Tissue]
   719   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
   719   C1278931:Pancreas [Body Part, Organ, or Organ Component]
Processing 00000000.tx.148: The expression levels of Pdx-1 and Neuro-D1 were already reduced in newborn mice (Fig. 1A). 

Phrase: "The expression levels of Pdx-1"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   767   C0456947:Level 1 [Intellectual Product]
   756   C3244092:expression level [Idea or Concept]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "Neuro-D1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416886:D1 [Gene or Genome]

Phrase: "were"

Phrase: "already"

Phrase: "reduced in newborn mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0021289:Newborn [Age Group]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0392756:Reduced [Qualitative Concept]
   770   C2239178:Newborn, NOS [Finding]
   770   C2939425:Newborn, NOS [Temporal Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.149: This indicates that Hnf-1 deficiency rather than nonspecific effects as a result of hyperglycemia is responsible for the abnormal expression of Pdx-1 and Neuro-D1. 

Phrase: "This"

Phrase: "indicates"

Phrase: "that Hnf-1 deficiency"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0011155:Deficiency [Functional Concept]
   827   C0162429:Deficiency [Disease or Syndrome]
   827   C1623416:deficiency [Qualitative Concept]
   755 E C1636779:% deficient [Quantitative Concept]

Phrase: "rather than"

Phrase: "nonspecific effects as a result of hyperglycemia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "responsible for the abnormal expression of Pdx-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "Neuro-D1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416886:D1 [Gene or Genome]
Processing 00000000.tx.150: Liver gene expression profiles in Hnf-1+/+ and Hnf-1-/- mice. 

Phrase: "Liver gene expression profiles in Hnf-1+/+"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   814   C1956267:Gene Expression Profiles [Quantitative Concept]
   797 E C1449575:gene expression profile [Laboratory Procedure]
   714   C1979963:Profile [Laboratory Procedure]
   714   C2003903:Profile [Functional Concept]

Phrase: "and"

Phrase: "Hnf-1-/- mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.151: To test whether the changes in gene expression profiles of pancreatic islets are also present in the liver of Hnf-1-/- animals, we measured mRNA concentrations of all the above-mentioned genes in Hnf-1 null, heterozygous, and wild-type mice. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "the changes in gene expression profiles of pancreatic islets"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0025320:The change [Physiologic Function]
   742   C0392747:changes [Functional Concept]
   742   C0443172:changes [Quantitative Concept]
   708 E C1705241:Change [Quantitative Concept]

Phrase: "are"

Phrase: "also"

Phrase: "present in the liver of Hnf-1-/- animals,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0003062:Animals [Animal]
   744   C0023884:Liver [Body Part, Organ, or Organ Component]
   744   C0150312:Present [Quantitative Concept]
   744   C0449450:Present [Idea or Concept]
   744   C0736268:LIVER [Body Part, Organ, or Organ Component]
   744   C1278929:Liver [Body Part, Organ, or Organ Component]
   744   C2346688:LIVER [Food]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "mRNA concentrations of all"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "the above-mentioned genes in Hnf-1 null, heterozygous,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0017337:Genes [Gene or Genome]

Phrase: "and"

Phrase: "wild-type mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.152: In contrast to pancreatic islets, the expression of Glut1, Glut2, and L-Pk was increased in Hnf-1-/- mice (Fig. 3). 

Phrase: "In contrast to pancreatic islets,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "the expression of Glut1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "Glut2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420172:GLUCOSE TRANSPORTER 2 [Gene or Genome]
   901   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "L-Pk"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034348:Pyruvate Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0034354:pyruvate [Organic Chemical]
   827   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]

Phrase: "was"

Phrase: "increased in Hnf-1-/- mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.153: The expression of the remaining glycolytic and mitochondrial genes was similar in mice of different Hnf-1 genotypes (data not shown). 

Phrase: "The expression of the remaining glycolytic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "mitochondrial genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1563761:Genes, Mitochondrial [Gene or Genome]
   861   C0017337:Genes [Gene or Genome]

Phrase: "was"

Phrase: "similar in mice of different Hnf-1 genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2348205:Similar [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.154: Consistent with previous observations (21,22), transcript levels of Hnf-1 were increased, whereas steady-state mRNA of DCoH and Igf-1 were reduced in Hnf-1 null liver (Fig. 3). 

Phrase: "Consistent with previous observations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(21,"

Phrase: "22"

Phrase: ")"

Phrase: ","

Phrase: "transcript levels of Hnf-1"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   781   C0456947:Level 1 [Intellectual Product]
   760   C0441889:Levels [Qualitative Concept]
   760   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "whereas"

Phrase: "steady-state mRNA of DCoH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "Igf-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]

Phrase: "were"

Phrase: "reduced in Hnf-1 null liver"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0023884:Liver [Body Part, Organ, or Organ Component]
   753   C0392756:Reduced [Qualitative Concept]
   753   C0456148:Null [Quantitative Concept]
   753   C0736268:LIVER [Body Part, Organ, or Organ Component]
   753   C1278929:Liver [Body Part, Organ, or Organ Component]
   753   C2346688:LIVER [Food]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.155: The expression of Hnf-3, -3, -3, and -4 were unchanged, whereas Hnf-6 was reduced eightfold in Hnf-1-/- mice compared with wild-type littermates (Fig. 3). 

Phrase: "The expression of Hnf-3, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "3, -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and -"

Phrase: "4"

Phrase: "were"

Phrase: "unchanged,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442739:Unchanged [Finding]
  1000   C2346711:Unchanged [Qualitative Concept]

Phrase: "whereas"

Phrase: "Hnf-6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417951:HNF-6 [Gene or Genome]

Phrase: "was"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "eightfold in Hnf-1-/- mice"

Phrase: "compared with wild-type littermates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.156: We also tested 100 additional genes, including genes of apolipoprotein, amino acid, and lipid metabolism. 

Phrase: "We also"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "100 additional genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "genes of apolipoprotein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C1445865:Apolipoprotein gene [Gene or Genome]
   790   C0017337:Genes [Gene or Genome]

Phrase: "amino acid,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "lipid metabolism."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0598783:Lipid Metabolism [Molecular Function]
  1000   C1517898:Lipid Metabolism [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.157: We found that in the liver of Hnf-1-/- mice, mRNA levels of Nbat were reduced 2.2-fold compared with wild-type littermates (Fig. 3). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that in the liver of Hnf-1-/- mice,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   750   C1517914:Mouse Liver [Tissue]
   744   C0023884:Liver [Body Part, Organ, or Organ Component]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0736268:LIVER [Body Part, Organ, or Organ Component]
   744   C1278929:Liver [Body Part, Organ, or Organ Component]
   744   C2346688:LIVER [Food]

Phrase: "mRNA levels of Nbat"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   742   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "2.2-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "compared with wild-type littermates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.158: In summary, these data demonstrate that differences exist in the gene expression profiles of islets versus liver in Hnf-1-/- mice. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "that differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "exist in the gene expression profiles of islets"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   800   C1956267:Gene Expression Profiles [Quantitative Concept]
   783 E C1449575:gene expression profile [Laboratory Procedure]
   770   C0017262:Gene Expression [Genetic Function]
   744   C0017337:Gene [Gene or Genome]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C2987476:Exist [Conceptual Entity]
   711   C1979963:Profile [Laboratory Procedure]
   711   C2003903:Profile [Functional Concept]

Phrase: "versus"

Phrase: "liver in Hnf-1-/- mice."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   781   C1517914:Mouse Liver [Tissue]
   760   C0023884:Liver [Body Part, Organ, or Organ Component]
   760   C0736268:LIVER [Body Part, Organ, or Organ Component]
   760   C1278929:Liver [Body Part, Organ, or Organ Component]
   760   C2346688:LIVER [Food]
   704 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.159: Therefore, in the liver, other mechanisms that can activate Hnf-1 target genes, such as Glut2 and L-Pk, and compensate for the loss of Hnf-1 function must be operative. 

Phrase: "Therefore,"

Phrase: "in the liver,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "other mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "can"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "Hnf-1 target genes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C1332838:Target Gene [Gene or Genome]
   812   C0017337:Genes [Gene or Genome]

Phrase: "such as Glut2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420172:GLUCOSE TRANSPORTER 2 [Gene or Genome]
   901   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "L-Pk,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034348:Pyruvate Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0034354:pyruvate [Organic Chemical]
   827   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "compensate for the loss of Hnf-1 function"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0031843:function [Physiologic Function]
   744   C0205432:compensate [Qualitative Concept]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1517945:Loss [Quantitative Concept]
   744   C1705273:Function [Intellectual Product]

Phrase: "must"

Phrase: "be"

Phrase: "operative."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882154:Operative [Temporal Concept]
Processing 00000000.tx.160: View larger version (44K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(44K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.161: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.162: Steady-state mRNA levels of HNF-1 target genes in livers of 4- to 6-week-old Hnf-1+/+, Hnf-1+/-, and Hnf-1-/- mice. 

Phrase: "Steady-state mRNA levels of HNF-1 target genes"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   738   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0441889:Levels [Qualitative Concept]
   737   C0456947:Level 1 [Intellectual Product]
   737   C0683927:state level [Spatial Concept]
   704 E C0456079:Level [Classification]
   704 E C1547707:Level [Geographic Area]
   704 E C2946261:Level [Pharmacologic Substance]

Phrase: "in livers"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0023884:Livers [Body Part, Organ, or Organ Component]
   966 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   966 E C1278929:Liver [Body Part, Organ, or Organ Component]
   966 E C2346688:LIVER [Food]
   928 E C0205054:Hepatic [Body Location or Region]

Phrase: "of 4-"

Phrase: "to 6-week-old Hnf-1+/+,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0332174:/week [Temporal Concept]
   804   C0439230:week [Temporal Concept]
   804   C0580836:Old [Temporal Concept]

Phrase: "Hnf-1+/-,"

Phrase: "and"

Phrase: "Hnf-1-/- mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.163: RT-PCR was performed from three separate RNA samples of each genotype as described in RESEARCH DESIGN AND METHODS. 

Phrase: "RT-PCR"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0599161:Reverse Transcriptase Polymerase Chain Reaction [Molecular Biology Research Technique]
   884   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   840   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0337112:Chain [Manufactured Object]
   804   C0443286:Reaction [Functional Concept]
   804   C1114821:Reaction [Clinical Attribute]
   804   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1524075:Chain [Idea or Concept]
   804   C1555029:Reverse [Idea or Concept]
   804   C2257077:transcriptase [Genetic Function]

Phrase: "was"

Phrase: "performed from three separate RNA samples of each genotype"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   742   C0017431:Genotype [Organism Attribute]
   742   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0205449:Three [Quantitative Concept]
   742   C0443299:Separate [Spatial Concept]
   742   C0884358:Performed [Functional Concept]
   708   C0370003:Sample [Substance]
   708   C2347026:Sample [Conceptual Entity]
   708 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described in RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0035171:Research Design [Research Activity]
   770   C0035168:research [Research Activity]
   770   C0242481:Research [Research Activity]
   770   C1552738:described [Idea or Concept]
   770   C1707689:Design [Activity]
   770   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.164: WT/Mut indicates the ratio of expression levels of the means of wild-type (Hnf-1+/+) and null (Hnf-1-/-) mice. 

Phrase: "WT/Mut"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1417504:MUT [Gene or Genome]

Phrase: "indicates"

Phrase: "the ratio of expression levels of the means of wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0456603:Ratio [Quantitative Concept]
   738   C1547037:Ratio [Intellectual Product]

Phrase: "(Hnf-1+/+"

Phrase: ")"

Phrase: "and"

Phrase: "null"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456148:Null [Quantitative Concept]

Phrase: "(Hnf-1-/-"

Phrase: ")"

Phrase: "mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.165: *P 0.05; 

Phrase: "*P 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.166: **P 0.01; 

Phrase: "*"

Phrase: "*P 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.167: ***P 0.005. 

Phrase: "*"

Phrase: "*"

Phrase: "*P 0.005."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.168: Differences in L-Pk and Glut2 expression in wild-type versus mutant livers reached marginal significance (P = 0.06).  

Phrase: "Differences in L-Pk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "Glut2 expression in wild-type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "versus"

Phrase: "mutant livers"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0023884:Livers [Body Part, Organ, or Organ Component]
   827 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   827 E C1278929:Liver [Body Part, Organ, or Organ Component]
   827 E C2346688:LIVER [Food]
   789 E C0205054:Hepatic [Body Location or Region]

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "marginal significance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0237881:Significance [Quantitative Concept]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "(P = 0.06"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.169: The transcriptional activation and inhibition of small heterodimer partner (Shp-1) is mediated by Hnf-4 in vitro. 

Phrase: "The transcriptional activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162493:Transcriptional Activation [Genetic Function]
   861   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "inhibition of small heterodimer partner"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "(Shp-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1334896:SMALL HETERODIMER PARTNER [Gene or Genome]
  1000   C1335142:Small Heterodimer Partner [Amino Acid, Peptide, or Protein,Receptor]
   827   C0682323:Partner [Family Group]
   827   C0700321:Small [Quantitative Concept]

Phrase: ")"

Phrase: "is"

Phrase: "mediated by Hnf-4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.170: Shp-1 is an orphan nuclear receptor that heterodimerizes with various nuclear hormone receptors, including Hnf-4 (38,39). 

Phrase: "Shp-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1334896:SMALL HETERODIMER PARTNER [Gene or Genome]
  1000   C1335142:Small Heterodimer Partner [Amino Acid, Peptide, or Protein,Receptor]
   827   C0682323:Partner [Family Group]
   827   C0700321:Small [Quantitative Concept]

Phrase: "is"

Phrase: "an orphan nuclear receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0206588:Nuclear Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0521447:Nuclear [Spatial Concept]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "that"

Phrase: "heterodimerizes with various nuclear hormone receptors,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0887829:Nuclear Hormone Receptors [Amino Acid, Peptide, or Protein,Receptor]
   799 E C1753269:nuclear hormone receptor [Molecular Function]
   790   C0019929:hormone receptors [Amino Acid, Peptide, or Protein,Receptor]
   783   C0206588:Receptors, Nuclear [Amino Acid, Peptide, or Protein,Receptor]
   756 E C1367453:HORMONE RECEPTOR [Gene or Genome]
   753   C0019932:Hormone [Hormone]
   753   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   753   C0521447:Nuclear [Spatial Concept]
   753   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Hnf-4"

Phrase: "(38,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.171: Our in vivo expression data indicate that Shp-1 expression was reduced in adult islets of Hnf-1 null mice but not in newborn islets (Fig. 1). 

Phrase: "Our in vivo expression data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1511726:Data [Idea or Concept]
   812   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that Shp-1 expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   756   C1334896:SMALL HETERODIMER PARTNER [Gene or Genome]
   756   C1335142:Small Heterodimer Partner [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "was"

Phrase: "reduced in adult islets of Hnf-1 null mice"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0206745:Null Mouse [Mammal]
   745   C1416480:ISLET 1 [Gene or Genome]
   745   C1522528:Mouse Islets [Tissue]
   742   C0001675:Adult [Age Group]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0392756:Reduced [Qualitative Concept]
   742   C0456148:Null [Quantitative Concept]
   742   C1706450:Adult [Human]

Phrase: "but"

Phrase: "not in newborn islets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021289:Newborn [Age Group]
   770   C1518422:Not [Functional Concept]
   770   C2239178:Newborn, NOS [Finding]
   770   C2939425:Newborn, NOS [Temporal Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.172: We then analyzed the promoter regions of human and murine Shp-1 but found no Hnf-1 binding sites (40). 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the promoter regions of human"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0033413:Promoter Regions [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]

Phrase: "and"

Phrase: "murine Shp-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1334896:SMALL HETERODIMER PARTNER [Gene or Genome]
   923   C1335142:Small Heterodimer Partner [Amino Acid, Peptide, or Protein,Receptor]
   812   C0682323:Partner [Family Group]
   812   C0700321:Small [Quantitative Concept]

Phrase: "but"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no Hnf-1 binding sites"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0005456:Binding Sites [Receptor]
   827 E C0682969:Binding Site [Amino Acid Sequence]
   812   C0205145:Sites [Spatial Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.173: In contrast, a putative HNF-4 consensus binding sequence was identified at position -551 to -570 bp in the human SHP-1 promoter. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "a putative HNF-4 consensus binding sequence"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   822   C0079160:Consensus Sequence [Nucleotide Sequence]
   793   C0004793:Sequence [Nucleotide Sequence]
   793   C0162326:Sequence [Nucleotide Sequence]
   793   C0162327:Sequence [Nucleotide Sequence]
   793   C0243122:binding [Functional Concept]
   793   C0376298:Consensus [Social Behavior]
   793   C1145667:Binding [Activity]
   793   C1167622:Binding [Molecular Function]
   793   C1519249:Sequence [Functional Concept]
   721 E C1548958:Sequential [Idea or Concept]
   721 E C1705294:Sequential [Qualitative Concept]

Phrase: "was"

Phrase: "identified at position -551 to -570 bp"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205396:Identified [Qualitative Concept]
   748   C0733755:Position [Spatial Concept]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]

Phrase: "in the human SHP-1 promoter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.174: This binding site was also conserved at a similar location in the murine Shp-1 promoter (Genbank accession nos. for murine and human sequences are AF044315 and AF044316, respectively). 

Phrase: "This binding site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0005456:Binding Site [Receptor]
  1000   C0682969:Binding Site [Amino Acid Sequence]
   861   C0205145:Site [Spatial Concept]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "was"

Phrase: "also"

Phrase: "conserved at a similar location"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0450429:Location [Spatial Concept]
   760   C1515974:Location [Body Location or Region]
   760   C2348205:Similar [Qualitative Concept]

Phrase: "in the murine Shp-1 promoter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   717   C1334896:SMALL HETERODIMER PARTNER [Gene or Genome]
   717   C1335142:Small Heterodimer Partner [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(Genbank accession nos."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1518425:{NOS} [Qualitative Concept]

Phrase: "for murine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026809:Murine [Mammal]
  1000   C0591833:Murine [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "human sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "are"

Phrase: "AF044315"

Phrase: "and"

Phrase: "AF044316,"

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.175: We therefore hypothesized that the downregulation of Shp-1 may be due to the reduced Hnf-4 message in Hnf-1-/- mice. 

Phrase: "We therefore"

Phrase: "hypothesized"

Phrase: "that"

Phrase: "the downregulation of Shp-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0013081:Down-Regulation [Cell Function,Molecular Function]

Phrase: "may"

Phrase: "be due to the reduced Hnf-4 message"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0678226:Due to [Functional Concept]
           due
   744   C0392756:Reduced [Qualitative Concept]
   744   C0470166:Message [Intellectual Product]
   744   C2987476:Be [Conceptual Entity]
   744   C3146286:Due [Idea or Concept]

Phrase: "in Hnf-1-/- mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.176: To further study the transcriptional regulation of Shp-1, we cloned a 582 bp of the 5' human SHP-1 promoter containing the putative HNF-4 binding site and linked it to a luciferase reporter gene (pGL2-pSHP-1). 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the transcriptional regulation of Shp-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1158770:Transcriptional Regulation [Genetic Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "we"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "a 582 bp of the 5' human SHP-1 promoter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0628295:A 1,5-BP [Carbohydrate]
   757   C2984182:BP-1 [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the putative HNF-4 binding site"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   818   C0005456:Binding Site [Receptor]
   818   C0682969:Binding Site [Amino Acid Sequence]
   795   C0205145:Site [Spatial Concept]
   795   C0243122:binding [Functional Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1515974:Site [Body Location or Region]
   795   C2825164:Site [Spatial Concept]
   710   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]

Phrase: "and"

Phrase: "linked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "it to a luciferase reporter gene"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0206414:Reporter Gene [Gene or Genome]
   783   C1334435:Luciferase Gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
   753   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   753   C0335038:Reporter [Professional or Occupational Group]
   753   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   753   C1705915:Reporter [Conceptual Entity]
   753   C1709908:Reporter [Group]

Phrase: "(pGL2-pSHP-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1866552:PGL2 [Disease or Syndrome]
   827   C3273616:PGL2 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.177: Cotransfection of this reporter plasmid with an HNF-4 expression vector (pcDNA3-pHNF-4) showed an approximate two- to fivefold dose-dependent activation of the SHP-1 promoter in three different cell lines, Cos7, HepG2, and HIT-T15 (Figs. 4AC). 

Phrase: "Cotransfection of this reporter plasmid"

Phrase: "with an HNF-4 expression vector"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0442335:Vector [Spatial Concept]
   799   C1705099:Vector [Idea or Concept]
   734   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]

Phrase: "(pcDNA3-pHNF-4"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "an approximate two-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205448:Two [Quantitative Concept]

Phrase: "to fivefold dose-dependent activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "of the SHP-1 promoter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1335283:SHP-1 [Gene or Genome]
   734   C1705637:SHP-1 [Gene or Genome]

Phrase: "in three different cell lines,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "Cos7,"

Phrase: "HepG2,"

Phrase: "and"

Phrase: "HIT-T15"

Phrase: "(Figs. 4AC"

Phrase: ")."
Processing 00000000.tx.178: In contrast, HNF-1 expression did not result in the transcriptional activation of this reporter construct (Figs. 4AC). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "HNF-1 expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   771   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]
   717   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "result in the transcriptional activation of this reporter construct"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0162493:Transcriptional Activation [Genetic Function]
   742   C0040649:Transcriptional [Genetic Function]
   742   C0335038:Reporter [Professional or Occupational Group]
   742   C1274040:Result [Functional Concept]
   742   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   742   C1546471:Result [Idea or Concept]
   742   C1705915:Reporter [Conceptual Entity]
   742   C1709908:Reporter [Group]
   742   C1879547:Activation [Activity]
   742   C2825142:Result [Finding]
   742   C2827421:Construct [Classification]

Phrase: "(Figs. 4AC"

Phrase: ")."
Processing 00000000.tx.179: To confirm that HNF-4 can directly activate the SHP-1 promoter, we mutated one hexamer half of the HNF-4 binding site in the reporter plasmid pGL2-pSHP-1. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that HNF-4"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   923   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0227525:Hepatocyte [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "can"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the SHP-1 promoter,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1335283:SHP-1 [Gene or Genome]
   734   C1705637:SHP-1 [Gene or Genome]

Phrase: "we"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "one hexamer half of the HNF-4 binding site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C2825407:Half [Quantitative Concept]

Phrase: "in the reporter plasmid pGL2-pSHP-1."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0335038:Reporter [Professional or Occupational Group]
   804   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   804   C1705915:Reporter [Conceptual Entity]
   804   C1709908:Reporter [Group]
   804   C1866552:PGL2 [Disease or Syndrome]
   804   C3273616:PGL2 [Gene or Genome]
Processing 00000000.tx.180: Transcriptional activation of HNF-4 on the resulting SHP-1 reporter plasmid (pGL2-pSHPmut) was abolished (Fig. 4DF), indicating that the HNF-4 binding site in the SHP-1 promoter is functionally important for its expression. 

Phrase: "Transcriptional activation of HNF-4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0162493:Transcriptional Activation [Genetic Function]
   748   C1879547:Activation [Activity]

Phrase: "on the resulting SHP-1 reporter plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(pGL2-pSHPmut"

Phrase: ")"

Phrase: "was"

Phrase: "abolished"

Phrase: "(Fig. 4DF"

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "the HNF-4 binding site in the SHP-1 promoter"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0005456:Binding Site [Receptor]
   753   C0682969:Binding Site [Amino Acid Sequence]
   736   C0205145:Site [Spatial Concept]
   736   C0243122:binding [Functional Concept]
   736   C1145667:Binding [Activity]
   736   C1167622:Binding [Molecular Function]
   736   C1515974:Site [Body Location or Region]
   736   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "functionally important for its expression."
Processing 00000000.tx.181: View larger version (56K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(56K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.182: 4. 

Phrase: "4."
Processing 00000000.tx.183: Transient expression and transcriptional activity of HNF-4 using a reporter plasmid that contains the SHP promoter upstream of the luciferase gene. 

Phrase: "Transient expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "transcriptional activity of HNF-4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   776   C1148759:transcription factor activity [Genetic Function]
   776   C3537021:Transcription Factor Activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a reporter plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "that"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the SHP promoter upstream of the luciferase gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0314621:Promoter gene [Gene or Genome]
   744   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.184: A C: The reporter construct pGL2-pSHP was cotransfected with pCMV-pHNF-4 or pcDNA3-pHNF-1 into Cos7, HepG2, and HIT-T15 cells. 

Phrase: "A C"

Phrase: ":"

Phrase: "The reporter construct pGL2-pSHP"

Phrase: "was"

Phrase: "cotransfected with pCMV-pHNF-4"

Phrase: "or"

Phrase: "pcDNA3-pHNF-1 into Cos7,"

Phrase: "HepG2,"

Phrase: "and"

Phrase: "HIT-T15 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.185: DF: The HNF-4 binding site in the SHP promoter is mutated in pGL2-pSHPmut. 

Phrase: "DF"

Phrase: ":"

Phrase: "The HNF-4 binding site in the SHP promoter"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   756   C0005456:Binding Site [Receptor]
   756   C0682969:Binding Site [Amino Acid Sequence]
   738   C0205145:Site [Spatial Concept]
   738   C0243122:binding [Functional Concept]
   738   C1145667:Binding [Activity]
   738   C1167622:Binding [Molecular Function]
   738   C1515974:Site [Body Location or Region]
   738   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "mutated in pGL2-pSHPmut."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C1705285:Mutated [Cell or Molecular Dysfunction]
   770   C1866552:PGL2 [Disease or Syndrome]
   770   C3273616:PGL2 [Gene or Genome]
   737 E C1513776:Mutate [Genetic Function]
Processing 00000000.tx.186: GI: Cotransfection in various cell types of pCMV-pHNF-4 and increasing amounts of pCMV-pSHP in the presence of reporter pGL2-pSHP. 

Phrase: "GI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539617:GI [Idea or Concept]

Phrase: ":"

Phrase: "Cotransfection in various cell types of pCMV-pHNF-4"

Phrase: "and"

Phrase: "increasing amounts of pCMV-pSHP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of reporter pGL2-pSHP."
Processing 00000000.tx.187: Cells were harvested 48 h after transfections and assayed for luciferase and -galactosidase activities. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "48 h after transfections"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "assayed for luciferase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]

Phrase: "and -"

Phrase: "galactosidase activities."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C1150051:galactosidase activity [Molecular Function]
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.188: The average fold inductions from two independent transfections done in duplicate and normalized to -galactosidase activity are shown. 

Phrase: "The average fold inductions from two independent transfections"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0857127:inductions [Therapeutic or Preventive Procedure]
   711 E C0205263:Induction [Functional Concept]

Phrase: "done in duplicate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205173:Duplicate [Functional Concept]
   790   C1272695:Done [Qualitative Concept]
   790   C2746065:Done [Temporal Concept]
   790   C3539942:Duplicate [Intellectual Product]

Phrase: "and"

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "to -galactosidase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1150051:galactosidase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.189: Error bars indicate SD.  

Phrase: "Error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "indicate"

Phrase: "SD."
Processing 00000000.tx.190: Electrophoretic mobility shift assays were performed to investigate whether HNF-4 can bind to the putative HNF-4 binding site in the SHP-1 promoter. 

Phrase: "Electrophoretic mobility shift assays"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   966   C0949632:Electrophoretic Mobility Shift Assay [Laboratory Procedure]
           Mobility Shift Assays
   812   C0333051:Shift [Functional Concept]
   812   C0425245:Mobility [Finding]
   812   C0449580:Mobility [Qualitative Concept]
   812   C2347509:Shift [Phenomenon or Process]
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]
   741   C0013855:Electrophoreses [Laboratory Procedure]
   741 E C0231435:Mobile [Functional Concept]
   741 E C1552449:Mobile [Health Care Related Organization,Manufactured Object]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "HNF-4"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   923   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0227525:Hepatocyte [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "can"

Phrase: "bind to the putative HNF-4 binding site"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   806   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   782   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0005456:Binding Site [Receptor]
   760   C0682969:Binding Site [Amino Acid Sequence]
   739   C0205145:Site [Spatial Concept]
   739   C0227525:Hepatocyte [Cell]
   739   C0243122:binding [Functional Concept]
   739   C0521447:Nuclear [Spatial Concept]
   739   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1145667:Bind [Activity]
           Binding
   739   C1167622:Binding [Molecular Function]
           bind
   739   C1515974:Site [Body Location or Region]
   739   C1521761:Factor [Functional Concept]
   739   C2825164:Site [Spatial Concept]
   739   C2827422:Factor [Conceptual Entity]

Phrase: "in the SHP-1 promoter."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1335283:SHP-1 [Gene or Genome]
   734   C1705637:SHP-1 [Gene or Genome]
Processing 00000000.tx.191: A major DNA/protein complex was detected with a 32P-labeled oligonucleotide that contained the HNF-4 binding site (Fig. 5, lane 2). 

Phrase: "A major DNA/protein complex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C2246376:DNA-protein complex [Cell Component]
   861   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1523872:protein complex [Cell Component]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "was"

Phrase: "detected with a 32P-labeled oligonucleotide"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1553631:32p [Medical Device]
   753   C1708632:Labeled [Qualitative Concept]
   719 E C0181496:Label [Manufactured Object]
   719 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "that"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "the HNF-4 binding site"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0005456:Binding Site [Receptor]
   827   C0682969:Binding Site [Amino Acid Sequence]
   799   C0205145:Site [Spatial Concept]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1515974:Site [Body Location or Region]
   799   C2825164:Site [Spatial Concept]
   734   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.192: This binding activity could be competed by an unlabeled excess of cold HNF-4 binding oligonucleotide (Fig. 5, lane 3). 

Phrase: "This binding activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2266866:Binding Activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "could"

Phrase: "be"

Phrase: "competed by an unlabeled excess of cold HNF-4 binding oligonucleotide"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   784   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   784   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   766   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C0009264:Cold [Natural Phenomenon or Process]
   735   C0009443:Cold [Disease or Syndrome]
   735   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   735   C0227525:Hepatocyte [Cell]
   735   C0234192:Cold [Physiologic Function]
   735   C0243122:binding [Functional Concept]
   735   C0521447:Nuclear [Spatial Concept]
   735   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   735   C1145667:Binding [Activity]
   735   C1167622:Binding [Molecular Function]
   735   C1521761:Factor [Functional Concept]
   735   C1979886:Excess [Qualitative Concept]
   735   C2827422:Factor [Conceptual Entity]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.193: Furthermore, a supershift of the complex was observed after preincubation of extract with a monospecific antiHNF-4 antiserum (-445) but not with antiSTAT-1 antibodies (Fig. 5, lanes 4 and 5), demonstrating that HNF-4 can bind to the HNF-4 site in the SHP-1 promoter. 

Phrase: "Furthermore,"

Phrase: "a supershift of the complex"

Phrase: "was"

Phrase: "observed after preincubation of extract"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1441672:Observed [Functional Concept]
   760   C2828366:Extract [Substance]

Phrase: "with a monospecific antiHNF-4 antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(-445"

Phrase: ")"

Phrase: "but"

Phrase: "not with antiSTAT-1 antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C1518422:Not [Functional Concept]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lanes 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "demonstrating"

Phrase: "that HNF-4"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   923   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0227525:Hepatocyte [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "can"

Phrase: "bind to the HNF-4 site"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   800   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205145:Site [Spatial Concept]
   744   C0227525:Hepatocyte [Cell]
   744   C0521447:Nuclear [Spatial Concept]
   744   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1145667:Bind [Activity]
   744   C1167622:bind [Molecular Function]
   744   C1515974:Site [Body Location or Region]
   744   C1521761:Factor [Functional Concept]
   744   C2825164:Site [Spatial Concept]
   744   C2827422:Factor [Conceptual Entity]

Phrase: "in the SHP-1 promoter."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1335283:SHP-1 [Gene or Genome]
   734   C1705637:SHP-1 [Gene or Genome]
Processing 00000000.tx.194: As expected, HNF-4 was not able to bind to the mutated HNF-4 site (Fig. 5, lane 7). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "HNF-4"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   923   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0227525:Hepatocyte [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "was"

Phrase: "not able to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]
   827   C1518422:Not [Functional Concept]

Phrase: "bind to the mutated HNF-4 site"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   818   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   790   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205145:Site [Spatial Concept]
   742   C0227525:Hepatocyte [Cell]
   742   C0521447:Nuclear [Spatial Concept]
   742   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1145667:Bind [Activity]
   742   C1167622:bind [Molecular Function]
   742   C1515974:Site [Body Location or Region]
   742   C1521761:Factor [Functional Concept]
   742   C1705285:Mutated [Cell or Molecular Dysfunction]
   742   C2825164:Site [Spatial Concept]
   742   C2827422:Factor [Conceptual Entity]
   708 E C1513776:Mutate [Genetic Function]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lane 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.195: View larger version (57K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(57K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.196: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.197: Electrophoretic mobility shift assay analysis of the HNF-4 binding site in the SHP promoter. 

Phrase: "Electrophoretic mobility shift assay analysis of the HNF-4 binding site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   749   C0085801:Analysis, Factor [Quantitative Concept]
   735   C0002778:Analysis [Laboratory Procedure]
   735   C0936012:Analysis [Research Activity]
   735   C1524024:analysis [Functional Concept]

Phrase: "in the SHP promoter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.198: The DNA binding activity was measured using a 32P-labeled double-stranded oligonucleotide containing the HNF-4 binding site as a probe and nuclear extracts of HIT-T15 cells that were transfected with pCMV-pHNF-4. 

Phrase: "The DNA binding activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C2266866:Binding Activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C1148673:DNA Binding [Genetic Function]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 32P-labeled double-stranded oligonucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the HNF-4 binding site as a probe"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0005456:Binding Site [Receptor]
   760   C0682969:Binding Site [Amino Acid Sequence]
   757   C0449996:Probe site [Spatial Concept]
   739   C0205145:Site [Spatial Concept]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1515974:Site [Body Location or Region]
   739   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "nuclear extracts of HIT-T15 cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0007592:Cell Extracts [Cell Component]
   756   C1518434:Nuclear Extract [Biomedical or Dental Material]
   753   C0521447:Nuclear [Spatial Concept]
   719   C2828366:Extract [Substance]

Phrase: "that"

Phrase: "were"

Phrase: "transfected with pCMV-pHNF-4."
Processing 00000000.tx.199: Competition was carried out with a 20-fold excess of cold probe (lane 3), and supershifts were performed with a monospecific antiHNF-4 antiserum or an antiStat-1 control antiserum (lanes 4 and 5, respectively). 

Phrase: "Competition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679932:competition [Social Behavior]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out with a 20-fold excess of cold probe"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   742   C0009264:Cold [Natural Phenomenon or Process]
   742   C0009443:Cold [Disease or Syndrome]
   742   C0182400:Probe [Medical Device]
   742   C0234192:Cold [Physiologic Function]
   742   C0332462:Fold [Spatial Concept]
   742   C0439787:Out [Spatial Concept]
   742   C0849355:Out [Qualitative Concept]
   742   C1704681:Probe [Gene or Genome]
   742   C1880834:FOLD [Phenomenon or Process]
   742   C1979886:Excess [Qualitative Concept]
   742   C2347609:Probe [Chemical Viewed Functionally]
   742   C3536729:Probe [Manufactured Object]

Phrase: "(lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "supershifts"

Phrase: "were"

Phrase: "performed with a monospecific antiHNF-4 antiserum"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0884358:Performed [Functional Concept]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "or"

Phrase: "an antiStat-1 control antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(lanes 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.200: No binding activity was detected with a probe containing a mutated HNF-4 binding site (lane 7). 

Phrase: "No binding activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2266866:Binding Activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "detected with a probe"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0182400:Probe [Medical Device]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1704681:Probe [Gene or Genome]
   770   C2347609:Probe [Chemical Viewed Functionally]
   770   C3536729:Probe [Manufactured Object]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a mutated HNF-4 binding site"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   818   C0005456:Binding Site [Receptor]
   818   C0682969:Binding Site [Amino Acid Sequence]
   795   C0205145:Site [Spatial Concept]
   795   C0243122:binding [Functional Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1515974:Site [Body Location or Region]
   795   C2825164:Site [Spatial Concept]
   710   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]

Phrase: "(lane 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.201: Free probe on the bottom of the gel is not shown.  

Phrase: "Free probe on the bottom of the gel"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0182400:Probe [Medical Device]
   744   C1704681:Probe [Gene or Genome]
   744   C2347609:Probe [Chemical Viewed Functionally]
   744   C3536729:Probe [Manufactured Object]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.202: To test whether SHP-1 can inhibit its own transcriptional activation, we cotransfected SHP-1 expression vector pcDNA3-pSHP-1 with constant quantities of pCMV-pHNF-4 and pGL2-pSHP-1 into Cos7, HIT-T15, and HepG2 cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "SHP-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1335283:SHP-1 [Gene or Genome]
  1000   C1705637:SHP-1 [Gene or Genome]
   861   C1334896:SHP [Gene or Genome]
   861   C1335142:SHP [Amino Acid, Peptide, or Protein,Receptor]
   861   C1705299:SHP [Gene or Genome]

Phrase: "can"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "its own transcriptional activation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0162493:Transcriptional Activation [Genetic Function]
   827   C1879547:Activation [Activity]

Phrase: "we"

Phrase: "cotransfected"

Phrase: "SHP-1 expression vector pcDNA3-pSHP-1 with constant quantities"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   760   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1335283:SHP-1 [Gene or Genome]
   760   C1705637:SHP-1 [Gene or Genome]
   739   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C0442335:Vector [Spatial Concept]
   739   C1265611:QUANTITIES [Quantitative Concept]
   739   C1334896:SHP [Gene or Genome]
   739   C1335142:SHP [Amino Acid, Peptide, or Protein,Receptor]
   739   C1547014:*Constant [Quantitative Concept]
   739   C1705099:Vector [Idea or Concept]
   739   C1705299:SHP [Gene or Genome]
   739   C1948059:Constant [Qualitative Concept]
   706 E C1554108:Quantity [Intellectual Product]
   706 E C1561573:Quantity [Intellectual Product]

Phrase: "of pCMV-pHNF-4"

Phrase: "and"

Phrase: "pGL2-pSHP-1 into Cos7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1866552:PGL2 [Disease or Syndrome]
   760   C3273616:PGL2 [Gene or Genome]

Phrase: "HIT-T15,"

Phrase: "and"

Phrase: "HepG2 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.203: Luciferase activity decreased in a dose-dependent manner when increasing amounts of pcDNA3-pSHP-1 vector were coexpressed with HNF-4 (Figs. 4GI). 

Phrase: "Luciferase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1151115:luciferase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "decreased in a dose-dependent manner"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C1512045:Dose-dependent [Quantitative Concept]
   753   C0178602:Dose [Quantitative Concept]
   753   C0205216:Decreased [Quantitative Concept]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0442797:decreased [Qualitative Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]
   719 E C0547047:Decrease [Quantitative Concept]

Phrase: "when"

Phrase: "increasing amounts of pcDNA3-pSHP-1 vector"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "coexpressed with HNF-4"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   882   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   882   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   833   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0227525:Hepatocyte [Cell]
   753   C0521447:Nuclear [Spatial Concept]
   753   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "(Figs. 4GI"

Phrase: ")."
Processing 00000000.tx.204: These data suggest that SHP-1 can inhibit its own transcription through a negative transcriptional feedback loop that is mediated by HNF-4 (Fig. 6). 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that SHP-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1335283:SHP-1 [Gene or Genome]
  1000   C1705637:SHP-1 [Gene or Genome]
   861   C1334896:SHP [Gene or Genome]
   861   C1335142:SHP [Amino Acid, Peptide, or Protein,Receptor]
   861   C1705299:SHP [Gene or Genome]

Phrase: "can"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "its own transcription through a negative transcriptional feedback"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0040649:Transcription [Genetic Function]

Phrase: "loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0419518:Loop [Medical Device]
  1000   C0445022:Loop [Spatial Concept]

Phrase: "that"

Phrase: "is"

Phrase: "mediated by HNF-4"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   882   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   882   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   833   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0227525:Hepatocyte [Cell]
   753   C0521447:Nuclear [Spatial Concept]
   753   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.205: View larger version (20K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.206: 6. 

Phrase: "6."
Processing 00000000.tx.207: Proposed model for a hierarchical transcriptional network in pancreatic islets. 

Phrase: "Proposed model for a hierarchical transcriptional network"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3161035:Model [Intellectual Product]

Phrase: "in pancreatic islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
Processing 00000000.tx.208: This diagram shows the transcriptional regulation of genes essential for pancreatic islet function by hepatocyte nuclear factors. 

Phrase: "This diagram"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681494:Diagram [Intellectual Product]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the transcriptional regulation of genes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   809   C1710463:Transcription Regulation Gene [Gene or Genome]
   806   C1158770:Transcriptional Regulation [Genetic Function]
   797   C0017263:genes regulation [Genetic Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "essential for pancreatic islet function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205224:Essential [Qualitative Concept]

Phrase: "by hepatocyte nuclear factors."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0872184:Hepatocyte Nuclear Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0521447:Nuclear [Spatial Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.209: Arrows show positive regulation. 

Phrase: "Arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "positive regulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0851285:Regulation [Governmental or Regulatory Activity]
   861   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.210: Bold arrows indicate transcriptional regulation described in this study; 

Phrase: "Bold arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "transcriptional regulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1158770:Transcriptional Regulation [Genetic Function]
   861   C0851285:Regulation [Governmental or Regulatory Activity]
   861   C1327622:Regulation [Biologic Function]

Phrase: "described in this study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C1552738:described [Idea or Concept]
   770   C2603343:Study [Research Activity]

Phrase: ";"
Processing 00000000.tx.211: numbers adjacent to arrows indicate references of previous in vitro and in vivo studies.   

Phrase: "numbers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "adjacent to arrows"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0205117:Adjacent to [Spatial Concept]
           Adjacent
   718 E C3242705:adjacency [Idea or Concept]

Phrase: "indicate"

Phrase: "references of previous in vitro"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1514811:Reference [Idea or Concept]
   726   C1706462:Reference [Conceptual Entity]

Phrase: "and"

Phrase: "in vivo studies."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0681829:in vivo study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C1515655:In Vivo [Spatial Concept]
Processing 00000000.tx.212: DISCUSSION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Previous studies demonstrated that the insulin secretory responses to glucose are impaired in Hnf-1-/- mice (27). 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the insulin secretory responses to glucose"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]

Phrase: "are"

Phrase: "impaired in Hnf-1-/- mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0221099:Impaired [Functional Concept]
   760   C0684336:Impaired [Pathologic Function]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.213: Physiological studies have shown that KATP in -cells of mutant mice are insensitive to suppression by glucose or glyceraldehyde but are normally sensitive to ATP. 

Phrase: "Physiological studies"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0205463:Physiological [Functional Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
   789 E C0031842:Physiology [Biomedical Occupation or Discipline]
   789 E C0031843:physiology [Physiologic Function]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that KATP in -cells of mutant mice"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "insensitive to suppression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0237677:Insensitivity [Finding]

Phrase: "by glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "or"

Phrase: "glyceraldehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017854:Glyceraldehyde [Carbohydrate]

Phrase: "but"

Phrase: "are"

Phrase: "normally sensitive to ATP."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332324:Sensitive to [Functional Concept]
           Sensitive
   770   C1550474:sensitive [Idea or Concept]
Processing 00000000.tx.214: Flux of glucose through glycolysis in islets of mutant mice is reduced, but mitochondrial substrates, such as methylpyruvate, can inhibit KATP, elevate [Ca2+], and restore the insulin secretion defect (28). 

Phrase: "Flux of glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348693:Flux [Natural Phenomenon or Process]

Phrase: "through glycolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017952:Glycolysis [Molecular Function]

Phrase: "in islets"

Phrase: "of mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "is"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: ","

Phrase: "but"

Phrase: "mitochondrial substrates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "such as methylpyruvate,"

Phrase: "can"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "KATP,"

Phrase: "elevate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:elevate [Qualitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "],"

Phrase: "and"

Phrase: "restore"

Phrase: "the insulin secretion defect"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1457869:Defect [Functional Concept]
   827   C1861101:DEFECT [Disease or Syndrome]
   734   C1256369:insulin secretion [Cell Function]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.215: These results indicate that insulin secretion is impaired by a defect proximal to mitochondrial metabolism in the -cell glycolytic signaling pathway. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "impaired by a defect"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0221099:Impaired [Functional Concept]
   770   C0684336:Impaired [Pathologic Function]
   770   C1457869:Defect [Functional Concept]
   770   C1861101:DEFECT [Disease or Syndrome]

Phrase: "proximal to mitochondrial metabolism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205107:Proximal [Spatial Concept]

Phrase: "in the -cell glycolytic signaling pathway."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0037083:signaling pathway [Cell Function]
           Cell Signaling
   861   C0086982:Signaling Pathway [Molecular Function]
   844 E C0037080:Signal Pathway [Molecular Function]
   839   C1512233:Glycolysis Pathway [Molecular Function]
   812   C1704259:Pathway [Molecular Function]
   812   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.216: However, a recent in vitro study showed that expressing a dominant negative form of Hnf-1, HNF1-P291fsinsC, in insulinoma INS-1 cells affects mitochondrial function by reducing the expression of Ogdh and increasing the expression of Ucp2 (31). 

Phrase: "However,"

Phrase: "a recent in vitro study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0681828:in vitro study [Research Activity]
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "expressing"

Phrase: "a dominant negative form of Hnf-1,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   748   C0205160:Negative [Qualitative Concept]
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1513916:Negative [Finding]
   748   C1522492:Form [Functional Concept]
   748   C1527180:Dominant [Functional Concept]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825491:Negative [Qualitative Concept]

Phrase: "HNF1-P291fsinsC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0065110:Hepatic Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in insulinoma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021670:insulinoma [Neoplastic Process]

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "mitochondrial function by reducing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "the expression of Ogdh"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the expression of Ucp2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.217: The net result of these expressing alterations is to impair mitochondrial function such as oxidation and ATP generation and to dissipate the mitochondrial membrane potential, leading to decreased glucose-stimulated insulin secretion (GSIS). 

Phrase: "The net result of these expressing alterations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]

Phrase: "is"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "impair"

Phrase: "mitochondrial function such as oxidation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0030011:Oxidation, function [Molecular Function]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "ATP generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "dissipate"

Phrase: "the mitochondrial membrane potential,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "leading to decreased glucose-stimulated insulin secretion (GSIS)."
Meta Candidates (Total=22; Excluded=6; Pruned=0; Remaining=16)
   804   C1371675:Decreased Insulin Secretion [Organ or Tissue Function]
   778   C0860801:decreased glucose [Finding]
   778   C1256369:insulin secretion [Cell Function]
   774 E C1704381:Glucose decreased [Finding]
   774   C1719133:Glucose/Insulin [Quantitative Concept]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C0205216:Decreased [Quantitative Concept]
   748   C0332152:Leading [Temporal Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C1522538:Leading [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1948023:Stimulated [Natural Phenomenon or Process]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C0547047:Decrease [Quantitative Concept]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.218: These inconsistent findings have not been resolved. 

Phrase: "These inconsistent findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "resolved."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514893:Resolved [Idea or Concept]
  1000   C2699488:Resolved [Conceptual Entity]
Processing 00000000.tx.219: In addition, the molecular basis by which Hnf-1 deficiency causes impaired GSIS are poorly understood. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the molecular basis by which Hnf-1 deficiency"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1853126:MOLECULAR BASIS [Idea or Concept]
   744   C1527178:Basis [Functional Concept]
   744   C1874451:Basis [Pharmacologic Substance]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "impaired GSIS"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   853   C1719133:Glucose/Insulin [Quantitative Concept]
   840   C1256369:insulin secretion [Cell Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "are"

Phrase: "poorly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Poorly [Qualitative Concept]

Phrase: "understood."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]
Processing 00000000.tx.220: In this study, we investigated the transcriptional defect resulting from Hnf-1 deficiency. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the transcriptional defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1457869:Defect [Functional Concept]
   861   C1861101:DEFECT [Disease or Syndrome]

Phrase: "resulting from Hnf-1 deficiency."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0011155:Deficiency [Functional Concept]
   760   C0162429:Deficiency [Disease or Syndrome]
   760   C0678226:resulting [Functional Concept]
   760   C1623416:deficiency [Qualitative Concept]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]
Processing 00000000.tx.221: We studied steady-state mRNA levels in adult and newborn islets of genes that are critical for -cell function. 

Phrase: "We"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "steady-state mRNA levels in adult"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C0683927:state level [Spatial Concept]
   753   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "newborn islets of genes"

Phrase: "that"

Phrase: "are"

Phrase: "critical for -cell function."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511545:Critical [Qualitative Concept]
Processing 00000000.tx.222: Gene transcript levels were also measured in the pancreas of newborn animals to control for secondary effects that hyperglycemia may have on gene expression profiles in HNF-1-/- mice. 

Phrase: "Gene transcript levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0441889:Levels [Qualitative Concept]
   827   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "also"

Phrase: "measured in the pancreas of newborn animals to"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   770   C0003065:Animals, Newborn [Animal]
   767   C0449768:Measured to [Quantitative Concept]
   744   C0003062:Animals [Animal]
   744   C0021289:Newborn [Age Group]
   744   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   744   C0444706:Measured [Qualitative Concept]
   744   C1278931:Pancreas [Body Part, Organ, or Organ Component]
   744   C2239178:Newborn, NOS [Finding]
   744   C2939425:Newborn, NOS [Temporal Concept]
   744   C3541902:MEASURED [Diagnostic Procedure]
   711 E C0079809:Measure [Quantitative Concept]
   711 E C0242485:Measure [Functional Concept]

Phrase: "control for secondary effects"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0027627:secondary [Neoplastic Process]
   770   C0175668:Secondary [Temporal Concept]
   770   C0205436:Secondary [Quantitative Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1280500:effects [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "that hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "may"

Phrase: "have on gene expression profiles"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C1956267:Gene Expression Profiles [Quantitative Concept]
   845 E C1449575:gene expression profile [Laboratory Procedure]
   806   C0017262:Gene Expression [Genetic Function]
   760   C0017337:Gene [Gene or Genome]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C3154893:Have [Idea or Concept]
   760   C3539897:Have [Qualitative Concept]
   726   C1979963:Profile [Laboratory Procedure]
   726   C2003903:Profile [Functional Concept]

Phrase: "in HNF-1-/- mice."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   771   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]
   717   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.223: Newborn Hnf-1-/- mice are normoglycemic (87 vs. 90 mg/dl in HNF-1+/+ and HNF-1-/- newborn mice, respectively), and blood glucose levels of HNF-1+/- females are indistinguishable from HNF-1+/+ females during the last week of pregnancy (118 vs. 121 mg/dl in HNF-1+/+ and HNF-1+/- pregnant mice, respectively). 

Phrase: "Newborn Hnf-1-/- mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "normoglycemic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0580545:Normoglycaemic [Finding]

Phrase: "(87"

Phrase: "vs. 90 mg/dl in HNF-1+/+"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   764   C0439269:mg dl [Quantitative Concept]
   762 E C3463848:dl mg [Quantitative Concept]
   742   C3642216:/dL [Quantitative Concept]

Phrase: "and"

Phrase: "HNF-1-/- newborn mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   734   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]

Phrase: "respectively"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "blood glucose levels of HNF-1+/- females"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   790   C0428554:blood glucose levels [Laboratory or Test Result]
   764   C0005802:Blood Glucose [Carbohydrate]
   764   C0428548:glucose levels [Laboratory or Test Result]
   745   C0456947:Level 1 [Intellectual Product]
   742   C0005767:Blood [Tissue]
   742   C0005768:blood [Body Substance]
   742   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0229664:Blood [Body Substance]
   742   C0441889:Levels [Qualitative Concept]
   731 E C0337438:glucose level [Laboratory Procedure]
   712   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "indistinguishable from HNF-1+/+ females"

Phrase: "during the last week"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332174:/week [Temporal Concept]
   861   C0439230:week [Temporal Concept]

Phrase: "of pregnancy"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "(118"

Phrase: "vs. 121 mg/dl in HNF-1+/+"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   764   C0439269:mg dl [Quantitative Concept]
   762 E C3463848:dl mg [Quantitative Concept]
   742   C3642216:/dL [Quantitative Concept]

Phrase: "and"

Phrase: "HNF-1+/- pregnant mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   734   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.224: This indicates that newborn islets of HNF-1-/- mice were not exposed to chronic hyperglycemia. 

Phrase: "This"

Phrase: "indicates"

Phrase: "that newborn islets of HNF-1-/- mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   745   C1416480:ISLET 1 [Gene or Genome]
   745   C1522528:Mouse Islets [Tissue]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exposed to chronic hyperglycemia."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   833   C0342300:Chronic hyperglycaemia [Pathologic Function]
   770   C0020456:Hyperglycaemia [Disease or Syndrome]
   770   C0205191:chronic [Temporal Concept]
Processing 00000000.tx.225: We found reduced expression of three genes involved in the glycolytic signaling pathway, namely Glut2, Gck, and L-Pk in Hnf-1-/- mice (Fig. 1A). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "reduced expression of three genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0017262:Gene Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "involved in the glycolytic signaling pathway,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0037083:signaling pathway [Cell Function]
           Signaling
   790   C0086982:Signaling Pathway [Molecular Function]
   783 E C0037080:pathway signaling [Molecular Function]
   753   C1314939:Involved [Functional Concept]
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]
   753   C3537152:signaling [Biologic Function]
   748   C1512233:Glycolysis Pathway [Molecular Function]
   719 E C1710082:Signal [Phenomenon or Process]

Phrase: "namely Glut2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1420172:GLUCOSE TRANSPORTER 2 [Gene or Genome]
   861   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Gck,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1415014:GCK [Gene or Genome]
  1000   C1417019:GCK [Gene or Genome]

Phrase: "and"

Phrase: "L-Pk in Hnf-1-/- mice"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   804   C1418609:PYRUVATE KINASE 1 [Gene or Genome]
   778   C0034348:Pyruvate Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   757   C1517914:Mouse Liver [Tissue]
   748   C0023884:Liver [Body Part, Organ, or Organ Component]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0034354:pyruvate [Organic Chemical]
   748   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
   748   C0736268:LIVER [Body Part, Organ, or Organ Component]
   748   C1278929:Liver [Body Part, Organ, or Organ Component]
   748   C2346688:LIVER [Food]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.226: In addition, we found diminished expression of Nbat, an amino acid transporter that transports both neutral and basic amino acids into the cell (Fig. 1A). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "diminished expression of Nbat,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   810   C1420122:NEUTRAL AMINO ACID TRANSPORTER [Gene or Genome]
   790   C0301714:Basic Amino Acid [Amino Acid, Peptide, or Protein]
   790   C0949771:Amino Acid Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   784   C0301715:Neutral amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   764   C2917660:Amino Acid [Pharmacologic Substance]
   742   C0001128:Acid [Chemical]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0202406:Acid [Laboratory Procedure]
   742   C0205216:Diminished [Quantitative Concept]
   742   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1527178:Basic [Functional Concept]
   742   C1882074:Neutral [Qualitative Concept]
   742   C2825492:Neutral [Phenomenon or Process]

Phrase: "an amino acid transporter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0949771:Amino Acid Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "that transports"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005528:Transport, NOS [Cell Function]
  1000   C1317949:Transport [Manufactured Object]
  1000   C3495449:transport [Medical Device]

Phrase: "both neutral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1882074:Neutral [Qualitative Concept]
  1000   C2825492:Neutral [Phenomenon or Process]

Phrase: "and"

Phrase: "basic amino acids into the cell"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0301714:Amino Acids, Basic [Amino Acid, Peptide, or Protein]
   790   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756 E C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acids [Chemical]
   753   C1527178:Basic [Functional Concept]
   719 E C0202406:Acid [Laboratory Procedure]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.227: Reduced expression of Glut2, Gck, and Nbat are likely to contribute to the defect in GSIS because mutant mice that lack Glut2 or Gck are hyperglycemic and hypoinsulinemic as a result of impaired GSIS (41,42). 

Phrase: "Reduced expression of Glut2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "Gck,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1415014:GCK [Gene or Genome]
  1000   C1417019:GCK [Gene or Genome]

Phrase: "and"

Phrase: "Nbat"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   919   C1420122:NEUTRAL AMINO ACID TRANSPORTER [Gene or Genome]
   885   C0301715:Neutral amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1882074:Neutral [Qualitative Concept]
   799   C2825492:Neutral [Phenomenon or Process]

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "contribute to the defect"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1457869:Defect [Functional Concept]
   770   C1861101:DEFECT [Disease or Syndrome]
   770   C1880177:Contribute [Activity]

Phrase: "in GSIS"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "because"

Phrase: "mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "Glut2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420172:GLUCOSE TRANSPORTER 2 [Gene or Genome]
   901   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "Gck"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1415014:GCK [Gene or Genome]
  1000   C1417019:GCK [Gene or Genome]

Phrase: "are"

Phrase: "hyperglycemic"

Phrase: "and"

Phrase: "hypoinsulinemic as a result of impaired GSIS"

Phrase: "(41,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.228: The downregulation of Nbat may reduce the transport of basic and neutral amino acids into the -cell. 

Phrase: "The downregulation of Nbat"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   810   C1420122:NEUTRAL AMINO ACID TRANSPORTER [Gene or Genome]
   790   C0301714:Basic Amino Acid [Amino Acid, Peptide, or Protein]
   790   C0949771:Amino Acid Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   784   C0301715:Neutral amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   764   C2917660:Amino Acid [Pharmacologic Substance]
   742   C0001128:Acid [Chemical]
   742   C0013081:Down-Regulation [Cell Function,Molecular Function]
   742   C0202406:Acid [Laboratory Procedure]
   742   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1527178:Basic [Functional Concept]
   742   C1882074:Neutral [Qualitative Concept]
   742   C2825492:Neutral [Phenomenon or Process]

Phrase: "may"

Phrase: "reduce"

Phrase: "the transport of basic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0005528:Transport, NOS [Cell Function]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "neutral amino acids into the -cell."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0301715:Amino Acids, Neutral [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756 E C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acids [Chemical]
   753   C1882074:Neutral [Qualitative Concept]
   753   C2825492:Neutral [Phenomenon or Process]
   719 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.229: Furthermore, the reduced expression of Nbat offers a molecular explanation of the decreased cellular ATP production in response to leucine in cells that express a dominant negative form of the HNF-1 protein (31). 

Phrase: "Furthermore,"

Phrase: "the reduced expression of Nbat"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   799   C1420122:NEUTRAL AMINO ACID TRANSPORTER [Gene or Genome]
   782   C0301714:Basic Amino Acid [Amino Acid, Peptide, or Protein]
   782   C0949771:Amino Acid Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   777   C0301715:Neutral amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C2917660:Amino Acid [Pharmacologic Substance]
   739   C0001128:Acid [Chemical]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C0202406:Acid [Laboratory Procedure]
   739   C0392756:Reduced [Qualitative Concept]
   739   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1527178:Basic [Functional Concept]
   739   C1882074:Neutral [Qualitative Concept]
   739   C2825492:Neutral [Phenomenon or Process]

Phrase: "offers"

Phrase: "a molecular explanation of the decreased cellular ATP production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0681841:Explanation [Intellectual Product]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to leucine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "express"

Phrase: "a dominant negative form of the HNF-1 protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   756   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   738   C0205160:Negative [Qualitative Concept]
   738   C0348078:Form [Qualitative Concept]
   738   C0376315:Form [Manufactured Object]
   738   C1513916:Negative [Finding]
   738   C1522492:Form [Functional Concept]
   738   C1527180:Dominant [Functional Concept]
   738   C2825415:Negative [Conceptual Entity]
   738   C2825491:Negative [Qualitative Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.230: In contrast, it is unlikely that decreased L-Pk expression levels contribute significantly to the -cell defect in HNF-1-/- mice because we did not observe a significant reduction in the overall enzyme activity of islet pyruvate kinase in Hnf-1-/- mice. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "it"

Phrase: "is"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that decreased L-Pk expression levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
   799   C0441889:Levels [Qualitative Concept]
   793   C3244092:expression level [Idea or Concept]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]

Phrase: "contribute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "significantly to the -cell defect"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1457869:Defect [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1861101:DEFECT [Disease or Syndrome]
   760   C1948049:Cell [Spatial Concept]

Phrase: "in HNF-1-/- mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   771   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]
   717   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "because"

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observe"

Phrase: "a significant reduction in the overall enzyme activity of islet pyruvate kinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   751   C2267000:Reduction Activity [Molecular Function]
   736   C0301630:Reduction [Natural Phenomenon or Process]
   736   C0392756:Reduction [Qualitative Concept]
   736   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in Hnf-1-/- mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.231: Therefore, our findings agree with previous studies that indicated that M2Pk is the major pyruvate kinase isoform in pancreatic islets (36,37). 

Phrase: "Therefore,"

Phrase: "our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "agree with previous studies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0205156:Previous [Temporal Concept]
   770   C0947630:studies [Laboratory Procedure]
   770   C1552607:previous [Temporal Concept]
   770   C3641827:Agree [Intellectual Product]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that M2Pk"

Phrase: "is"

Phrase: "the major pyruvate kinase isoform in pancreatic islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "(36,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.232: Our data suggest, then, that the lack of Glut2, Gck, and Nbat, which was not compensated for by increased expression levels of other glucose and amino acid transporters, may contribute to the diminished glucose or amino acidstimulated insulin secretion rates in HNF-1-/- animals. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: ","

Phrase: "then,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "that"

Phrase: "the lack of Glut2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332268:lack [Qualitative Concept]

Phrase: "Gck,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1415014:GCK [Gene or Genome]
  1000   C1417019:GCK [Gene or Genome]

Phrase: "and"

Phrase: "Nbat,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   919   C1420122:NEUTRAL AMINO ACID TRANSPORTER [Gene or Genome]
   885   C0301715:Neutral amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1882074:Neutral [Qualitative Concept]
   799   C2825492:Neutral [Phenomenon or Process]

Phrase: "which"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "compensated for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0205432:Compensated [Qualitative Concept]

Phrase: "by increased expression levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   867   C3244092:expression level [Idea or Concept]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "of other glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acid transporters,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0949771:Amino Acid Transporters [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0596902:transporters [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "may"

Phrase: "contribute to the diminished glucose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0205216:Diminished [Quantitative Concept]
   760   C1880177:Contribute [Activity]

Phrase: "or"

Phrase: "amino acidstimulated insulin secretion rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0871208:Rate [Activity]
   771   C1521828:Rate [Quantitative Concept]

Phrase: "in HNF-1-/- animals."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0003062:Animals [Animal]
   771   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]
   717   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.233: To study whether Hnf-1 deficiency also impairs the expression of genes that are critical for mitochondrial function, we measured mRNA levels of numerous mitochondrial genes, including Ogdh and Ucp2. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "whether"

Phrase: "Hnf-1 deficiency also"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0011155:Deficiency [Functional Concept]
   812   C0162429:Deficiency [Disease or Syndrome]
   812   C1623416:deficiency [Qualitative Concept]
   741 E C1636779:% deficient [Quantitative Concept]

Phrase: "impairs"

Phrase: "the expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0017262:Gene Expression [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "are"

Phrase: "critical for mitochondrial function,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511545:Critical [Qualitative Concept]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "mRNA levels of numerous mitochondrial genes,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   783   C0066598:mRNA, mitochondrial [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Ogdh"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022626:Oxoglutarate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417943:OXOGLUTARATE DEHYDROGENASE [Gene or Genome]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Ucp2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0536847:uncoupling protein-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421314:UNCOUPLING PROTEIN 2 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.234: Ogdh constitutes the rate-limiting enzyme in the mitochondrial TCA cycle, and Ucp2 uncouples respiration from oxidative phosphorylation and inhibits the efficiency of ATP synthesis. 

Phrase: "Ogdh"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022626:Oxoglutarate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417943:OXOGLUTARATE DEHYDROGENASE [Gene or Genome]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "constitutes"

Phrase: "the rate-limiting enzyme in the mitochondrial TCA cycle,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "and"

Phrase: "Ucp2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0536847:uncoupling protein-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421314:UNCOUPLING PROTEIN 2 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "uncouples"

Phrase: "respiration from oxidative phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0035203:Respiration [Physiologic Function]
   770   C0282636:respiration [Cell Function]
   770   C1160636:respiration [Biologic Function]

Phrase: "and"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the efficiency of ATP synthesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0013682:Efficiency [Quantitative Concept]
Processing 00000000.tx.235: In contrast to a previous report (31), the expression of Ogdh and Ucp2 were not changed in the absence of Hnf-1 (Fig. 1B). 

Phrase: "In contrast to a previous report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "the expression of Ogdh"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Ucp2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0536847:uncoupling protein-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421314:UNCOUPLING PROTEIN 2 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "changed in the absence of Hnf-1"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0332197:absence [Quantitative Concept]
   748   C0392747:Changed [Functional Concept]
   748   C0443172:Changed [Quantitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]
   714 E C1705241:Change [Quantitative Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.236: We also did not find the expression of other mitochondrial enzymes involved in the TCA cycle to be affected by Hnf-1 deficiency (Fig. 1B). 

Phrase: "We also"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "the expression of other mitochondrial enzymes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "involved in the TCA cycle to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0008858:TCA Cycle [Molecular Function]
   753   C0041405:TCA [Geographic Area]
   753   C0085758:TCA [Congenital Abnormality]
   753   C1314939:Involved [Functional Concept]
   753   C1415587:TCA [Gene or Genome]
   753   C1511572:Cycle [Temporal Concept]
   753   C3536819:TCA [Pharmacologic Substance]

Phrase: "be"

Phrase: "affected by Hnf-1 deficiency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0011155:Deficiency [Functional Concept]
   760   C0162429:Deficiency [Disease or Syndrome]
   760   C0392760:Affected [Functional Concept]
   760   C1314939:Affected [Functional Concept]
   760   C1623416:deficiency [Qualitative Concept]
   726 E C0001721:Affect [Mental Process]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.237: Several reasons may account for these discrepancies. 

Phrase: "Several reasons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0392360:reasons [Idea or Concept]

Phrase: "may"

Phrase: "account for these discrepancies."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1290905:discrepancies [Finding]
   770   C1551359:account [Idea or Concept]
   770   C2741673:Account # [Clinical Attribute]
   770   C2981730:Account [Classification]
Processing 00000000.tx.238: First, the previous study investigated the consequences of Hnf-1 deficiency by using a deoxycycline-inducible dominant negative Hnf-1. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the previous study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the consequences of Hnf-1 deficiency"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   773   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a deoxycycline-inducible dominant negative Hnf-1."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   799   C0205160:Negative [Qualitative Concept]
   799   C0205263:Inducible [Functional Concept]
   799   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1513916:Negative [Finding]
   799   C1527180:Dominant [Functional Concept]
   799   C2825415:Negative [Conceptual Entity]
   799   C2825491:Negative [Qualitative Concept]
Processing 00000000.tx.239: Deoxycycline has been shown to be cytotoxic and thus may alter gene expression in treated cells (43,44). 

Phrase: "Deoxycycline"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "cytotoxic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
  1000   C1511636:cytotoxic [Functional Concept]

Phrase: "and"

Phrase: "thus"

Phrase: "may"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "gene expression in treated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "(43,"

Phrase: "44"

Phrase: ")."
Processing 00000000.tx.240: Second, because Hnf-1 can either homodimerize or heterodimerize with Hnf-1, the dominant negative Hnf-1 used in the previous study may inhibit the function of both Hnf-1 and Hnf-1 (45). 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "because"

Phrase: "Hnf-1"

Phrase: "can"

Phrase: "either"

Phrase: "homodimerize"

Phrase: "or"

Phrase: "heterodimerize with Hnf-1,"

Phrase: "the dominant negative Hnf-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   812   C0205160:Negative [Qualitative Concept]
   812   C1513916:Negative [Finding]
   812   C1527180:Dominant [Functional Concept]
   812   C2825415:Negative [Conceptual Entity]
   812   C2825491:Negative [Qualitative Concept]

Phrase: "used in the previous study"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   781   C0869040:study use [Research Activity]
   760   C0205156:Previous [Temporal Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1273517:used [Finding]
   760   C1552607:previous [Temporal Concept]
   760   C2603343:Study [Research Activity]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "may"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the function of both Hnf-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "Hnf-1"

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.241: As a result, reduced Ogdh and increased Ucp2 expression may be due to impaired Hnf-1 function and not solely to Hnf-1. 

Phrase: "As a result,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "reduced Ogdh"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0022626:Oxoglutarate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1417943:OXOGLUTARATE DEHYDROGENASE [Gene or Genome]
   827   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "Ucp2 expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C1171362:protein expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   756   C0536847:uncoupling protein-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   756   C1421314:UNCOUPLING PROTEIN 2 [Gene or Genome]

Phrase: "may"

Phrase: "be due to impaired Hnf-1 function"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0031843:function [Physiologic Function]
   748   C0221099:Impaired [Functional Concept]
   748   C0542341:Function [Functional Concept]
   748   C0684336:Impaired [Pathologic Function]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]
   748   C2987476:Be [Conceptual Entity]
   748   C3146286:Due [Idea or Concept]

Phrase: "and"

Phrase: "not solely to Hnf-1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1518422:Not [Functional Concept]
Processing 00000000.tx.242: Finally, the previous study was done in a transformed insulinoma cell line (INS-1), and there are differences between INS-1 cell line (46) and islets (used in the present study) that may explain the differences in Hnf-1regulated genes in the mitochondria. 

Phrase: "Finally,"

Phrase: "the previous study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "done in a transformed insulinoma cell line"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   804   C0007601:Cell Line, Transformed [Cell]
   778   C0007600:Cell Line [Cell]
   748   C0007634:Cell [Cell]
   748   C0021670:insulinoma [Neoplastic Process]
   748   C0205132:Line [Spatial Concept]
   748   C1269647:Cell [Cell]
   748   C1272695:Done [Qualitative Concept]
   748   C1510411:Transformed [Pathologic Function]
   748   C1550648:Line [Substance]
   748   C1552960:Line [Quantitative Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C2746065:Done [Temporal Concept]

Phrase: "("

Phrase: "INS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "there"

Phrase: "are"

Phrase: "differences between"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C1705241:*Difference [Quantitative Concept]
   799   C1705242:Difference [Qualitative Concept]
   750 E C0443199:Differential [Qualitative Concept]

Phrase: "INS-1 cell line"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0007600:Cell Line [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "(46"

Phrase: ")"

Phrase: "and"

Phrase: "islets"

Phrase: "("

Phrase: "used in the present study"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   781   C0869040:study use [Research Activity]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1273517:used [Finding]
   760   C2603343:Study [Research Activity]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: ")"

Phrase: "that"

Phrase: "may"

Phrase: "explain"

Phrase: "the differences in Hnf-1regulated genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "in the mitochondria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]
Processing 00000000.tx.243: In addition to the transcriptional defect in genes regulating -cell glycolytic signaling, we found the expression levels of several other transcription factors to be significantly reduced in mice with Hnf-1 deficiency. 

Phrase: "In addition to the transcriptional defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1457869:Defect [Functional Concept]
   861   C1861101:DEFECT [Disease or Syndrome]

Phrase: "in genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "regulating -"

Phrase: "cell glycolytic signaling,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0037083:Cell Signaling [Cell Function]
           Signaling
   827   C3537152:signaling [Biologic Function]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "the expression levels of several"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C3244092:expression level [Idea or Concept]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "other transcription factors to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040649:Transcription [Genetic Function]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "be"

Phrase: "significantly"

Phrase: "reduced in mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "with Hnf-1 deficiency."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0011155:Deficiency [Functional Concept]
   827   C0162429:Deficiency [Disease or Syndrome]
   827   C1623416:deficiency [Qualitative Concept]
   755 E C1636779:% deficient [Quantitative Concept]
Processing 00000000.tx.244: The steady-state mRNAs of Hnf-4, Pdx-1, and Neuro-D1/Beta-2, as well as the dimerization cofactor Dcoh, were reduced shortly after birth in islets of Hnf-1-/- mice, suggesting that these changes are caused by HNF-1 deficiency and are likely to contribute to the molecular defects in Hnf-1-/- islets. 

Phrase: "The steady-state mRNAs of Hnf-4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Pdx-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "Neuro-D1/Beta-2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C1416886:D1 [Gene or Genome]
   812   C2004068:Beta [Qualitative Concept]

Phrase: "as well as"

Phrase: "the dimerization cofactor Dcoh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1418296:DCOH [Gene or Genome]

Phrase: "were"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "shortly after birth in islets of Hnf-1-/- mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0005615:Birth [Organism Function]
   742   C1550722:birth [Idea or Concept]
   742   C3245487:birth [Intellectual Product]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "are"

Phrase: "caused by HNF-1 deficiency"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   853   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]
   814   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011155:Deficiency [Functional Concept]
   748   C0162429:Deficiency [Disease or Syndrome]
   748   C0227525:Hepatocyte [Cell]
   748   C0521447:Nuclear [Spatial Concept]
   748   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1521761:Factor [Functional Concept]
   748   C1623416:deficiency [Qualitative Concept]
   748   C2827422:Factor [Conceptual Entity]
   714   C0015127:cause [Functional Concept]
   714   C1524003:Cause [Conceptual Entity]

Phrase: "and"

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "contribute to the molecular defects"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0243067:defects [Functional Concept]
   760   C1521991:Molecular [Qualitative Concept]
   760   C1880177:Contribute [Activity]
   726 E C1457869:Defect [Functional Concept]
   726 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "in Hnf-1-/- islets."
Processing 00000000.tx.245: Decreased expression of several of these genes may be mediated directly by Hnf-1. 

Phrase: "Decreased expression of several of these genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0017262:Gene Expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "be"

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "directly by Hnf-1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1947931:Directly [Qualitative Concept]
Processing 00000000.tx.246: For instance, a functional HNF-1 binding site was identified recently in the HNF-4 promoter P2 that is located 46 kb upstream of the hepatic (P1) promoter. 

Phrase: "For instance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550608:Instance [Idea or Concept]

Phrase: "a functional HNF-1 binding site"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   818   C0005456:Binding Site [Receptor]
   818   C0682969:Binding Site [Amino Acid Sequence]
   795   C0205145:Site [Spatial Concept]
   795   C0243122:binding [Functional Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1515974:Site [Body Location or Region]
   795   C2825164:Site [Spatial Concept]
   710   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]

Phrase: "was"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "recently in the HNF-4 promoter P2"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   818   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   790   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0227525:Hepatocyte [Cell]
   742   C0332185:Recently [Temporal Concept]
   742   C0521447:Nuclear [Spatial Concept]
   742   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1384585:P2 [Immunologic Factor]
   742   C1419693:P2 [Gene or Genome]
   742   C1521761:Factor [Functional Concept]
   742   C1539372:p2 [Gene or Genome]
   742   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "is"

Phrase: "located"

Phrase: "46 kb upstream of the hepatic"

Phrase: "(P1) promoter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.247: Transcription from the P2 promoter is responsible for the expression of the most abundant HNF-4 isoform in pancreatic -cells, and HNF-1 is a potent activator of HNF-4 transcription from the P2 promoter in vitro (47). 

Phrase: "Transcription from the P2 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040649:Transcription [Genetic Function]

Phrase: "is"

Phrase: "responsible for the expression of the most abundant HNF-4 isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   735   C1273518:Responsible [Finding]

Phrase: "in pancreatic -cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "HNF-1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]
   923   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0227525:Hepatocyte [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "is"

Phrase: "a potent activator of HNF-4 transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C1336776:Transcription Activator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "from the P2 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(47"

Phrase: ")."
Processing 00000000.tx.248: Our finding suggests that in pancreatic islets, Hnf-1 and Hnf-4 form an autoregulatory loop and that a haploinsufficiency in either of these transcription factors causes an expression disequilibrium (Fig. 6). 

Phrase: "Our finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that in pancreatic islets,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   770   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "Hnf-1"

Phrase: "and"

Phrase: "Hnf-4"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "an autoregulatory loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]

Phrase: "and"

Phrase: "that"

Phrase: "a haploinsufficiency in either of these transcription factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2936267:Haploinsufficiency [Cell or Molecular Dysfunction]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "an expression disequilibrium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.249: This observation may also explain a possible molecular mechanism for the similar pancreatic -cell defects in MODY1 and MODY3 patients (25,48,49). 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "may"

Phrase: "also"

Phrase: "explain"

Phrase: "a possible molecular mechanism for the similar pancreatic -cell defects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0441712:Mechanism [Functional Concept]
   739   C1706376:Mechanism [Manufactured Object]

Phrase: "in MODY1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1852093:MODY1 [Disease or Syndrome]

Phrase: "and"

Phrase: "MODY3 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "(25,"

Phrase: "48,"

Phrase: "49"

Phrase: ")."
Processing 00000000.tx.250: It is interesting that the expression of the insulin promoter factor Ipf-1/Pdx-1 was reduced in a dose-dependent manner in Hnf-1+/+, Hnf-1+/-, and Hnf-1-/- mice. 

Phrase: "It"

Phrase: "is"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "that"

Phrase: "the expression of the insulin promoter factor Ipf-1/Pdx-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "reduced in a dose-dependent manner"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1512045:Dose-dependent [Quantitative Concept]
   783   C1707814:Dose Reduced [Therapeutic or Preventive Procedure]
   753   C0178602:Dose [Quantitative Concept]
   753   C0392756:Reduced [Qualitative Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "in Hnf-1+/+,"

Phrase: "Hnf-1+/-,"

Phrase: "and"

Phrase: "Hnf-1-/- mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.251: Pdx-1 is an essential transcription factor for pancreas development and -cell function, including insulin gene transcription (50,51). 

Phrase: "Pdx-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "an essential transcription factor for pancreas development"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0040649:Transcription [Genetic Function]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]

Phrase: "and -"

Phrase: "cell function,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0007613:Cell Function [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1705273:Function [Intellectual Product]
   861   C1948049:Cell [Spatial Concept]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "insulin gene transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0040649:Gene Transcription [Genetic Function]
           Transcription
   734   C1337112:Insulin Gene [Gene or Genome]

Phrase: "(50,"

Phrase: "51"

Phrase: ")."
Processing 00000000.tx.252: Expression levels of Pdx-1 in Hnf-1-/- islets were reduced 3050% (Fig. 1A). 

Phrase: "Expression levels of Pdx-1"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   781   C0456947:Level 1 [Intellectual Product]
   773   C3244092:expression level [Idea or Concept]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in Hnf-1-/- islets"

Phrase: "were"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "3050%"

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.253: This reduction was sufficient for a significant downregulation of Pdx-1 target genes, such as Gck and insulin (51,52,53,54). 

Phrase: "This reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0301630:Reduction [Natural Phenomenon or Process]
  1000   C0392756:Reduction [Qualitative Concept]
  1000   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "sufficient for a significant downregulation of Pdx-1 target genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205410:Sufficient [Qualitative Concept]

Phrase: "such as Gck"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1415014:GCK [Gene or Genome]
  1000   C1417019:GCK [Gene or Genome]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(51,"

Phrase: "52,"

Phrase: "53,"

Phrase: "54"

Phrase: ")."
Processing 00000000.tx.254: Functional Hnf-1 as well as Hnf-4 binding sites have been reported in evolutionarily conserved enhancer elements of the Pdx-1 promoter (11,12). 

Phrase: "Functional Hnf-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205245:Functional [Functional Concept]
   827   C0542341:Functional [Functional Concept]
   827   C2700217:Functional [Conceptual Entity]

Phrase: "as well as"

Phrase: "Hnf-4 binding sites"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0005456:Binding Sites [Receptor]
   827 E C0682969:Binding Site [Amino Acid Sequence]
   812   C0205145:Sites [Spatial Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: "have"

Phrase: "been"

Phrase: "reported in evolutionarily conserved enhancer elements of the Pdx-1 promoter"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   756   C0014290:Enhancer Elements [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C1826562:PDX-1 [Gene or Genome]
   738   C0013879:Elements [Element, Ion, or Isotope]
   738   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0332134:PDX [Qualitative Concept]
   738   C0684224:Reported [Intellectual Product]
   738   C0700287:Reported [Health Care Activity]
   738   C0879404:PDX [Organic Chemical,Pharmacologic Substance]
   738   C3496591:Reported [Clinical Attribute]
   704 E C1705248:Element [Conceptual Entity]
   704 E C3273238:Report [Intellectual Product]

Phrase: "(11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.255: Therefore, decreased Pdx-1 expression in Hnf-1-/- islets may also be the result of reduced HNF-1 and HNF-4 gene expression. 

Phrase: "Therefore,"

Phrase: "decreased Pdx-1 expression in Hnf-1-/- islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "the result of reduced HNF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]

Phrase: "and"

Phrase: "HNF-4 gene expression."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0017262:Gene Expression [Genetic Function]
   799   C0017337:Gene [Gene or Genome]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
Processing 00000000.tx.256: We also found that the mRNA levels of Neuro-D1, a helix-loop-helix transcription factor that can activate insulin gene transcription in vitro (55), were reduced 80% in Hnf-1-/- mice. 

Phrase: "We also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the mRNA levels of Neuro-D1,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "a helix-loop-helix transcription factor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0040649:Transcription [Genetic Function]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   717   C0282642:helix loop helix [Spatial Concept]

Phrase: "that"

Phrase: "can"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "insulin gene transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0040649:Gene Transcription [Genetic Function]
           Transcription
   734   C1337112:Insulin Gene [Gene or Genome]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "80% in Hnf-1-/- mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
Processing 00000000.tx.257: Despite the reduced expression of Pdx-1 and Neuro-D1, mRNA levels of Ins-2 were indistinguishable in islets of HNF-1+/+ and HNF-1-/- mice (Fig. 1A). 

Phrase: "Despite the reduced expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of Pdx-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "Neuro-D1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416886:D1 [Gene or Genome]

Phrase: "mRNA levels of"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "Ins-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "were"

Phrase: "indistinguishable in islets of HNF-1+/+"

Phrase: "and"

Phrase: "HNF-1-/- mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   771   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]
   717   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.258: This finding is in agreement with other reports (27,29) that did not find significantly reduced insulin mRNA levels in HNF-1-/- mice and may be explained by compensation through other transcriptional activators of the insulin gene, such as Nkx2.2, Cdx2/3, Isl-1, and Pax4. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "is in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with other reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0684224:Reports [Intellectual Product]
  1000   C0700287:reports [Health Care Activity]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(27,"

Phrase: "29"

Phrase: ")"

Phrase: "that"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "significantly reduced insulin mRNA levels in HNF-1-/- mice"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   754   C0202098:insulin levels [Laboratory Procedure]
   754   C0428405:insulin levels [Laboratory or Test Result]
   738   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0441889:Levels [Qualitative Concept]
   737   C0456947:Level 1 [Intellectual Product]
   704 E C0456079:Level [Classification]
   704 E C1547707:Level [Geographic Area]
   704 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "may"

Phrase: "be"

Phrase: "explained by compensation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0152057:Compensation [Mental Process]
   790   C0152058:Compensation [Physiologic Function]
   790   C0220808:Compensation [Quantitative Concept]

Phrase: "through other transcriptional activators"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   983   C1336776:Transcriptional Activator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "of the insulin gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1337112:Insulin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "such as Nkx2.2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417735:NKX2-2 [Gene or Genome]

Phrase: "Cdx2/3,"

Phrase: "Isl-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416480:ISL1 [Gene or Genome]
   861   C0020750:ISL [Geographic Area]

Phrase: "and"

Phrase: "Pax4."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418275:PAX4 [Gene or Genome]
Processing 00000000.tx.259: In contrast, we found that Ins-1 expression was reduced 50% in islets of in HNF-1-/- mice (Fig. 1A). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that Ins-1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "50% in islets of"

Phrase: "in HNF-1-/- mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   771   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]
   717   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.260: This reduction is most likely a direct effect of Hnf-1 deficiency, mediated by an Hnf-1 binding element in the Ins-1 promoter that is lacking in the murine Ins-2 promoter (56). 

Phrase: "This reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0301630:Reduction [Natural Phenomenon or Process]
  1000   C0392756:Reduction [Qualitative Concept]
  1000   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "most likely"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0750501:most likely [Idea or Concept]
   861   C0205393:Most [Quantitative Concept]
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "a direct effect of Hnf-1 deficiency,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "mediated by an Hnf-1 binding element"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0013879:Element [Element, Ion, or Isotope]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1705248:Element [Conceptual Entity]

Phrase: "in the Ins-1 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "that"

Phrase: "is"

Phrase: "lacking in the murine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0026809:Murine [Mammal]
   770   C0332268:Lacking [Qualitative Concept]
   770   C0591833:Murine [Organic Chemical,Pharmacologic Substance]

Phrase: "Ins-2 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(56"

Phrase: ")."
Processing 00000000.tx.261: It is worth noting that expression levels of other islet transcription factors that are important for -cell metabolism, differentiation, and insulin gene transcription, including Hnf-1, -3, -3, -3, -4, -6, Cdx-2, Nkx2.2, Isl-1, Pax4, and Pax6, were unchanged in Hnf-1-/- mice. 

Phrase: "It"

Phrase: "is worth noting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1316572:Note [Clinical Attribute]
   756   C1317574:Note [Intellectual Product]
   756   C1369612:Note [Clinical Attribute]

Phrase: "that expression levels of other islet transcription factors"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0441889:Levels [Qualitative Concept]
   737   C3244092:expression level [Idea or Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "are"

Phrase: "important for -cell metabolism,"

Phrase: "differentiation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "insulin gene transcription,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0040649:Gene Transcription [Genetic Function]
           Transcription
   734   C1337112:Insulin Gene [Gene or Genome]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Hnf-1, -"

Phrase: "3, -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "3, -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "3, -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4, -"

Phrase: "6,"

Phrase: "Cdx-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0285590:CDX [Organic Chemical,Pharmacologic Substance]

Phrase: "Nkx2.2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417735:NKX2-2 [Gene or Genome]

Phrase: "Isl-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416480:ISL1 [Gene or Genome]
   861   C0020750:ISL [Geographic Area]

Phrase: "Pax4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418275:PAX4 [Gene or Genome]

Phrase: "and"

Phrase: "Pax6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418276:PAX6 [Gene or Genome]

Phrase: "were"

Phrase: "unchanged in Hnf-1-/- mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0442739:Unchanged [Finding]
   760   C2346711:Unchanged [Qualitative Concept]
Processing 00000000.tx.262: These findings support our hypothesis that loss of Hnf-1 function causes a pleiotropic but distinct defect in the -cell transcriptional network essential for its normal function. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "our hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that loss of Hnf-1 function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a pleiotropic"

Phrase: "but"

Phrase: "distinct defect in the -cell transcriptional network"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1457869:Defect [Functional Concept]
   748   C1861101:DEFECT [Disease or Syndrome]

Phrase: "essential for its normal function."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205224:Essential [Qualitative Concept]
Processing 00000000.tx.263: It is interesting that the transcriptional control of this network and the regulation of downstream target genes are distinct in pancreatic islets and in the liver. 

Phrase: "It"

Phrase: "is"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "that"

Phrase: "the transcriptional control of this network"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1158770:Transcriptional Control [Genetic Function]
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "the regulation of downstream target genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0017263:genes regulation [Genetic Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "are"

Phrase: "distinct in pancreatic islets"

Phrase: "and in the liver."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C1515981:And [Idea or Concept]
   770   C2346688:LIVER [Food]
   715 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.264: For instance, the expression of Glut2, Gck, and L-Pk was normal or increased in the liver but significantly decreased in islets of Hnf-1-/- mice compared with wild-type littermates. 

Phrase: "For instance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550608:Instance [Idea or Concept]

Phrase: "the expression of Glut2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "Gck,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1415014:GCK [Gene or Genome]
  1000   C1417019:GCK [Gene or Genome]

Phrase: "and"

Phrase: "L-Pk"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034348:Pyruvate Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0034354:pyruvate [Organic Chemical]
   827   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]

Phrase: "was"

Phrase: "normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "or"

Phrase: "increased in the liver"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "but"

Phrase: "significantly"

Phrase: "decreased in islets of Hnf-1-/- mice"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   757   C1416480:ISLET 1 [Gene or Genome]
   757   C1522528:Mouse Islets [Tissue]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0205216:Decreased [Quantitative Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   714 E C0547047:Decrease [Quantitative Concept]

Phrase: "compared with wild-type littermates."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]
Processing 00000000.tx.265: These differences may be explained by compensatory upregulation of transcriptional regulators (e.g., Hnf-1) in the liver, reduced expression of liver-enriched transcription factors absent in adult pancreatic islets (e.g., Hnf-6), or differential regulation of transcription factors and downstream targets through tissue-specific promoters (e.g., Hnf-4 and Gck). 

Phrase: "These differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "explained by compensatory upregulation of transcriptional regulators"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0040649:Transcriptional [Genetic Function]
   748   C0041904:Up-Regulation [Cell Function,Molecular Function]
   748   C0162493:Up-Regulation [Genetic Function]
   748   C0182953:regulators [Medical Device]
   748   C0231186:Compensatory [Functional Concept]
   714 E C1704734:Regulator [Medical Device]
   714 E C1704735:Regulator [Conceptual Entity]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "Hnf-1"

Phrase: ")"

Phrase: "in the liver,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "reduced expression of liver-enriched transcription factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "absent in adult pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:Absent [Quantitative Concept]
   760   C2699517:ABSENT [Finding]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "Hnf-6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417951:HNF-6 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "differential regulation of transcription factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1158770:Transcription Regulation [Genetic Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "downstream targets through tissue-specific promoters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1521840:Target [Functional Concept]
   719   C2986546:TARGET [Diagnostic Procedure]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "Hnf-4"

Phrase: "and"

Phrase: "Gck"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1415014:GCK [Gene or Genome]
  1000   C1417019:GCK [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.266: Finally, in vitro studies have suggested that SHP-1 may heterodimerize with HNF-4 and inhibit its transcriptional activity (39). 

Phrase: "Finally,"

Phrase: "in vitro studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C0681828:in vitro study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that SHP-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1335283:SHP-1 [Gene or Genome]
  1000   C1705637:SHP-1 [Gene or Genome]
   861   C1334896:SHP [Gene or Genome]
   861   C1335142:SHP [Amino Acid, Peptide, or Protein,Receptor]
   861   C1705299:SHP [Gene or Genome]

Phrase: "may"

Phrase: "heterodimerize with HNF-4"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   882   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   882   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   833   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0227525:Hepatocyte [Cell]
   753   C0521447:Nuclear [Spatial Concept]
   753   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "its transcriptional activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.267: Mutations in SHP-1 have also been identified in humans and may be associated with mild obesity in Japanese study subjects (57). 

Phrase: "Mutations in SHP-1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "identified in humans"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0086418:Humans [Human]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "and"

Phrase: "may"

Phrase: "be"

Phrase: "associated with mild obesity"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0028754:Obesity [Disease or Syndrome]
   770   C1963185:Obesity [Finding]
   770   C2945599:Mild [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in Japanese study subjects"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0681850:Study Subject [Group]
           Subject
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "(57"

Phrase: ")."
Processing 00000000.tx.268: Shp-1 expression was markedly reduced in islets of adult Hnf-1-/- mice, suggesting that Shp-1 may be regulated by Hnf-1, Hnf-4, Pdx-1, or Neuro-D. 

Phrase: "Shp-1 expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   756   C1334896:SMALL HETERODIMER PARTNER [Gene or Genome]
   756   C1335142:Small Heterodimer Partner [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "was"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "reduced in islets of adult Hnf-1-/- mice,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   750   C1416480:ISLET 1 [Gene or Genome]
   750   C1522528:Mouse Islets [Tissue]
   744   C0001675:Adult [Age Group]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0392756:Reduced [Qualitative Concept]
   744   C1706450:Adult [Human]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that Shp-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1334896:SMALL HETERODIMER PARTNER [Gene or Genome]
  1000   C1335142:Small Heterodimer Partner [Amino Acid, Peptide, or Protein,Receptor]
   827   C0682323:Partner [Family Group]
   827   C0700321:Small [Quantitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "regulated by Hnf-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "Hnf-4,"

Phrase: "Pdx-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "Neuro-D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0297513:NeuroD [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1417683:NEUROD [Gene or Genome]
  1000   C3273872:NEUROD [Gene or Genome]
Processing 00000000.tx.269: To better understand the molecular basis of Shp-1 gene regulation, we studied the Shp-1 promoter. 

Phrase: "To better"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0332272:Better [Qualitative Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205170:Well [Qualitative Concept]
   827 E C3146287:Well [Manufactured Object]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the molecular basis of Shp-1 gene regulation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1853126:MOLECULAR BASIS [Idea or Concept]
   742   C1527178:Basis [Functional Concept]
   742   C1874451:Basis [Pharmacologic Substance]

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the Shp-1 promoter."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C1334896:SMALL HETERODIMER PARTNER [Gene or Genome]
   756   C1335142:Small Heterodimer Partner [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.270: The 5' regulatory sequence of Shp-1 lacked binding sites for Hnf-1, Pdx-1, and Neuro-D but contained a conserved and functional Hnf-4 site. 

Phrase: "The 5' regulatory sequence of Shp-1 lacked binding sites"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   756   C0314642:Regulatory sequence [Nucleotide Sequence]
   738   C0004793:Sequence [Nucleotide Sequence]
   738   C0162326:Sequence [Nucleotide Sequence]
   738   C0162327:Sequence [Nucleotide Sequence]
   738   C0220905:regulatory [Regulation or Law]
   738   C1519249:Sequence [Functional Concept]
   738   C1704735:Regulatory [Conceptual Entity]

Phrase: "for Hnf-1,"

Phrase: "Pdx-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "Neuro-D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0297513:NeuroD [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1417683:NEUROD [Gene or Genome]
  1000   C3273872:NEUROD [Gene or Genome]

Phrase: "but"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "a conserved"

Phrase: "and"

Phrase: "functional Hnf-4 site."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]
Processing 00000000.tx.271: The biochemical characterization of this site and in vitro transactivation studies indicate that Hnf-4 is a transcriptional activator of the Shp-1 and that the reduced Shp-1 mRNA levels in pancreatic islets of HNF-1-/- mice likely are due to the reduced expression of HNF-4 in Hnf-1deficient islets. 

Phrase: "The biochemical characterization of this site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "in vitro transactivation studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   906   C0681828:in vitro study [Research Activity]
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "indicate"

Phrase: "that Hnf-4"

Phrase: "is"

Phrase: "a transcriptional activator of the Shp-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1336776:Transcriptional Activator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "that"

Phrase: "the reduced Shp-1 mRNA levels in pancreatic islets"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   739   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0441889:Levels [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "of HNF-1-/- mice likely"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   734   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]

Phrase: "are due to the reduced expression of HNF-4"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   797   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   775   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0678226:Due to [Functional Concept]
           due
   738   C0185117:Expression [Therapeutic or Preventive Procedure]
   738   C0227525:Hepatocyte [Cell]
   738   C0392756:Reduced [Qualitative Concept]
   738   C0521447:Nuclear [Spatial Concept]
   738   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   738   C1521761:Factor [Functional Concept]
   738   C1551058:Are [Quantitative Concept]
   738   C2827422:Factor [Conceptual Entity]
   738   C3146286:Due [Idea or Concept]

Phrase: "in Hnf-1deficient islets."
Processing 00000000.tx.272: In addition, our data indicate that Shp-1 may regulate its own expression by inhibiting Hnf-4 function, thus forming a negative feedback loop, and indirectly (through Hnf-4) regulate the activity of Hnf-1, Pdx-1, and Neuro-D (Fig. 6). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that Shp-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1334896:SMALL HETERODIMER PARTNER [Gene or Genome]
  1000   C1335142:Small Heterodimer Partner [Amino Acid, Peptide, or Protein,Receptor]
   827   C0682323:Partner [Family Group]
   827   C0700321:Small [Quantitative Concept]

Phrase: "may"

Phrase: "regulate"

Phrase: "its own expression by inhibiting Hnf-4 function,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "thus"

Phrase: "forming"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205431:Forming [Functional Concept]
  1000   C1522492:Forming [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]

Phrase: "a negative feedback loop,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0015744:Feedback [Phenomenon or Process]
   827   C0205160:Negative [Qualitative Concept]
   827   C0419518:Loop [Medical Device]
   827   C0445022:Loop [Spatial Concept]
   827   C1513916:Negative [Finding]
   827   C2825415:Negative [Conceptual Entity]
   827   C2825491:Negative [Qualitative Concept]
   827   C2911691:Feedback [Mental Process]

Phrase: "and"

Phrase: "indirectly"

Phrase: "("

Phrase: "through Hnf-4"

Phrase: ")"

Phrase: "regulate"

Phrase: "the activity of Hnf-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "Pdx-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "Neuro-D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0297513:NeuroD [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1417683:NEUROD [Gene or Genome]
  1000   C3273872:NEUROD [Gene or Genome]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.273: Additional studies, including targeted mutagenesis of the Shp-1 gene in mice, are needed to shed light on the biological role of Shp-1 in pancreatic islet function.  

Phrase: "Additional studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "targeted mutagenesis of the Shp-1 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0079866:Mutagenesis [Molecular Function]
   744   C3146302:Mutagenesis [Laboratory Procedure]

Phrase: "in mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "shed"

Phrase: "light on the biological role of Shp-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0023693:Light [Natural Phenomenon or Process]
   742   C1306462:Light [Functional Concept]
   742   C1881376:Light [Qualitative Concept]

Phrase: "in pancreatic islet function."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0597166:pancreatic islet function [Organ or Tissue Function]
   913   C0232786:Pancreatic function [Organ or Tissue Function]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
   734   C0022131:Pancreatic islet [Body Part, Organ, or Organ Component]
Processing 00000000.tx.274: ACKNOWLEDGMENTS  This work was supported in part by the American Diabetes Association, National Institutes of Health Grant R01-DK-55033-01 (M.S.), Human Frontier Science Program Organization research grant (M.P. and M.S.), and National Institutes of Health Medical Scientists Training Program Grant GM07739 (D.Q.S.). 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by the American Diabetes Association,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1705019:American Diabetes Association [Professional Society]
   827   C0004083:Association [Mental Process]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0439849:Association [Qualitative Concept]
   827   C0596070:American [Population Group]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "National Institutes of Health Grant R01-DK-55033-01"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   849   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   791   C0011318:DK [Geographic Area]
   791   C0018173:Grant [Quantitative Concept]
   791   C0018684:Health [Idea or Concept]
   791   C0021622:Institutes [Organization]
   791   C1548284:Grant [Idea or Concept]
   791   C1549838:R01 [Intellectual Product]
   791   C3245503:national [Intellectual Product]
   758 E C1272753:Institute [Idea or Concept]

Phrase: "(M.S."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "Human Frontier Science Program Organization research grant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   818   C0260206:research grant [Research Activity]
   795   C0018173:Grant [Quantitative Concept]
   795   C1548284:Grant [Idea or Concept]

Phrase: "("

Phrase: "M."

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "M.S."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "National Institutes of Health Medical Scientists"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0402112:Scientists [Professional or Occupational Group]
   734   C0027468:National Institutes of Health [Health Care Related Organization]

Phrase: "Training"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0040607:Training [Educational Activity]
  1000   C0220931:Training [Educational Activity]
  1000   C2673163:training [Qualitative Concept]
   966 E C0336809:Train [Manufactured Object]
   966 E C1552514:Train [Manufactured Object]
   928 E C0009647:Conditioned [Mental Process]
   928 E C0012634:condition [Disease or Syndrome]
   928 E C0348080:Condition [Qualitative Concept]
   928 E C1705253:Condition [Conceptual Entity]

Phrase: "Program Grant GM07739"

Phrase: "("

Phrase: "D."

Phrase: "Q.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1699029:q.s. [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.275: M.S. is an Irma Hirschl Scholar, Pew Scholar, and Robert and Harriet Heilbrunn Professor. 

Phrase: "M.S."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "is"

Phrase: "an Irma Hirschl Scholar,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0684017:scholar [Professional or Occupational Group]

Phrase: "Pew Scholar,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0684017:scholar [Professional or Occupational Group]

Phrase: "and"

Phrase: "Robert"

Phrase: "and"

Phrase: "Harriet Heilbrunn Professor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0599518:Professor [Professional or Occupational Group]
Processing 00000000.tx.276: K.N.M. was supported by the GATEWAYS to the Laboratory Program.  

Phrase: "K.N.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "was"

Phrase: "supported by the GATEWAYS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]

Phrase: "to the Laboratory Program."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1709697:Program [Conceptual Entity]
   861   C2728259:Program [Pharmacologic Substance]
   861   C3484370:Program [Functional Concept]
Processing 00000000.tx.277: FOOTNOTES  Address correspondence and reprint requests to Markus Stoffel MD, Laboratory of Metabolic Diseases, The Rockefeller University, 1230 York Ave., Box 292, New York, NY 10021. 

Phrase: "FOOTNOTES  Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0686900:request [Functional Concept]
  1000   C1272683:Request [Functional Concept]
  1000   C1522634:Request [Intellectual Product]

Phrase: "to Markus Stoffel MD,"

Phrase: "Laboratory of Metabolic Diseases,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1557169:METABOLIC/LABORATORY [Finding]
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C3244292:laboratory [Functional Concept]

Phrase: "The Rockefeller University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "1230 York Ave.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0108844:AVE [Therapeutic or Preventive Procedure]

Phrase: "Box 292,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NY 10021."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027976:NY [Geographic Area]
   861   C1879958:NY [Intellectual Product]
Processing 00000000.tx.278: E-mail: stoffel{at}rockvax.rockefeller.edu . Received for publication 26 March 2001 and accepted in revised form 26 July 2001. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "stoffel{at}rockvax.rockefeller.edu ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "Received for publication 26 March 2001"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0034036:Publication [Intellectual Product,Manufactured Object]
   753   C0034037:Publication [Occupational Activity]
   753   C1514756:Received [Qualitative Concept]
   753   C1704324:Publication [Intellectual Product]

Phrase: "and"

Phrase: "accepted in revised form 26 July 2001."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1272684:Accepted [Qualitative Concept]
   748   C1522492:Form [Functional Concept]
   748   C1527075:Revised [Therapeutic or Preventive Procedure]
   748   C1548435:Accepted [Idea or Concept]
   714 E C1548601:Accept [Idea or Concept]
Processing 00000000.tx.279: D.Q.S. and S.S. contributed equally to the work. 

Phrase: "D."

Phrase: "Q.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1699029:q.s. [Quantitative Concept]

Phrase: "and S.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "equally to the work."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043227:Work [Occupational Activity]
Processing 00000000.tx.280: DMEM, Dulbeccos modified Eagles medium; 

Phrase: "DMEM,"

Phrase: "Dulbeccos modified Eagles medium"

Phrase: ";"
Processing 00000000.tx.281: GLUT2, glucose transporter 2; 

Phrase: "GLUT2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420172:GLUT2 [Gene or Genome]

Phrase: "glucose transporter 2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420172:GLUCOSE TRANSPORTER 2 [Gene or Genome]
   901   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.282: GSIS, glucose-stimulated insulin secretion; 

Phrase: "GSIS,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "glucose-stimulated insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.283: HNF-1, hepatocyte nuclear factor 1; 

Phrase: "HNF-1,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]
   923   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0227525:Hepatocyte [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "hepatocyte nuclear factor 1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]
   923   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0227525:Hepatocyte [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.284: IPF-1/PDX-1, insulin promoter factor 1; 

Phrase: "IPF-1/PDX-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0332134:PDX [Qualitative Concept]
   812   C0879404:PDX [Organic Chemical,Pharmacologic Substance]
   812   C1800706:IPF [Disease or Syndrome]

Phrase: "insulin promoter factor 1"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0248419:insulin promoter factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826562:INSULIN PROMOTER FACTOR 1 [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1521761:Factor [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C2827422:Factor [Conceptual Entity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.285: L-Pk, liver pyruvate kinase; 

Phrase: "L-Pk,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034348:Pyruvate Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0034354:pyruvate [Organic Chemical]
   827   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]

Phrase: "liver pyruvate kinase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034348:Pyruvate Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0034354:pyruvate [Organic Chemical]
   827   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]

Phrase: ";"
Processing 00000000.tx.286: MODY, maturity-onset diabetes of the young; 

Phrase: "MODY, maturity-onset diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   716   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   716   C2984262:Maturity onset diabetes of the young [Functional Concept]

Phrase: "of the young"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.287: Ogdh, 2-oxoglutarate dehydrogenase; 

Phrase: "Ogdh,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022626:Oxoglutarate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417943:OXOGLUTARATE DEHYDROGENASE [Gene or Genome]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "2-oxoglutarate dehydrogenase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0022626:2-Oxoglutarate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
           Oxoglutarate Dehydrogenase
   901   C1291208:2-Oxoglutarate [Organic Chemical,Pharmacologic Substance]
   901   C1417943:OXOGLUTARATE DEHYDROGENASE [Gene or Genome]
   827   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.288: PBS, phosphate-buffered saline; 

Phrase: "PBS,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.289: RT-PCR, reverse transcriptasepolymerase chain reaction; 

Phrase: "RT-PCR,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0599161:Reverse Transcriptase Polymerase Chain Reaction [Molecular Biology Research Technique]
   884   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   840   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0337112:Chain [Manufactured Object]
   804   C0443286:Reaction [Functional Concept]
   804   C1114821:Reaction [Clinical Attribute]
   804   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1524075:Chain [Idea or Concept]
   804   C1555029:Reverse [Idea or Concept]
   804   C2257077:transcriptase [Genetic Function]

Phrase: "reverse transcriptasepolymerase chain reaction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0337112:Chain [Manufactured Object]
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]
   812   C1524075:Chain [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.290: SHP, small heterodimer partner; 

Phrase: "SHP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1334896:SHP [Gene or Genome]
  1000   C1335142:SHP [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1705299:SHP [Gene or Genome]

Phrase: "small heterodimer partner"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1334896:SMALL HETERODIMER PARTNER [Gene or Genome]
  1000   C1335142:Small Heterodimer Partner [Amino Acid, Peptide, or Protein,Receptor]
   827   C0682323:Partner [Family Group]
   827   C0700321:Small [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.291: Ucp2, uncoupling protein 2.  

Phrase: "Ucp2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0536847:uncoupling protein-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421314:UNCOUPLING PROTEIN 2 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "uncoupling protein 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0536847:uncoupling protein-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421314:UNCOUPLING PROTEIN 2 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.292: REFERENCES TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Fajans SS: Maturity-onset diabetes of the young (MODY). 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Fajans SS"

Phrase: ":"

Phrase: "Maturity-onset diabetes of the young"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
  1000   C2984262:Maturity onset diabetes of the young [Functional Concept]
   833   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0332162:Onset [Qualitative Concept]
   753   C0449989:Maturity [Qualitative Concept]
   753   C0700597:Maturity [Temporal Concept]

Phrase: "(MODY"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
  1000   C2984262:Maturity onset diabetes of the young [Functional Concept]
   833   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0332162:Onset [Qualitative Concept]
   753   C0449989:Maturity [Qualitative Concept]
   753   C0700597:Maturity [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.293: Diabetes Metab Rev 5:579606, 1989[Medline] Vionnet N, Stoffel M, Takeda J, Yasuda K, Bell GI, Zouali H, Lesage S, Velho G, Iris F, Passa P, Froguel P, Cohen D: Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. 

Phrase: "Diabetes Metab Rev 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "579606,"

Phrase: "1989"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Vionnet N,"

Phrase: "Stoffel M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Takeda J,"

Phrase: "Yasuda K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Bell GI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: "Zouali H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Lesage S,"

Phrase: "Velho G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Iris F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Passa P,"

Phrase: "Froguel P,"

Phrase: "Cohen D"

Phrase: ":"

Phrase: "Nonsense mutation in the glucokinase gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0544885:Mutation, Nonsense [Cell or Molecular Dysfunction]
   783   C0596611:Gene Mutation [Genetic Function]
   753   C0026882:Mutation [Genetic Function]
   753   C0746939:nonsense [Idea or Concept]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "early-onset non-insulin-dependent diabetes mellitus."
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   913   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
   913   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   877   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   818   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   795   C0011847:Diabetes [Disease or Syndrome]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0851827:Dependent [Qualitative Concept]
   795   C1518422:Non [Functional Concept]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   795   C1701901:Dependent [Qualitative Concept]
   795   C3244310:dependent [Functional Concept]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.294: Nature 356:721722, 1992[Medline] Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Stoffel M, Bell GI: Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young. 

Phrase: "Nature 356"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "721722,"

Phrase: "1992"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yamagata K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Furuta H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Oda N,"

Phrase: "Kaisaki PJ,"

Phrase: "Menzel S,"

Phrase: "Cox NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Fajans SS,"

Phrase: "Signorini S,"

Phrase: "Stoffel M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bell GI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: ":"

Phrase: "Mutations in the hepatocyte nuclear factor-4alpha gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0596611:gene mutations [Genetic Function]
   744   C0026882:Mutations [Genetic Function]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in maturity-onset diabetes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332162:Onset [Qualitative Concept]
   827   C0449989:Maturity [Qualitative Concept]
   827   C0700597:Maturity [Temporal Concept]
   755 E C0205286:Mature [Temporal Concept]

Phrase: "of the young."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]
Processing 00000000.tx.295: Nature 384:458460, 1996[Medline] Yamagata K, Oda N, Kaisaki PJ, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM, Boriraj VV, Chen X, Cox NJ, Oda Y, Yano H, Le Beau MM, Yamada S, Nishigori H, Takeda J, Fajans SS, Hattersley AT, Iwasaki N, Hansen T, Pedersen O, Polonsky KS, Bell GI: Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young. 

Phrase: "Nature 384"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "458460,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yamagata K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Oda N,"

Phrase: "Kaisaki PJ,"

Phrase: "Furuta H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Vaxillaire M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Southam L,"

Phrase: "Cox RD,"

Phrase: "Lathrop GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Boriraj VV,"

Phrase: "Chen X,"

Phrase: "Cox NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Oda Y,"

Phrase: "Yano H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Le Beau MM,"

Phrase: "Yamada S,"

Phrase: "Nishigori H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Takeda J,"

Phrase: "Fajans SS,"

Phrase: "Hattersley AT,"

Phrase: "Iwasaki N,"

Phrase: "Hansen T,"

Phrase: "Pedersen O,"

Phrase: "Polonsky KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Bell GI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: ":"

Phrase: "Mutations in the hepatocyte nuclear factor-1alpha gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0596611:gene mutations [Genetic Function]
   744   C0026882:Mutations [Genetic Function]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in maturity-onset diabetes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332162:Onset [Qualitative Concept]
   827   C0449989:Maturity [Qualitative Concept]
   827   C0700597:Maturity [Temporal Concept]
   755 E C0205286:Mature [Temporal Concept]

Phrase: "of the young."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]
Processing 00000000.tx.296: Nature 384:455458, 1996[Medline] Stoffers A, Ferrer J, Clarke WL, Habener JF: Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. 

Phrase: "Nature 384"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "455458,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Stoffers A,"

Phrase: "Ferrer J,"

Phrase: "Clarke WL,"

Phrase: "Habener JF"

Phrase: ":"

Phrase: "Early-onset type-II diabetes mellitus"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   901   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
   901   C2984301:Type II diabetes mellitus [Functional Concept]
   839   C1320657:type diabetes [Finding]
   827   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   827   C0441730:Type II [Classification]
   799   C0011847:Diabetes [Disease or Syndrome]
   799   C0332307:Type [Qualitative Concept]
   799   C1547052:*Type [Quantitative Concept]

Phrase: "(MODY4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1826562:MODY4 [Gene or Genome]
  1000   C1833382:MODY4 [Disease or Syndrome]

Phrase: ")"

Phrase: "linked to IPF1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1826562:IPF1 [Gene or Genome]
   756   C1517892:Link [Intellectual Product]
   756   C1704666:Link [Intellectual Product]
Processing 00000000.tx.297: Nat Genet 17:138139, 1997[Medline] Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cockburn BN, Lindner T, Yamagata K, Ogata M, Tomonaga O, Kuroki H, Kasahara T, Iwamoto Y, Bell GI: Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. 

Phrase: "Nat Genet 17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "138139,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Horikawa Y,"

Phrase: "Iwasaki N,"

Phrase: "Hara M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Furuta H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hinokio Y,"

Phrase: "Cockburn BN,"

Phrase: "Lindner T,"

Phrase: "Yamagata K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Ogata M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Tomonaga O,"

Phrase: "Kuroki H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kasahara T,"

Phrase: "Iwamoto Y,"

Phrase: "Bell GI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: ":"

Phrase: "Mutation in hepatocyte nuclear factor-1 beta gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0596611:Gene Mutation [Genetic Function]
   744   C0026882:Mutation [Genetic Function]
   744   C1705285:Mutation [Cell or Molecular Dysfunction]
   703   C0126037:Hepatocyte Nuclear Factor 1-beta [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1420636:HEPATOCYTE NUCLEAR FACTOR-1-BETA [Gene or Genome]

Phrase: "(TCF2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1420636:TCF2 [Gene or Genome]
  1000   C2348633:TCF2 [Gene or Genome]

Phrase: ")"

Phrase: "associated with MODY."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   909   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   909   C2984262:Maturity onset diabetes of the young [Functional Concept]
   800   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]
   744   C0332162:Onset [Qualitative Concept]
   744   C0332239:Young [Temporal Concept]
   744   C0449989:Maturity [Qualitative Concept]
   744   C0700597:Maturity [Temporal Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.298: Nat Genet 17:384385, 1997[Medline] Malecki MT, Jhala US, Antonellis A, Fields L, Doria A, Orban T, Saad M, Warram JH, Montminy M, Krolewski AS: Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. 

Phrase: "Nat Genet 17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "384385,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Malecki MT,"

Phrase: "Jhala"

Phrase: "US,"

Phrase: "Antonellis A,"

Phrase: "Fields L,"

Phrase: "Doria A,"

Phrase: "Orban T,"

Phrase: "Saad M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Warram JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "Montminy M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Krolewski"

Phrase: "AS"

Phrase: ":"

Phrase: "Mutations in NEUROD1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0026882:Mutations [Genetic Function]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "associated with the development of type 2 diabetes mellitus."
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   818   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
   818   C2984301:Type II diabetes mellitus [Functional Concept]
   764   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   764   C0441730:Type 2 [Classification]
   762   C1320657:Diabetes type [Finding]
   742   C0011847:Diabetes [Disease or Syndrome]
   742   C0243107:development [Physiologic Function]
   742   C0332307:Type [Qualitative Concept]
   742   C0678723:Development [Organism Function]
   742   C1527148:Development [Functional Concept]
   742   C1547052:*Type [Quantitative Concept]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.299: Nat Genet 23:323328, 1999[Medline] Steiner DF, Tager HS, Chan SJ, Nanjo K, Sanke T, Rubenstein AH: Lessons learned from molecular biology of insulin-gene mutations. 

Phrase: "Nat Genet 23"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0325074:Genet [Mammal]
   827   C0450348:23 [Quantitative Concept]

Phrase: ":"

Phrase: "323328,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Steiner DF,"

Phrase: "Tager HS,"

Phrase: "Chan SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Nanjo K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Sanke T,"

Phrase: "Rubenstein AH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1836672:AH [Disease or Syndrome]

Phrase: ":"

Phrase: "Lessons"

Phrase: "learned from molecular biology of insulin-gene mutations."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   770   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   770   C0596611:gene mutations [Genetic Function]
   770   C1337112:Insulin Gene [Gene or Genome]
   744   C0005532:Biology [Biomedical Occupation or Discipline]
   744   C0017337:Gene [Gene or Genome]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0023185:learned [Mental Process]
   744   C0026882:Mutations [Genetic Function]
   744   C1521991:Molecular [Qualitative Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.300: Diabetes Care 13:600609, 1990[Abstract] Duncan SA, Navas MA, Dufort D, Rossant J, Stoffel M: Regulation of a transcription factor network required for differentiation and metabolism. 

Phrase: "Diabetes Care 13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C1947933:Care [Activity]

Phrase: ":"

Phrase: "600609,"

Phrase: "1990"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Duncan SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Navas MA,"

Phrase: "Dufort D,"

Phrase: "Rossant J,"

Phrase: "Stoffel M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Regulation of a transcription factor network"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1158770:Transcription Regulation [Genetic Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "required for differentiation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0007589:Differentiation [Cell Function]
   790   C1511938:Differentiation [Clinical Attribute]
   790   C1514873:Required [Functional Concept]
   790   C2945687:Differentiation [Functional Concept]
   718 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "metabolism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.301: Science 281:692695, 1998[Abstract/Free FullText] Wu KL, Gannon M, Peshavaria M, Offield MF, Henderson E, Ray M, Marks A, Gamer LW, Wright CV, Stein R: Hepatocyte nuclear factor 3beta is involved in pancreatic beta-cell-specific transcription of the pdx-1 gene. 

Phrase: "Science 281"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "692695,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wu KL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1366480:KL [Gene or Genome]
   861   C1416656:KL [Gene or Genome]

Phrase: "Gannon M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Peshavaria M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Offield MF,"

Phrase: "Henderson E,"

Phrase: "Ray M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Marks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:mark [Qualitative Concept]

Phrase: "A,"

Phrase: "Gamer LW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1415842:LW [Gene or Genome]

Phrase: "Wright CV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538987:CV [Idea or Concept]

Phrase: "Stein R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "Hepatocyte nuclear factor 3beta"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0121471:Hepatocyte Nuclear Factor 3beta [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "involved in pancreatic beta-cell-specific transcription"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   814   C0030281:Pancreatic beta cell [Cell]
           Beta cell
   748   C0007634:Cell [Cell]
   748   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   748   C0040649:Transcription [Genetic Function]
   748   C0205369:Specific [Qualitative Concept]
   748   C0330390:Beta [Plant]
   748   C0439096:Beta [Intellectual Product]
   748   C1269647:Cell [Cell]
   748   C1314939:Involved [Functional Concept]
   748   C1552740:specific [Intellectual Product]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C2004068:Beta [Qualitative Concept]

Phrase: "of the pdx-1 gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017337:Gene [Gene or Genome]
   734   C1826562:PDX-1 [Gene or Genome]
Processing 00000000.tx.302: Mol Cell Biol 17:60026013, 1997[Abstract] Gerrish K, Gannon M, Shih D, Henderson E, Stoffel M, Wright CV, Stein R: Pancreatic beta cell-specific transcription of the pdx-1 gene: the role of conserved upstream control regions and their hepatic nuclear factor 3beta sites. 

Phrase: "Mol Cell Biol 17"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "60026013,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Gerrish K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Gannon M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Shih D,"

Phrase: "Henderson E,"

Phrase: "Stoffel M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Wright CV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538987:CV [Idea or Concept]

Phrase: "Stein R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "Pancreatic beta cell-specific transcription of the pdx-1 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0040649:Gene Transcription [Genetic Function]
           Transcription

Phrase: ":"

Phrase: "the role of conserved upstream control regions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "their hepatic nuclear factor 3beta sites."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0205145:Sites [Spatial Concept]
   771 E C1515974:Site [Body Location or Region]
   771 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.303: J Biol Chem 275:34853494, 2000[Abstract/Free FullText] Ben-Shushan E, Marshak S, Shoshkes M, Cerasi E, Melloul D: A pancreatic -cell-specific enhancer in the human PDX-1 gene is regulated by hepatocyte nuclear factor 3 (HNF-3), HNF-1, and SPs transcription factors. 

Phrase: "J Biol Chem 275"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "34853494,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ben-Shushan E,"

Phrase: "Marshak S,"

Phrase: "Shoshkes M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Cerasi E,"

Phrase: "Melloul D"

Phrase: ":"

Phrase: "A pancreatic -cell-specific enhancer in the human PDX-1 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "regulated by hepatocyte nuclear factor 3 (HNF-3),"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0227525:Hepatocyte [Cell]
   753   C0521447:Nuclear [Spatial Concept]
   753   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "HNF-1,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]
   923   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0227525:Hepatocyte [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "SPs transcription factors."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040649:Transcription [Genetic Function]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.304: J Biol Chem 276:1753317540, 2001[Abstract/Free FullText] Kuo CJ, Conley PB, Chen L, Sladek FM, Darnell JE Jr, Crabtree GR: A transcriptional hierarchy involved in mammalian cell-type specification. 

Phrase: "J Biol Chem 276"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1753317540,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kuo CJ,"

Phrase: "Conley PB,"

Phrase: "Chen L,"

Phrase: "Sladek FM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: "Darnell JE Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: "Crabtree GR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552950:[gr] [Quantitative Concept]

Phrase: ":"

Phrase: "A transcriptional hierarchy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0699032:Hierarchy [Functional Concept]

Phrase: "involved in mammalian cell-type specification."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0007634:Cell Type [Cell]
           Cell
   790   C0449475:cell type [Intellectual Product]
   790   C1512977:Mammalian Cell [Cell]
   753   C0024660:Mammalian [Mammal]
   753   C0332307:Type [Qualitative Concept]
   753   C1269647:Cell [Cell]
   753   C1314939:Involved [Functional Concept]
   753   C1547052:*Type [Quantitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C2348235:Specification [Conceptual Entity]
Processing 00000000.tx.305: Nature 355:457461, 1992[Medline] Duncan SA, Nagy A, Chan W: Murine gastrulation requires HNF-4 regulated gene expression in the visceral endoderm: tetraploid rescue of Hnf-4(-/-) embryos. 

Phrase: "Nature 355"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "457461,"

Phrase: "1992"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Duncan SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Nagy A,"

Phrase: "Chan W"

Phrase: ":"

Phrase: "Murine gastrulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0259902:Gastrulation [Organism Function]

Phrase: "requires"

Phrase: "HNF-4 regulated gene expression in the visceral endoderm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0017262:Gene Expression [Genetic Function]
   738   C0017337:Gene [Gene or Genome]
   738   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ":"

Phrase: "tetraploid rescue of Hnf-4"

Phrase: "(-/-"

Phrase: ")"

Phrase: "embryos."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013935:Embryos [Embryonic Structure]
   966 E C1305370:Embryo [Embryonic Structure]
Processing 00000000.tx.306: Development 124:279287, 1997[Abstract/Free FullText] Stoffel M, Duncan SA: The maturity-onset diabetes of the young (MODY1) transcription factor HNF4alpha regulates expression of genes required for glucose transport and metabolism. 

Phrase: "Development 124"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: ":"

Phrase: "279287,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Stoffel M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Duncan SA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: ":"

Phrase: "The maturity-onset diabetes of the young"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   905   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   905   C2984262:Maturity onset diabetes of the young [Functional Concept]
   814   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
   748   C0332162:Onset [Qualitative Concept]
   748   C0449989:Maturity [Qualitative Concept]
   748   C0700597:Maturity [Temporal Concept]

Phrase: "(MODY1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1852093:MODY1 [Disease or Syndrome]

Phrase: ")"

Phrase: "transcription factor HNF4alpha"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "regulates"

Phrase: "expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C0017262:Gene Expression [Genetic Function]
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "required for glucose transport"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0178666:glucose transport [Cell Function]
   770   C0005528:Transport, NOS [Cell Function]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C1317949:Transport [Manufactured Object]
   770   C1514873:Required [Functional Concept]
   770   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "metabolism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.307: Proc Natl Acad Sci U S A 94:1320913214, 1997[Abstract/Free FullText] Gragnoli C, Lindner T, Cockburn BN, Kaisaki PJ, Gragnoli F, Marozzi G, Bell GI: Maturity-onset diabetes of the young due to a mutation in the hepatocyte nuclear factor-4 alpha binding site in the promoter of the hepatocyte nuclear factor-1 alpha gene. 

Phrase: "Proc Natl Acad Sci U S A 94"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C0041703:U.S.A. [Geographic Area]
           U S
   793   C0268596:ACAD [Disease or Syndrome]
   793   C1418943:PROC [Gene or Genome]
   793   C2700624:ACAD [Cell Function]
   793   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "1320913214,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gragnoli C,"

Phrase: "Lindner T,"

Phrase: "Cockburn BN,"

Phrase: "Kaisaki PJ,"

Phrase: "Gragnoli F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Marozzi G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Bell GI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: ":"

Phrase: "Maturity-onset diabetes of the young"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
  1000   C2984262:Maturity onset diabetes of the young [Functional Concept]
   833   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0332162:Onset [Qualitative Concept]
   753   C0449989:Maturity [Qualitative Concept]
   753   C0700597:Maturity [Temporal Concept]

Phrase: "due to a mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the hepatocyte nuclear factor-4 alpha binding site"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   818   C0005456:Binding Site [Receptor]
   818   C0682969:Binding Site [Amino Acid Sequence]
   795   C0205145:Site [Spatial Concept]
   795   C0243122:binding [Functional Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1515974:Site [Body Location or Region]
   795   C2825164:Site [Spatial Concept]
   747   C1415629:HEPATOCYTE NUCLEAR FACTOR 4-ALPHA [Gene or Genome]
           HEPATOCYTE NUCLEAR FACTOR 4
   747   C1565829:Hepatocyte Nuclear Factor 4-alpha [Amino Acid, Peptide, or Protein,Receptor]
   710   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of the hepatocyte nuclear factor-1 alpha gene."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C1537647:ALPHA GENE [Gene or Genome]
   827   C2985256:Alpha Gene [Gene or Genome]
   799   C0017337:Gene [Gene or Genome]
   780   C0209278:Hepatocyte Nuclear Factor 1-alpha [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   780   C1420631:HEPATIC NUCLEAR FACTOR-1-ALPHA [Gene or Genome]
           HEPATOCYTE NUCLEAR FACTOR 1
   734   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.308: Diabetes 46:16481651, 1997[Abstract] Barbacci E, Reber M, Ott M, Breillat C, Huetz F, Cereghini S: Variant hepatocyte nuclear factor 1 is required for visceral endoderm specification. 

Phrase: "Diabetes 46"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "16481651,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Barbacci E,"

Phrase: "Reber M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ott M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Breillat C,"

Phrase: "Huetz F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Cereghini S"

Phrase: ":"

Phrase: "Variant hepatocyte nuclear factor 1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   937   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]
   884   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0227525:Hepatocyte [Cell]
   804   C0521447:Nuclear [Spatial Concept]
   804   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]

Phrase: "is"

Phrase: "required for visceral endoderm specification."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0014144:Endoderm [Embryonic Structure]
   760   C0442045:Visceral [Spatial Concept]
   760   C1514873:Required [Functional Concept]
   760   C2348235:Specification [Conceptual Entity]
Processing 00000000.tx.309: Development 126:47954805, 1999[Abstract/Free FullText] Coffinier C, Thepot D, Babinet C, Yaniv M, Barra J: Essential role for the homeoprotein vHNF1/HNF1beta in visceral endoderm differentiation. 

Phrase: "Development 126"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: ":"

Phrase: "47954805,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Coffinier C,"

Phrase: "Thepot D,"

Phrase: "Babinet C,"

Phrase: "Yaniv M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Barra J"

Phrase: ":"

Phrase: "Essential role for the homeoprotein vHNF1/HNF1beta"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in visceral endoderm differentiation."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   865   C1707910:Endodermal Differentiation [Finding]
   827   C0007589:Differentiation [Cell Function]
   827   C1511938:Differentiation [Clinical Attribute]
   827   C2945687:Differentiation [Functional Concept]
   755 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.310: Development 126:47854794, 1999[Abstract/Free FullText] Mendel DB, Crabtree GR: A member of a novel class of dimerizing homeodomain proteins. 

Phrase: "Development 126"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: ":"

Phrase: "47854794,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Mendel DB,"

Phrase: "Crabtree GR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552950:[gr] [Quantitative Concept]

Phrase: ":"

Phrase: "A member of a novel class of dimerizing homeodomain proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0680022:member [Population Group]
   739   C2698041:Member [Professional or Occupational Group]
Processing 00000000.tx.311: J Biol Chem 266:677680, 1991[Free FullText] Blumenfeld M, Maury M, Chouard T, Yaniv M, Condamine H: Hepatic nuclear factor 1 (HNF1) shows a wider distribution than products of its known target genes in the developing mouse. 

Phrase: "J Biol Chem 266"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "677680,"

Phrase: "1991"

Phrase: "[Free FullText"

Phrase: "] Blumenfeld M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Maury M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Chouard T,"

Phrase: "Yaniv M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Condamine H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Hepatic nuclear factor 1 (HNF1)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0065110:Hepatic Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0521447:Nuclear [Spatial Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a wider distribution than products of its known target genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   741   C0680977:product distribution [Functional Concept]
   739   C0520511:distribution [Idea or Concept]
   739   C1704711:Distribution [Functional Concept]

Phrase: "in the developing mouse."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]
Processing 00000000.tx.312: Development 113:589599, 1991[Abstract] Pontoglio M, Barra J, Hadchouel M, Doyen A, Kress C, Bach JP, Babinet C, Yaniv M: Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. 

Phrase: "Development 113"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: ":"

Phrase: "589599,"

Phrase: "1991"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Pontoglio M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Barra J,"

Phrase: "Hadchouel M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Doyen A,"

Phrase: "Kress C,"

Phrase: "Bach JP,"

Phrase: "Babinet C,"

Phrase: "Yaniv M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Hepatocyte nuclear factor 1 inactivation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0544461:Inactivation [Cell or Molecular Dysfunction]
   771   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]
   717   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "results in hepatic dysfunction,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0086565:Hepatic dysfunction [Pathologic Function]
   770   C0031847:dysfunction [Functional Concept]
   770   C0205054:Hepatic [Body Location or Region]
   770   C0277785:Dysfunction, NOS [Qualitative Concept]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]
   715 E C0231174:Malfunction [Functional Concept]
   715 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "phenylketonuria,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031485:Phenylketonuria [Disease or Syndrome]
  1000   C0751434:Phenylketonuria [Disease or Syndrome]
  1000   C2720373:PHENYLKETONURIA [Gene or Genome]

Phrase: "and"

Phrase: "renal Fanconi syndrome."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0341703:Renal Fanconi Syndrome [Disease or Syndrome]
   901   C0015624:Fanconi Syndrome [Disease or Syndrome]
   901   C0015625:fanconi syndrome [Disease or Syndrome]
   901   C1857395:Fanconi syndrome [Disease or Syndrome]
   827   C0039082:Syndrome [Disease or Syndrome]
Processing 00000000.tx.313: Cell 84:575585, 1996[Medline] Lee YH, Sauer B, Gonzalez FJ: Laron dwarfism and non-insulin-dependent diabetes mellitus in the Hnf-1alpha knockout mouse. 

Phrase: "Cell 84"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "575585,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lee YH,"

Phrase: "Sauer B,"

Phrase: "Gonzalez FJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016080:FJ [Geographic Area]

Phrase: ":"

Phrase: "Laron dwarfism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0271568:Laron Dwarfism [Disease or Syndrome]
   861   C0013336:Dwarfism [Congenital Abnormality,Disease or Syndrome]

Phrase: "and"

Phrase: "non-insulin-dependent diabetes mellitus"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
  1000   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
  1000   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   937   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   840   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0851827:Dependent [Qualitative Concept]
   804   C1518422:Non [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1701901:Dependent [Qualitative Concept]
   804   C3244310:dependent [Functional Concept]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in the Hnf-1alpha knockout mouse."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0206745:Knock-Out Mouse [Mammal]
   812   C0025914:Mouse [Mammal]
   812   C0025929:mouse [Mammal]
   812   C0026809:Mouse [Mammal]
Processing 00000000.tx.314: Mol Cell Biol 18:30593068, 1998[Abstract/Free FullText] Shih DQ, Bussen M, Sehayek E, Ananthanarayanan M, Shneider BL, Suchy FJ, Shefer S, Bollileni JS, Gonzalez FJ, Breslow JL, Stoffel M: Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism. 

Phrase: "Mol Cell Biol 18"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "30593068,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shih DQ,"

Phrase: "Bussen M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sehayek E,"

Phrase: "Ananthanarayanan M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Shneider BL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006413:BL [Neoplastic Process]
   861   C1552663:BL [Idea or Concept]
   861   C2827109:BL [Geographic Area]

Phrase: "Suchy FJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016080:FJ [Geographic Area]

Phrase: "Shefer S,"

Phrase: "Bollileni JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Gonzalez FJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016080:FJ [Geographic Area]

Phrase: "Breslow JL,"

Phrase: "Stoffel M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Hepatocyte nuclear factor-1alpha"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0209278:Hepatocyte Nuclear Factor 1-alpha [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420631:HEPATIC NUCLEAR FACTOR-1-ALPHA [Gene or Genome]
   923   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0227525:Hepatocyte [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "is"

Phrase: "an essential regulator of bile acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0182953:REGULATOR [Medical Device]
   753   C1704734:Regulator [Medical Device]
   753   C1704735:Regulator [Conceptual Entity]

Phrase: "and"

Phrase: "plasma cholesterol metabolism."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1373181:Plasma Metabolism [Organism Function]
   901   C1156530:cholesterol metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
   734   C0858034:plasma cholesterol [Laboratory Procedure]
Processing 00000000.tx.315: Nat Genet 27:375382, 2001[Medline] Lehto M, Tuomi T, Mahtani MM, Widen E, Forsblom C, Sarelin L, Gullstrom M, Isomaa B, Lehtovirta M, Hyrkko A, Kanninen T, Orho M, Manley S, Turner RC, Brettin T, Kirby A, Thomas J, Duyk G, Lander E, Taskinen MR, Groop L: Characterization of the MODY3 phenotype: early-onset diabetes caused by an insulin secretion defect. 

Phrase: "Nat Genet 27"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "375382,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lehto M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Tuomi T,"

Phrase: "Mahtani MM,"

Phrase: "Widen"

Phrase: "E,"

Phrase: "Forsblom C,"

Phrase: "Sarelin L,"

Phrase: "Gullstrom M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Isomaa B,"

Phrase: "Lehtovirta M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hyrkko A,"

Phrase: "Kanninen T,"

Phrase: "Orho M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Manley S,"

Phrase: "Turner RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Brettin T,"

Phrase: "Kirby A,"

Phrase: "Thomas J,"

Phrase: "Duyk G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Lander E,"

Phrase: "Taskinen MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Groop L"

Phrase: ":"

Phrase: "Characterization of the MODY3 phenotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: ":"

Phrase: "early-onset diabetes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1833334:Early-onset [Finding]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332162:Onset [Qualitative Concept]
   827   C1279919:Early [Temporal Concept]

Phrase: "caused by an insulin secretion defect."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C1256369:insulin secretion [Cell Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C1457869:Defect [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1861101:DEFECT [Disease or Syndrome]
   719   C0015127:cause [Functional Concept]
   719   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.316: J Clin Invest 99:582591, 1997[Abstract/Free FullText] Byrne MM, Sturis J, Menzel S, Yamagata Y, Fajans SS, Dronsfield MJ, Bain SC, Hattersley AT, Velho G, Froguel P, Bell GI, Polonsky KS: Altered insulin secretory response to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "99"

Phrase: ":"

Phrase: "582591,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Byrne MM,"

Phrase: "Sturis J,"

Phrase: "Menzel S,"

Phrase: "Yamagata Y,"

Phrase: "Fajans SS,"

Phrase: "Dronsfield MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Bain SC,"

Phrase: "Hattersley AT,"

Phrase: "Velho G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Froguel P,"

Phrase: "Bell GI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: "Polonsky KS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: ":"

Phrase: "Altered insulin secretory response to glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "in diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "nondiabetic subjects with mutations"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "in the diabetes susceptibility gene MODY3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1838100:MODY3 [Disease or Syndrome]
   812   C3273648:MODY3 [Gene or Genome]

Phrase: "on chromosome 12."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008654:Chromosome 12 [Cell Component]
   861   C0008633:Chromosome [Cell Component]
Processing 00000000.tx.317: Diabetes 46:15031511, 1996 Yamagata K, Yang Q, Yamamoto K, Iwahashi H, Miyagawa J, Okita K, Yoshiuchi I, Miyazaki J, Noguchi T, Nakajima H, Namba M, Hanafusa T, Matsuzawa Y: Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1alpha is dominant negative. 

Phrase: "Diabetes 46"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "15031511,"

Phrase: "1996 Yamagata K,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0450339:1996 K [Intellectual Product]
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: "Yang"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "Q,"

Phrase: "Yamamoto K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Iwahashi H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Miyagawa J,"

Phrase: "Okita K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Yoshiuchi I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Miyazaki J,"

Phrase: "Noguchi T,"

Phrase: "Nakajima H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Namba M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hanafusa T,"

Phrase: "Matsuzawa Y"

Phrase: ":"

Phrase: "Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1alpha"

Phrase: "is"

Phrase: "dominant negative."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C1527180:Dominant [Functional Concept]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
Processing 00000000.tx.318: Diabetes 47:12311235, 1998[Abstract] Pontoglio M, Sreenan S, Roe M, Pugh W, Ostrega D, Doyen A, Pick AJ, Baldwin A, Velho G, Froguel P, Levisetti M, Bonner-Weir S, Bell GI, Yaniv M, Polonsky KS: Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice. 

Phrase: "Diabetes 47"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "12311235,"

Phrase: "1998"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Pontoglio M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sreenan S,"

Phrase: "Roe M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Pugh W,"

Phrase: "Ostrega D,"

Phrase: "Doyen A,"

Phrase: "Pick AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Baldwin A,"

Phrase: "Velho G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Froguel P,"

Phrase: "Levisetti M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bonner-Weir S,"

Phrase: "Bell GI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: "Yaniv M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Polonsky KS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: ":"

Phrase: "Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C1256369:insulin secretion [Cell Function]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0036536:secretion [Biologic Function]
   739   C0036537:Secretion [Body Substance]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.319: J Clin Invest101:22152222, 1998 Dukes ID, Sreenan S, Roe MW, Levisetti M, Zhou YP, Ostrega D, Bell GI, Pontoglio M, Yaniv M, Philipson L, Polonsky KS: Defective pancreatic beta-cell glycolytic signaling in hepatocyte nuclear factor-1alpha-deficient mice. 

Phrase: "J Clin Invest101"

Phrase: ":"

Phrase: "22152222,"

Phrase: "1998 Dukes ID,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0600091:ID [Intellectual Product]

Phrase: "Sreenan S,"

Phrase: "Roe MW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024548:MW [Geographic Area]
   861   C0026385:mw [Quantitative Concept]
   861   C0556966:mW [Quantitative Concept]

Phrase: "Levisetti M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Zhou YP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520214:Yp [Nucleotide Sequence]

Phrase: "Ostrega D,"

Phrase: "Bell GI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: "Pontoglio M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Yaniv M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Philipson L,"

Phrase: "Polonsky KS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: ":"

Phrase: "Defective pancreatic beta-cell glycolytic signaling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C0037083:Cell Signaling [Cell Function]
           Signaling
   799   C3537152:signaling [Biologic Function]

Phrase: "in hepatocyte nuclear factor-1alpha-deficient mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   734   C0209278:Hepatocyte Nuclear Factor 1-alpha [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420631:HEPATIC NUCLEAR FACTOR-1-ALPHA [Gene or Genome]
Processing 00000000.tx.320: J Biol Chem273:2445724464, 1998 Parrizas M, Maestro MA, Boj SF, Paniagua A, Casamitjana R, Gomis R, Rivera F, Ferrer J: Hepatic nuclear factor 1- directs nucleosomal hyperacetylation to its tissue-specific transcriptional targets. 

Phrase: "J Biol Chem273"

Phrase: ":"

Phrase: "2445724464,"

Phrase: "1998 Parrizas M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Maestro MA,"

Phrase: "Boj SF,"

Phrase: "Paniagua A,"

Phrase: "Casamitjana R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Gomis R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Rivera F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Ferrer J"

Phrase: ":"

Phrase: "Hepatic nuclear factor 1-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0065110:Hepatic Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0521447:Nuclear [Spatial Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "directs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "nucleosomal hyperacetylation to its tissue-specific transcriptional targets."
Processing 00000000.tx.321: Mol Cell Biol 21:32343243, 2001[Abstract/Free FullText] Wang H, Maechler P, Hagenfeldt KA, Wollheim CB: Dominant-negative suppression of HNF-1 function results in defective insulin gene transcription and impaired metabolism-secretion coupling in a pancreatic -cell line. 

Phrase: "Mol Cell Biol 21"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "32343243,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wang H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Maechler P,"

Phrase: "Hagenfeldt KA,"

Phrase: "Wollheim CB"

Phrase: ":"

Phrase: "Dominant-negative suppression of HNF-1 function results"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0221103:Suppression [Pathologic Function]
   739   C0301625:Suppression [Organism Function]
   739   C0439181:% suppression [Quantitative Concept]
   739   C0728721:suppression [Mental Process]

Phrase: "in defective insulin gene transcription"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040649:Gene Transcription [Genetic Function]
           Transcription

Phrase: "and"

Phrase: "impaired metabolism-secretion coupling in a pancreatic -cell line."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1948027:Coupling [Functional Concept]
Processing 00000000.tx.322: EMBO J 17:67016713, 1998[Abstract/Free FullText] Wang H, Antinozzi PA, Hagenfeldt KA, Maechler P, Wollheim CB: Molecular targets of a human HNF1 mutation responsible for pancreatic -cell dysfunction. 

Phrase: "EMBO J 17"

Phrase: ":"

Phrase: "67016713,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wang H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Antinozzi PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "Hagenfeldt KA,"

Phrase: "Maechler P,"

Phrase: "Wollheim CB"

Phrase: ":"

Phrase: "Molecular targets of a human HNF1 mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   743   C1513403:Molecular Target [Chemical Viewed Functionally,Chemical Viewed Structurally]
   706   C1521840:Target [Functional Concept]
   706   C2986546:TARGET [Diagnostic Procedure]

Phrase: "responsible for pancreatic -cell dysfunction."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]
Processing 00000000.tx.323: EMBO J 19:42574264, 2000[Abstract/Free FullText] Sturis J, Pugh WL, Tang J, Polonsky KS: Prevention of diabetes does not completely prevent insulin secretory defects in the ZDF rat. 

Phrase: "EMBO J 19"

Phrase: ":"

Phrase: "42574264,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Sturis J,"

Phrase: "Pugh WL,"

Phrase: "Tang J,"

Phrase: "Polonsky KS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: ":"

Phrase: "Prevention of diabetes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C1659987:diabetes prevention [Educational Activity]
   790   C0199176:Prevention [Therapeutic or Preventive Procedure]
   790   C1706420:PREVENTION [Research Activity]
   790   C2700409:prevention [Qualitative Concept]

Phrase: "does"

Phrase: "not completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205197:Completely [Qualitative Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "insulin secretory defects in the ZDF rat."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0243067:defects [Functional Concept]
   714 E C1457869:Defect [Functional Concept]
   714 E C1861101:DEFECT [Disease or Syndrome]
Processing 00000000.tx.324: Am J Physiol 269:E786E792, 1995[Abstract/Free FullText] Wilson PA, Melton DA: Mesodermal patterning by an inducer gradient depends on secondary cell-cell communication. 

Phrase: "Am"

Phrase: "J Physiol 269"

Phrase: ":"

Phrase: "E786E792,"

Phrase: "1995"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wilson PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "Melton DA"

Phrase: ":"

Phrase: "Mesodermal patterning by an inducer gradient"

Phrase: "depends on secondary cell-cell communication."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   783   C0007582:Cell Communication [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0009452:Communication [Social Behavior]
   753   C0027627:secondary [Neoplastic Process]
   753   C0175668:Secondary [Temporal Concept]
   753   C0205436:Secondary [Quantitative Concept]
   753   C0725813:depend [Medical Device]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.325: Curr Biol 4:676686, 1994[Medline] Alam J, Cook JL: Reporter genes: application to the study of mammalian gene transcription. 

Phrase: "Curr Biol 4"

Phrase: ":"

Phrase: "676686,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Alam J,"

Phrase: "Cook JL"

Phrase: ":"

Phrase: "Reporter genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206414:Genes, Reporter [Gene or Genome]
   861   C0017337:Genes [Gene or Genome]

Phrase: ":"

Phrase: "application to the study of mammalian gene transcription."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0185125:Application [Health Care Activity]
   744   C1947919:Application [Intellectual Product]
   744   C2347934:Application [Intellectual Product]
   744   C3539080:APPLICATION [Quantitative Concept]
Processing 00000000.tx.326: Anal Biochem 188:245254, 1990[Medline] Webb GC, Akbar MS, Zhao C, Steiner DF: Expression profiling of pancreatic beta cells: glucose regulation of secretory and metabolic pathway genes. 

Phrase: "Anal Biochem 188"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003461:Anal [Body Part, Organ, or Organ Component]
   827   C2939124:Anal [Spatial Concept]

Phrase: ":"

Phrase: "245254,"

Phrase: "1990"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Webb GC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3537453:GC [Gene or Genome]

Phrase: "Akbar MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Zhao C,"

Phrase: "Steiner DF"

Phrase: ":"

Phrase: "Expression profiling of pancreatic beta cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1513400:Expression Profiling [Molecular Biology Research Technique]
   719   C1979963:Profile [Laboratory Procedure]
   719   C2003903:Profile [Functional Concept]

Phrase: ":"

Phrase: "glucose regulation of secretory"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "metabolic pathway genes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017337:Genes [Gene or Genome]
   734   C1291081:Metabolic Pathway [Functional Concept]
Processing 00000000.tx.327: Proc Natl Acad Sci U S A97:57735778, 2000 MacDonald MJ, Kowluru A: Evidence for calcium enhanced phosphorylation of pyruvate kinase by pancreatic islets. 

Phrase: "Proc Natl Acad Sci U S A97"

Phrase: ":"

Phrase: "57735778,"

Phrase: "2000 MacDonald MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439254:MJ [Medical Device]

Phrase: "Kowluru A"

Phrase: ":"

Phrase: "Evidence for calcium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332120:Evidence [Functional Concept]

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "phosphorylation of pyruvate kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "by pancreatic islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
Processing 00000000.tx.328: Mol Cell Biochem68:107114, 1985 MacDonald MJ, Kowluru A, Chang CM: Evidence for phosphorylation of pancreatic islet pyruvate kinase. 

Phrase: "Mol Cell Biochem68"

Phrase: ":"

Phrase: "107114,"

Phrase: "1985 MacDonald MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439254:MJ [Medical Device]

Phrase: "Kowluru A,"

Phrase: "Chang CM"

Phrase: ":"

Phrase: "Evidence for phosphorylation of pancreatic islet pyruvate kinase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0332120:Evidence of [Functional Concept]
           Evidence
Processing 00000000.tx.329: Metabolism 34:600603, 1985[Medline] Seol W, Choi HS, Moore DD: An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. 

Phrase: "Metabolism 34"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: ":"

Phrase: "600603,"

Phrase: "1985"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Seol W,"

Phrase: "Choi HS,"

Phrase: "Moore DD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538867:DD [Gene or Genome]

Phrase: ":"

Phrase: "An orphan nuclear hormone receptor"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   923   C0887829:Nuclear Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   923   C1753269:nuclear hormone receptor [Molecular Function]
   875   C0206588:Nuclear Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0019929:Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1367453:HORMONE RECEPTOR [Gene or Genome]
   812   C0019932:Hormone [Hormone]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   741 E C0458083:Hormonal [Qualitative Concept]

Phrase: "that"

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "a DNA binding domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1511662:DNA Binding Domain [Amino Acid Sequence]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "heterodimerizes with other receptors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.330: Science 272:13361369, 1996[Abstract] Lee YK, Dell H, Dowhan DH, Hadzopoulou-Cladaras M, Moore DD: The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: two mechanisms for repression. 

Phrase: "Science 272"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "13361369,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lee YK,"

Phrase: "Dell H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Dowhan DH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1832586:DH [Disease or Syndrome]

Phrase: "Hadzopoulou-Cladaras M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Moore DD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538867:DD [Gene or Genome]

Phrase: ":"

Phrase: "The orphan nuclear receptor SHP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1335142:Orphan Nuclear Receptor SHP [Amino Acid, Peptide, or Protein,Receptor]
           SHP
   812   C1334896:SHP [Gene or Genome]
   812   C1705299:SHP [Gene or Genome]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "hepatocyte nuclear factor 4"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   923   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0227525:Hepatocyte [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "retinoid X receptor transactivation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C3158809:receptor transactivation [Physiologic Function]
   812   C0040624:Transactivation [Genetic Function]
   756   C0140283:Retinoid X Receptor [Amino Acid, Peptide, or Protein,Receptor]
   708   C0140278:Retinoid Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ":"

Phrase: "two mechanisms for repression."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0441712:Mechanisms [Functional Concept]
   737 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.331: Mol Cell Biol 20:187195, 2000[Abstract/Free FullText] Lee HK, Lee YK, Park SH, Kim YS, Lee JW, Kwon HB, Soh J, Moore DD, Cho HS: Structure and expression of the orphan nuclear receptor SHP gene. 

Phrase: "Mol Cell Biol 20"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "187195,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lee HK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0019907:HK [Geographic Area]
   861   C2681927:HK [Gene or Genome]
   861   C2987742:HK [Fish]

Phrase: "Lee YK,"

Phrase: "Park SH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038108:SH [Geographic Area]

Phrase: "Kim YS,"

Phrase: "Lee JW,"

Phrase: "Kwon HB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019046:Hb [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Soh J,"

Phrase: "Moore DD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538867:DD [Gene or Genome]

Phrase: "Cho HS"

Phrase: ":"

Phrase: "Structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "expression of the orphan nuclear receptor SHP gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0017262:Gene Expression [Genetic Function]
   767   C0597360:receptor expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.332: J Biol Chem 273:1439814402, 1998[Abstract/Free FullText] Grupe A, Hultgren B, Ryan A, Ma YH, Bauer M, Stewart TA: Transgenic knockouts reveal a critical requirement for pancreatic beta cell glucokinase in maintaining glucose homeostasis. 

Phrase: "J Biol Chem 273"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1439814402,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Grupe A,"

Phrase: "Hultgren B,"

Phrase: "Ryan A,"

Phrase: "Ma YH,"

Phrase: "Bauer M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Stewart TA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: ":"

Phrase: "Transgenic knockouts"

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a critical requirement for pancreatic beta cell glucokinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1514873:Requirement [Functional Concept]

Phrase: "in maintaining glucose homeostasis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1326961:glucose homeostasis [Physiologic Function]
   827   C0019868:Homeostasis [Biologic Function]
Processing 00000000.tx.333: Cell 83:6978, 1995[Medline] Guillam MT, Hummler E, Schaerer E, Yeh JI, Birnbaum MJ, Beermann F, Schmidt A, Deriaz N, Thorens B, Wu JY: Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2. 

Phrase: "Cell 83"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "6978,"

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Guillam MT,"

Phrase: "Hummler E,"

Phrase: "Schaerer E,"

Phrase: "Yeh JI,"

Phrase: "Birnbaum MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Beermann F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Schmidt A,"

Phrase: "Deriaz N,"

Phrase: "Thorens B,"

Phrase: "Wu JY"

Phrase: ":"

Phrase: "Early diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "abnormal postnatal pancreatic islet development in mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0000768:Abnormal development [Congenital Abnormality]
   774   C1135598:postnatal development [Organism Function]
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "Glut-2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420172:GLUT2 [Gene or Genome]
   861   C1335837:GLUT [Gene or Genome]
   861   C1705603:GLUT [Gene or Genome]
Processing 00000000.tx.334: Nat Genet 17:327330, 1997[Medline] Tsukuda N, Gabler WL: The influence of doxycycline of the attachment of fibroblasts to gelatin-coated surfaces and its cytotoxicity. 

Phrase: "Nat Genet 17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "327330,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tsukuda N,"

Phrase: "Gabler WL"

Phrase: ":"

Phrase: "The influence of doxycycline of the attachment of fibroblasts"

Phrase: "to gelatin-coated surfaces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205148:Surface [Spatial Concept]

Phrase: "and"

Phrase: "its cytotoxicity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   928 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   928 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.335: J Periodontol 64:12191224, 1993[Medline] Saez E, No D, West A, Evans RM: Inducible gene expression in mammalian cells and transgenic mice. 

Phrase: "J Periodontol 64"

Phrase: ":"

Phrase: "12191224,"

Phrase: "1993"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Saez E,"

Phrase: "No D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "West A,"

Phrase: "Evans RM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: ":"

Phrase: "Inducible gene expression in mammalian cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0017262:Gene Expression [Genetic Function]
   767   C1861886:CELL Gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.336: Curr Opin Biotechnol 8:608616, 1997[Medline] Chouard T, Blumenfeld M, Bach I, Vandekerckhove J, Cereghini S, Yaniv M: A distal dimerization domain is essential for DNA-binding by the atypical HNF1 homeodomain. 

Phrase: "Curr Opin Biotechnol 8"

Phrase: ":"

Phrase: "608616,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chouard T,"

Phrase: "Blumenfeld M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bach I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Vandekerckhove J,"

Phrase: "Cereghini S,"

Phrase: "Yaniv M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "A distal dimerization domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "essential for DNA-binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]

Phrase: "by the atypical HNF1 homeodomain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0598306:Homeo Domain [Spatial Concept]
   734   C0065110:Hepatic Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.337: Nucleic Acids Res 18:58535863, 1990[Abstract] Asfari M, Janijic D, Meda P, Li G, Halban PA, Wollheim CB: Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. 

Phrase: "Nucleic Acids Res 18"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0001128:Acids [Chemical]
   812   C0007610:Nucleic [Cell Component]
   812   C2347379:RES [Finding]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: ":"

Phrase: "58535863,"

Phrase: "1990"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Asfari M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Janijic D,"

Phrase: "Meda P,"

Phrase: "Li G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Halban PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "Wollheim CB"

Phrase: ":"

Phrase: "Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines."
Processing 00000000.tx.338: Endocrinology 130:167178, 1992[Abstract] Mitchell SMS, Thomas H, Jaschkowitz K, Bulman MP, Frayling TM, Ellard S, Tack C, Ryffel GU, Hattersley AT: A mutation of a novel splice variant of HNF-4 co-segregates with MODY. 

Phrase: "Endocrinology 130"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "167178,"

Phrase: "1992"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mitchell SMS,"

Phrase: "Thomas H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Jaschkowitz K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Bulman MP,"

Phrase: "Frayling TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Ellard S,"

Phrase: "Tack C,"

Phrase: "Ryffel GU,"

Phrase: "Hattersley AT"

Phrase: ":"

Phrase: "A mutation of a novel splice variant of HNF-4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   751   C2985438:Novel Mutation [Cell or Molecular Dysfunction]
   736   C0026882:Mutation [Genetic Function]
   736   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "co-segregates with MODY."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   882   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   882   C2984262:Maturity onset diabetes of the young [Functional Concept]
   790   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   742   C0011847:Diabetes [Disease or Syndrome]
   742   C0011849:Diabetes [Disease or Syndrome]
   742   C0332162:Onset [Qualitative Concept]
   742   C0332239:Young [Temporal Concept]
   742   C0449989:Maturity [Qualitative Concept]
   742   C0700597:Maturity [Temporal Concept]
Processing 00000000.tx.339: Diabetologia In press Byrne MM, Sturis J, Fajans SS, Stoltz A, Oritz FJ, Stoffel M, Smith MJ, Bell GI, Halter JB, Polonsky KS: Altered insulin secretory responses to glucose in subjects with mutation in the MODY1 gene on chromosome 20. 

Phrase: "Diabetologia In press Byrne MM,"

Phrase: "Sturis J,"

Phrase: "Fajans SS,"

Phrase: "Stoltz A,"

Phrase: "Oritz FJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016080:FJ [Geographic Area]

Phrase: "Stoffel M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Smith MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Bell GI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: "Halter JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Polonsky KS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: ":"

Phrase: "Altered insulin secretory responses to glucose"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]

Phrase: "in subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "with mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the MODY1 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "on chromosome 20."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008663:Chromosome 20 [Cell Component]
   861   C0008633:Chromosome [Cell Component]
Processing 00000000.tx.340: Diabetes 44:699705, 1994[Abstract] Shih DQ, Dansky HM, Fleisher M, Assmann G, Fajans SS, Stoffel M: Genotype phenotype relationships in HNF-4a/MODY1. 

Phrase: "Diabetes 44"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "699705,"

Phrase: "1994"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Shih DQ,"

Phrase: "Dansky HM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0262500:hm [Health Care Activity]
   861   C1512358:HM [Geographic Area]
   861   C3538713:HM [Idea or Concept]

Phrase: "Fleisher M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Assmann G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Fajans SS,"

Phrase: "Stoffel M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Genotype phenotype relationships in HNF-4a/MODY1."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0439849:Relationships [Qualitative Concept]
   708 E C1705630:Relationship [Idea or Concept]
   708 E C1706279:Relationship [Idea or Concept]
   708 E C3540605:Relationship [Intellectual Product]
Processing 00000000.tx.341: Haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein (a), and triglyceride levels. 

Phrase: "Haploinsufficiency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2936267:Haploinsufficiency [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "associated with reduced apolipoprotein (AII),"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0392756:Reduced [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "apolipoprotein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(CIII"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547548:CIII [Regulation or Law]

Phrase: ")"

Phrase: ","

Phrase: "lipoprotein (a),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065058:Lipoprotein (a) [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0125953:Lipoprotein (a-) [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1096202:Lipoprotein-a [Laboratory Procedure]
   861   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "triglyceride levels."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0428475:Triglyceride level [Laboratory or Test Result]
   861   C0041004:Triglyceride [Biologically Active Substance,Lipid]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.342: Diabetes 49:832837, 2000[Abstract] Jonsson J, Carlson L, Edlund T, Edlund H: Insulin-promoter-factor 1 is required for pancreas development in mice. 

Phrase: "Diabetes 49"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "832837,"

Phrase: "2000"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Jonsson J,"

Phrase: "Carlson L,"

Phrase: "Edlund T,"

Phrase: "Edlund H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Insulin-promoter-factor 1"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0248419:insulin promoter factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826562:INSULIN PROMOTER FACTOR 1 [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1521761:Factor [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C2827422:Factor [Conceptual Entity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "required for pancreas development"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1523495:pancreas development [Biologic Function]
   770   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1278931:Pancreas [Body Part, Organ, or Organ Component]
   770   C1514873:Required [Functional Concept]
   770   C1527148:Development [Functional Concept]

Phrase: "in mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.343: Nature 371:606609, 1994[Medline] Ahlgren U, Jonsson J, Jonsson L, Simu K, Edlund H: Beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. 

Phrase: "Nature 371"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "606609,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ahlgren U,"

Phrase: "Jonsson J,"

Phrase: "Jonsson L,"

Phrase: "Simu K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Edlund H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0598496:Gene Inactivation [Genetic Function]
   739   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "results in loss of the beta-cell phenotype"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   793   C1318445:Cell phenotype result [Laboratory or Test Result]
   770   C0030281:Beta cell [Cell]
   770   C0427385:Cell phenotype [Laboratory Procedure]
   770   C1318444:Cell phenotype [Organism Attribute]
   744   C0007634:Cell [Cell]
   744   C0031437:Phenotype [Organism Attribute]
   744   C0330390:Beta [Plant]
   744   C0439096:Beta [Intellectual Product]
   744   C1269647:Cell [Cell]
   744   C1274040:Result [Functional Concept]
   744   C1285572:Phenotype [Laboratory Procedure]
   744   C1517945:Loss [Quantitative Concept]
   744   C1546471:Result [Idea or Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C2004068:Beta [Qualitative Concept]
   744   C2825142:Result [Finding]

Phrase: "and"

Phrase: "maturity onset diabetes."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332162:Onset [Qualitative Concept]
   827   C0449989:Maturity [Qualitative Concept]
   827   C0700597:Maturity [Temporal Concept]
   755 E C0205286:Mature [Temporal Concept]
Processing 00000000.tx.344: Genes Dev 12:17631768, 1998[Abstract/Free FullText] Waeber G, Thompson N, Nicod P, Bony C: Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor. 

Phrase: "Genes Dev 12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: ":"

Phrase: "17631768,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Waeber G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Thompson N,"

Phrase: "Nicod P,"

Phrase: "Bony C"

Phrase: ":"

Phrase: "Transcriptional activation of the GLUT2 gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0162493:Transcriptional Activation [Genetic Function]
   783   C0017255:Gene Activation [Genetic Function]
   753   C1879547:Activation [Activity]

Phrase: "by the IPF-1/STF-1/IDX-1 homeobox factor."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.345: Mol Endocrinol 10:13271334, 1998[Abstract] Carty MD, Lillquist JS, Peshavaria M, Stein R, Soeller WC: Identification of cis- and trans-active factors regulating human islet amyloid polypeptide gene expression in pancreatic beta-cells. 

Phrase: "Mol Endocrinol 10"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0027960:Mole [Neoplastic Process]
   827   C0324740:Mole [Mammal]
   827   C0439189:Mole [Quantitative Concept]
   827   C1456781:mole [Neoplastic Process]
   827   C1824986:mol [Gene or Genome]
   743 E C0026367:Molar [Body Part, Organ, or Organ Component]
   727 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "13271334,"

Phrase: "1998"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Carty MD,"

Phrase: "Lillquist JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Peshavaria M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Stein R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Soeller WC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: ":"

Phrase: "Identification of cis-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020792:Identification [Mental Process]
   790   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "trans-active factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "regulating"

Phrase: "human islet amyloid polypeptide gene expression in pancreatic beta-cells."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0017262:Gene Expression [Genetic Function]
   757   C0314604:Human gene [Gene or Genome]
   741   C1861886:CELL Gene [Gene or Genome]
   739   C0017337:Gene [Gene or Genome]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.346: J Biol Chem 272:1198611993, 1997[Abstract/Free FullText] Melloul D, Ben-Neriah Y, Cerasi E: Glucose modulates the binding of an islet-specific factor to a conserved sequence within the rat 1 and the human insulin promoters. 

Phrase: "J Biol Chem 272"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1198611993,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Melloul D,"

Phrase: "Ben-Neriah Y,"

Phrase: "Cerasi E"

Phrase: ":"

Phrase: "Glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the binding of an islet-specific factor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "to a conserved sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0009802:Conserved Sequence [Nucleotide Sequence]
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "within the rat 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514732:Rat-1 [Cell]
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]

Phrase: "and"

Phrase: "the human insulin promoters."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.347: Proc Natl Acad Sci U S A 90:38653969, 1993[Abstract] Dumonteil E, Laser B, Constant I, Philippe J: Differential regulation of the glucagon and insulin I gene promoters by the basic helix-loop-helix transcription factors E47 and BETA2. 

Phrase: "Proc Natl Acad Sci U S A 90"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   836   C2919042:U-90 [Organic Chemical,Pharmacologic Substance]
   835   C0041703:U.S.A. [Geographic Area]
           U S
   793   C0268596:ACAD [Disease or Syndrome]
   793   C0439083:>90 [Quantitative Concept]
   793   C0439087:<90 [Quantitative Concept]
   793   C1418943:PROC [Gene or Genome]
   793   C2700624:ACAD [Cell Function]
   793   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "38653969,"

Phrase: "1993"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Dumonteil E,"

Phrase: "Laser B,"

Phrase: "Constant I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Philippe J"

Phrase: ":"

Phrase: "Differential regulation of the glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "insulin I gene promoters"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0314621:gene promoters [Gene or Genome]
   812   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   708   C1337112:Insulin Gene [Gene or Genome]

Phrase: "by the basic helix-loop-helix transcription factors E47"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1336596:E47 [Gene or Genome]
   787   C0288972:Basic Helix-Loop-Helix Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "BETA2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1417683:BETA2 [Gene or Genome]
  1000   C1823554:Beta2 [Gene or Genome]
  1000   C3273872:BETA2 [Gene or Genome]
Processing 00000000.tx.348: J Biol Chem 273:1994519954, 1998[Abstract/Free FullText] Emens LA, Landers DW, Moss LG: Hepatocyte nuclear factor 1 alpha is expressed in a hamster insulinoma line and transactivates the rat insulin I gene. 

Phrase: "J Biol Chem 273"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1994519954,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Emens LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Landers DW,"

Phrase: "Moss LG"

Phrase: ":"

Phrase: "Hepatocyte nuclear factor 1 alpha"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
  1000   C0209278:Hepatocyte Nuclear Factor 1-alpha [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420631:HEPATIC NUCLEAR FACTOR-1-ALPHA [Gene or Genome]
           HEPATOCYTE NUCLEAR FACTOR 1
   937   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0227525:Hepatocyte [Cell]
   804   C0439095:Alpha [Intellectual Product]
   804   C0521447:Nuclear [Spatial Concept]
   804   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1521761:Factor [Functional Concept]
   804   C2003941:Alpha [Intellectual Product]
   804   C2350010:Alpha [Qualitative Concept]
   804   C2827422:Factor [Conceptual Entity]

Phrase: "is"

Phrase: "expressed in a hamster insulinoma line"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0018557:Hamster [Mammal]
   753   C0021670:insulinoma [Neoplastic Process]
   753   C0205132:Line [Spatial Concept]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "transactivates"

Phrase: "the rat insulin I gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C1337112:Insulin Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.349: Proc Natl Acad Sci U S A89:73007304, 1992 Nishigori H, Tomura H, Tonooka N, Kanamori M, Yamada S, Sho K, Inoue I, Kikuchi N, Onigata K, Kojima I, Kohama T, Yamagata K, Yang Q, Matsuzawa Y, Miki T, Seino S, Kim MY, Choi HS, Lee YK, Moore DD, Takeda J: Mutations in the small heterodimer partner gene are associated with mild obesity in Japanese subjects. 

Phrase: "Proc Natl Acad Sci U S A89"

Phrase: ":"

Phrase: "73007304,"

Phrase: "1992 Nishigori H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Tomura H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Tonooka N,"

Phrase: "Kanamori M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Yamada S,"

Phrase: "Sho K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Inoue I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Kikuchi N,"

Phrase: "Onigata K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kojima I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Kohama T,"

Phrase: "Yamagata K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Yang"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "Q,"

Phrase: "Matsuzawa Y,"

Phrase: "Miki T,"

Phrase: "Seino S,"

Phrase: "Kim"

Phrase: "MY,"

Phrase: "Choi HS,"

Phrase: "Lee YK,"

Phrase: "Moore DD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538867:DD [Gene or Genome]

Phrase: "Takeda J"

Phrase: ":"

Phrase: "Mutations in the small heterodimer partner gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0596611:gene mutations [Genetic Function]
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "associated with mild obesity"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0028754:Obesity [Disease or Syndrome]
   770   C1963185:Obesity [Finding]
   770   C2945599:Mild [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in Japanese subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.350: Proc Natl Acad Sci U S A 98:575580, 2001[Abstract/Free FullText] Vaulont S, Puzenat N, Levrat B, Cognet M, Kahn A, Raymondjean M: Proteins binding to the liver specific pyruvate kinase gene promoter: a unique combination of known factors. 

Phrase: "Proc Natl Acad Sci U S A 98"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C0041703:U.S.A. [Geographic Area]
           U S
   793   C0268596:ACAD [Disease or Syndrome]
   793   C1418943:PROC [Gene or Genome]
   793   C2700624:ACAD [Cell Function]
   793   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "575580,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Vaulont S,"

Phrase: "Puzenat N,"

Phrase: "Levrat B,"

Phrase: "Cognet M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kahn A,"

Phrase: "Raymondjean M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "binding to the liver specific pyruvate kinase gene promoter"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   764   C0034348:Pyruvate Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0314621:Promoter gene [Gene or Genome]
   762   C1149289:kinase binding [Molecular Function]
   742   C0017337:Gene [Gene or Genome]
   742   C0023884:Liver [Body Part, Organ, or Organ Component]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0034354:pyruvate [Organic Chemical]
   742   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0205369:Specific [Qualitative Concept]
   742   C0243122:binding [Functional Concept]
   742   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
   742   C0736268:LIVER [Body Part, Organ, or Organ Component]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1278929:Liver [Body Part, Organ, or Organ Component]
   742   C1552740:specific [Intellectual Product]
   742   C2346688:LIVER [Food]

Phrase: ":"

Phrase: "a unique combination of known factors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205195:Combination [Qualitative Concept]
   753   C1947911:Combination [Physical Object]
Processing 00000000.tx.351: J Mol Biol 209215, 1989 Citron BA, Davis MD, Milstien S, Gutierrez J, Mendel DB, Crabtree GR, Kaufman S: Identity of 4a-carbinolamine dehydratase, a component of the phenylalanine hydroxylation system, and DCoH, a transregulator of homeodomain proteins. 

Phrase: "J Mol Biol 209215,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C2346604:J/mol [Quantitative Concept]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: "1989 Citron BA,"

Phrase: "Davis MD,"

Phrase: "Milstien S,"

Phrase: "Gutierrez J,"

Phrase: "Mendel DB,"

Phrase: "Crabtree GR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552950:[gr] [Quantitative Concept]

Phrase: "Kaufman S"

Phrase: ":"

Phrase: "Identity of 4a-carbinolamine dehydratase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0424215:Identity [Mental Process]
   760   C2003939:Identity [Finding]

Phrase: "a component of the phenylalanine hydroxylation system,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "DCoH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418296:DCOH [Gene or Genome]

Phrase: "a transregulator of homeodomain proteins."
Processing 00000000.tx.352: Proc Natl Acad Sci U S A89:1189111894, 1992

Phrase: "Proc Natl Acad Sci U S A89"

Phrase: ":"

Phrase: "1189111894,"

Phrase: "1992"

